Disease of genetic or genomic mechanism
MONDO:7770009A grouping class for human diseases caused by genetic or genomic alterations, including chromosomal abnormalities and heritable mutations.
18379 clinical trials for this condition and its sub-types, 2 tagged with Disease of genetic or genomic mechanism itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Disease of genetic or genomic mechanism
-
Hereditary disease 194 trials · 18,235 incl. sub-types
1,925 sub-types
- Hereditary neurological disease 6 trials · 5,791 incl. sub-types Sub-types →
- Inborn errors of metabolism 48 trials · 2,231 incl. sub-types Sub-types →
- Autosomal genetic disease 0 trials · 1,670 incl. sub-types Sub-types →
- Hereditary disorder of connective tissue 0 trials · 1,314 incl. sub-types Sub-types →
- Inflammatory bowel disease 430 trials · 1,081 incl. sub-types Sub-types →
- Hereditary skin disorder 7 trials · 885 incl. sub-types Sub-types →
- Immunodeficiency disease 55 trials · 779 incl. sub-types Sub-types →
- Hereditary neoplastic syndrome 60 trials · 731 incl. sub-types Sub-types →
- Skeletal dysplasia 1 trial · 663 incl. sub-types Sub-types →
- Cardiogenetic disease 3 trials · 618 incl. sub-types Sub-types →
- Inherited hemoglobinopathy 38 trials · 440 incl. sub-types Sub-types →
- COPD, severe early onset 406 trials
- Hereditary skeletal muscle disorder 1 trial · 406 incl. sub-types Sub-types →
- X-linked disease 19 trials · 327 incl. sub-types Sub-types →
- Inherited blood coagulation disorder 8 trials · 323 incl. sub-types Sub-types →
- Hereditary dementia 2 trials · 322 incl. sub-types Sub-types →
- Inherited kidney disorder 1 trial · 317 incl. sub-types Sub-types →
- Cataract 294 trials · 305 incl. sub-types Sub-types →
- Myopia 259 trials · 274 incl. sub-types Sub-types →
- Preeclampsia 232 trials · 236 incl. sub-types Sub-types →
- Burkitt lymphoma 221 trials Sub-types →
- Gastroesophageal reflux disease 217 trials Sub-types →
- Intervertebral disk degenerative disorder 123 trials · 217 incl. sub-types Sub-types →
- Polycystic ovary syndrome 201 trials
- Classic Hodgkin lymphoma 147 trials · 149 incl. sub-types Sub-types →
- Ewing sarcoma 125 trials · 126 incl. sub-types Sub-types →
- Bronchiectasis 119 trials · 120 incl. sub-types Sub-types →
- Inherited auditory system disease 0 trials · 120 incl. sub-types Sub-types →
- Hereditary otorhinolaryngologic disease 0 trials · 102 incl. sub-types Sub-types →
- Osteonecrosis of genetic origin 0 trials · 102 incl. sub-types Sub-types →
- RASopathy 9 trials · 101 incl. sub-types Sub-types →
- Hypogonadotropic hypogonadism 19 trials · 100 incl. sub-types Sub-types →
- Lymphoproliferative syndrome 70 trials · 100 incl. sub-types Sub-types →
- Gastrointestinal stromal tumor 93 trials
- Familial polycythemia 1 trial · 92 incl. sub-types Sub-types →
- Familial colorectal cancer 3 trials · 91 incl. sub-types Sub-types →
- Celiac disease 81 trials Sub-types →
- Cirrhosis, familial 4 trials · 79 incl. sub-types Sub-types →
- Spondylolisthesis 77 trials Sub-types →
- Orofacial cleft 4 trials · 69 incl. sub-types Sub-types →
- Developmental dysplasia of the hip 62 trials Sub-types →
- Keratoconus 61 trials Sub-types →
- Anodontia 59 trials Sub-types →
- Enterocolitis 3 trials · 58 incl. sub-types Sub-types →
- Lymphatic malformation 17 trials · 56 incl. sub-types Sub-types →
- Inherited aplastic anemia 2 trials · 53 incl. sub-types Sub-types →
- Synovial sarcoma 53 trials Sub-types →
- Hereditary glaucoma 0 trials · 50 incl. sub-types Sub-types →
- Ciliopathy 2 trials · 49 incl. sub-types Sub-types →
- Bone marrow failure syndrome 48 trials Sub-types →
- Inherited primary ovarian failure 2 trials · 48 incl. sub-types Sub-types →
- Ehlers-Danlos syndrome 20 trials · 46 incl. sub-types Sub-types →
- Malocclusion due to protuberant upper front teeth 41 trials
- Craniosynostosis 17 trials · 39 incl. sub-types Sub-types →
- Chronic granulomatous disease 37 trials Sub-types →
- Hereditary hyperparathyroidism 1 trial · 35 incl. sub-types Sub-types →
- Hypospadias 35 trials Sub-types →
- Preterm premature rupture of the membranes 35 trials
- Fragile X syndrome 34 trials Sub-types →
- Fuchs' endothelial dystrophy 33 trials Sub-types →
- Pilonidal sinus 33 trials
- Spondylosis, cervical 33 trials
- Arteriovenous malformations of the brain 32 trials
- MALT lymphoma 30 trials · 31 incl. sub-types Sub-types →
- Deafness, unilateral 30 trials
- Hirschsprung disease 29 trials
- Inherited thrombocytopenia 2 trials · 29 incl. sub-types Sub-types →
- Pathological gambling 28 trials
- Familial hemolytic anemia 4 trials · 27 incl. sub-types Sub-types →
- Hereditary hypoparathyroidism 0 trials · 26 incl. sub-types Sub-types →
- Inherited bleeding disorder, platelet-type 6 trials · 26 incl. sub-types Sub-types →
- Laminopathy 4 trials · 26 incl. sub-types Sub-types →
- Oculocerebral hypopigmentation syndrome of Preus 26 trials
- Syncope, familial vasovagal 26 trials
- Hypogonadism, male 24 trials
- Diastasis recti and weakness of the linea alba 23 trials
- Trigger thumb 23 trials
- Speech-sound disorder 22 trials
- Tooth agenesis 22 trials Sub-types →
- Anterior segment dysgenesis 2 trials · 21 incl. sub-types Sub-types →
- Alveolar soft part sarcoma 20 trials Sub-types →
- Pectus excavatum 20 trials
- Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 16 trials · 19 incl. sub-types Sub-types →
- Familial clubfoot with or without associated lower limb anomalies 0 trials · 18 incl. sub-types Sub-types →
- Hereditary hypophosphatemic rickets 1 trial · 18 incl. sub-types Sub-types →
- Familial osteosclerosis 0 trials · 16 incl. sub-types Sub-types →
- Hereditary hemophagocytic lymphohistiocytosis 8 trials · 16 incl. sub-types Sub-types →
- Familial nonmedullary thyroid carcinoma 3 trials · 15 incl. sub-types Sub-types →
- Arts syndrome 14 trials
- Chiari malformation 13 trials · 14 incl. sub-types Sub-types →
- Klippel-Feil syndrome 14 trials Sub-types →
- Cryptorchidism 14 trials Sub-types →
- Essential hypertension, genetic 14 trials
- Periodontitis, chronic, adult 14 trials
- Pregnancy loss, recurrent, 4 14 trials
- Visceral leishmaniasis 14 trials
- Aorta coarctation 13 trials Sub-types →
- Familial spontaneous pneumothorax 13 trials
- Hereditary anemia 2 trials · 13 incl. sub-types Sub-types →
- SMAD6-related disease 0 trials · 12 incl. sub-types Sub-types →
- Familial thoracic aortic aneurysm and aortic dissection 11 trials · 12 incl. sub-types Sub-types →
- Ovarian hyperstimulation syndrome 12 trials
- Pleomorphic adenoma 12 trials
- Spermatogenic failure 1 trial · 12 incl. sub-types Sub-types →
- CDKL5 disorder 8 trials · 11 incl. sub-types Sub-types →
- CGF1 11 trials
- Ankyloglossia 11 trials
- Familial long QT syndrome 1 trial · 11 incl. sub-types Sub-types →
- Heritable pulmonary arterial hypertension 10 trials · 11 incl. sub-types Sub-types →
- Inherited interstitial lung disease 5 trials · 11 incl. sub-types Sub-types →
- Parasomnia, sleep bruxism type 11 trials
- Progeroid syndrome 3 trials · 11 incl. sub-types Sub-types →
- Syndromic microphthalmia 0 trials · 11 incl. sub-types Sub-types →
- Tardive dyskinesia 11 trials
- Thyroid Hurthle cell carcinoma 11 trials
- Trichotillomania 11 trials
- Phelan-McDermid syndrome 10 trials Sub-types →
- Raynaud disease 10 trials
- Arthritis, sacroiliac 10 trials
- Bile duct cyst 10 trials
- Central precocious puberty 9 trials · 10 incl. sub-types Sub-types →
- Erythromelalgia 3 trials · 10 incl. sub-types Sub-types →
- Fibrodysplasia ossificans progressiva 10 trials
- Hereditary breast carcinoma 10 trials Sub-types →
- Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome 10 trials
- Multinodular goiter 10 trials Sub-types →
- Myostatin-related muscle hypertrophy 10 trials
- IgE responsiveness, atopic 9 trials
- Familial pancreatic carcinoma 9 trials
- Immunodeficiency 32B 9 trials
- Impacted teeth, multiple 9 trials
- Inherited obesity 8 trials · 9 incl. sub-types Sub-types →
- Neuropathy, painful 9 trials
- Obesity-hypoventilation syndrome 9 trials
- Peripheral arterial occlusive disease 1 9 trials
- Polydactyly 2 trials · 9 incl. sub-types Sub-types →
- Syndactyly 3 trials · 9 incl. sub-types Sub-types →
- Central centrifugal cicatricial alopecia 8 trials
- Familial ovarian cancer 1 trial · 8 incl. sub-types Sub-types →
- Hyperhidrosis palmaris ET plantaris 8 trials
- Lower urinary tract obstruction, congenital 8 trials
- Masticatory muscles, hypertrophy of 8 trials
- Severe congenital neutropenia 5 trials · 8 incl. sub-types Sub-types →
- Spondylocostal dysostosis 5 trials · 8 incl. sub-types Sub-types →
- Van der Woude syndrome 8 trials Sub-types →
- Silver-Russell syndrome 7 trials Sub-types →
- Amelogenesis imperfecta 3 trials · 7 incl. sub-types Sub-types →
- Arterial calcification of infancy 7 trials Sub-types →
- Extraskeletal myxoid chondrosarcoma 7 trials Sub-types →
- Febrile seizures, familial 4 trials · 7 incl. sub-types Sub-types →
- Inherited sideroblastic anemia 2 trials · 7 incl. sub-types Sub-types →
- Malposition of teeth with or without hypodontia/oligodontia 7 trials
- Protein-losing enteropathy 7 trials
- Spermatic cord torsion 7 trials
- CSF1R-related disorder 0 trials · 6 incl. sub-types Sub-types →
- DICER1-related tumor predisposition 1 trial · 6 incl. sub-types Sub-types →
- Angioosteohypertrophic syndrome 6 trials
- Bundle branch block, familial isolated complete right 6 trials
- Channelopathy-associated congenital insensitivity to pain, autosomal recessive 6 trials
- Familial isolated congenital asplenia 6 trials
- Fibromuscular dysplasia 6 trials Sub-types →
- Hereditary chronic pancreatitis 6 trials Sub-types →
- Hereditary gastric cancer 1 trial · 6 incl. sub-types Sub-types →
- Hereditary pulmonary alveolar proteinosis 3 trials · 6 incl. sub-types Sub-types →
- Hypotrichosis 5 trials · 6 incl. sub-types Sub-types →
- Laryngeal adductor paralysis 6 trials
- Leukoencephalopathy, hereditary diffuse, with spheroids 1 trial · 6 incl. sub-types Sub-types →
- Periodontitis, aggressive 4 trials · 6 incl. sub-types Sub-types →
- Sclerosteosis 6 trials Sub-types →
- Uterine anomalies 6 trials
- COL4A1/A2-related disorder 2 trials · 5 incl. sub-types Sub-types →
- Cornelia de Lange syndrome 4 trials · 5 incl. sub-types Sub-types →
- Central hypoventilation syndrome, congenital 0 trials · 5 incl. sub-types Sub-types →
- Congenital diarrhea 0 trials · 5 incl. sub-types Sub-types →
- Hereditary Wilms tumor 1 trial · 5 incl. sub-types Sub-types →
- Hereditary narcolepsy 0 trials · 5 incl. sub-types Sub-types →
- Hydatidiform mole 3 trials · 5 incl. sub-types Sub-types →
- Oculoauriculovertebral spectrum with radial defects 0 trials · 5 incl. sub-types Sub-types →
- Primary failure of tooth eruption 5 trials
- Progesterone resistance 5 trials
- Pulmonic stenosis 5 trials
- CTNNB1-related neurodevelopmental disorder and/or vitreoretinopathy 3 trials · 4 incl. sub-types Sub-types →
- WHIM syndrome 4 trials Sub-types →
- Alopecia universalis 4 trials
- Asthma, nasal polyps, and aspirin intolerance 4 trials
- Bile acid malabsorption, primary, 1 4 trials
- Diastema, dental medial 4 trials
- Familial juvenile hypertrophy of the breast 4 trials
- Fetal and neonatal alloimmune thrombocytopenia 4 trials Sub-types →
- Global developmental delay with or without impaired intellectual development 4 trials
- Growth delay due to insulin-like growth factor I resistance 4 trials
- Hernia, double inguinal 4 trials
- Hyperreflexia 4 trials
- Low density lipoprotein cholesterol, mild elevation of 4 trials
- Parathyroid gland carcinoma 4 trials
- Prostate cancer, hereditary 1 trial · 4 incl. sub-types Sub-types →
- Pulmonary atresia-intact ventricular septum syndrome 4 trials
- Urinary bladder, atony of 4 trials
- Volvulus of midgut 4 trials Sub-types →
- 7q11.23 microduplication syndrome 3 trials Sub-types →
- AP-4 deficiency syndrome 0 trials · 3 incl. sub-types Sub-types →
- Cushing syndrome due to macronodular adrenal hyperplasia 3 trials Sub-types →
- Pitt-Hopkins or Pitt-Hopkins-like syndrome 0 trials · 3 incl. sub-types Sub-types →
- Protrusio acetabuli 3 trials
- Capillary malformation-arteriovenous malformation syndrome 3 trials Sub-types →
- Delayed puberty, self-limited 3 trials
- Distal arthrogryposis 0 trials · 3 incl. sub-types Sub-types →
- Ear malformation 3 trials Sub-types →
- Epithelial-stromal TGFBI dystrophy 1 trial · 3 incl. sub-types Sub-types →
- Fibrinolytic defect 3 trials
- Genu valgum, st. Helena familial 3 trials
- Hematuria, benign familial 3 trials Sub-types →
- Lethal congenital contracture syndrome 0 trials · 3 incl. sub-types Sub-types →
- Patella, familial recurrent dislocation of 3 trials
- Pigment dispersion syndrome 3 trials
- Popliteal cyst 3 trials
- Portal hypertension, noncirrhotic 3 trials Sub-types →
- Retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and migraine headache syndrome 3 trials
- Spatial visualization, aptitude for 3 trials
- Striae distensae, familial 3 trials
- Tooth ankylosis 3 trials
- Achoo syndrome 2 trials
- Kabuki syndrome 2 trials Sub-types →
- Kasabach-Merritt syndrome 2 trials
- POLR3A-related disorder 0 trials · 2 incl. sub-types Sub-types →
- Pseudofolliculitis barbae 2 trials
- Young syndrome 2 trials
- Alcohol sensitivity, acute 2 trials
- Androgen insensitivity syndrome 1 trial · 2 incl. sub-types Sub-types →
- Anisomastia 2 trials
- Arthrogryposis multiplex congenita 1 trial · 2 incl. sub-types Sub-types →
- Arthropathy, erosive 2 trials
- Atrichia with papular lesions 2 trials
- Autoimmune disease, multisystem, infantile-onset 0 trials · 2 incl. sub-types Sub-types →
- Bone Paget disease 2 trials Sub-types →
- Breath-holding Spells 2 trials
- Capillary infantile hemangioma 2 trials
- Cardiac valvular defect 2 trials Sub-types →
- Celiac trunk compression syndrome 2 trials
- Congenital hereditary endothelial dystrophy of cornea 2 trials
- Congenital pseudoarthrosis of the limbs 1 trial · 2 incl. sub-types Sub-types →
- Cornea plana 0 trials · 2 incl. sub-types Sub-types →
- Cystic disease of lung 2 trials
- Dementia/parkinsonism with non-Alzheimer amyloid plaques 2 trials
- Dyskinesia with orofacial involvement 1 trial · 2 incl. sub-types Sub-types →
- Expansile bone lesions 2 trials
- Familial abdominal aortic aneurysm 0 trials · 2 incl. sub-types Sub-types →
- Familial hyperaldosteronism 0 trials · 2 incl. sub-types Sub-types →
- Familial thrombocytosis 2 trials Sub-types →
- Grouped pigmentation of the retina 2 trials
- Hereditary gingival fibromatosis 0 trials · 2 incl. sub-types Sub-types →
- Histiocytoma, Angiomatoid fibrous 2 trials
- Inherited cutis laxa 0 trials · 2 incl. sub-types Sub-types →
- Inosine triphosphatase deficiency 2 trials
- Insect Stings, hypersensitivity to 2 trials
- Insulin-resistance syndrome type A 2 trials
- Intussusception 2 trials
- Islet cell adenomatosis 0 trials · 2 incl. sub-types Sub-types →
- Juvenile arthritis due to defect in LACC1 2 trials
- Kyphoscoliosis 1 2 trials
- Multisystemic smooth muscle dysfunction syndrome 2 trials Sub-types →
- Muscular hypertonia, lethal 2 trials
- Myelodysplastic syndrome associated with isolated del(5q) 2 trials
- Nose, anomalous shape of 2 trials
- Platelet aggregation, spontaneous 2 trials
- Portal vein, cavernous transformation of 2 trials
- Primary pigmented nodular adrenocortical disease 2 trials Sub-types →
- Ragweed sensitivity 2 trials
- Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome 2 trials
- Teeth, supernumerary 2 trials
- 17q11.2 microduplication syndrome 1 trial
- A20 haploinsufficiency 1 trial
- ACAN-related short stature spectrum 0 trials · 1 incl. sub-types Sub-types →
- Axenfeld-Rieger syndrome 1 trial Sub-types →
- BENTA disease 1 trial
- CACNA1C-related disorder 0 trials · 1 incl. sub-types Sub-types →
- CFTR-related disorder 1 trial Sub-types →
- Caroli syndrome 1 trial
- Caronte 1 trial
- Charcot-Marie-Tooth disease-hearing loss-intellectual disability syndrome 1 trial
- Chopra-Amiel-Gordon syndrome 1 trial
- Coffin-Siris syndrome 1 trial Sub-types →
- Congenital adrenal insufficiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency 1 trial
- DHDDS-CDG 1 trial Sub-types →
- ELANE-related neutropenia 0 trials · 1 incl. sub-types Sub-types →
- Koolen-de Vries syndrome 1 trial Sub-types →
- L-ferritin deficiency 1 trial
- Mazabraud syndrome 1 trial
- Mendelian encephalopathy 0 trials · 1 incl. sub-types Sub-types →
- NKX2-1 related choreoathetosis and congenital hypothyroidism with or without pulmonary dysfunction 0 trials · 1 incl. sub-types Sub-types →
- PLEC-related muscular dystrophy-epidermolysis bullosa simplex spectrum disorder 0 trials · 1 incl. sub-types Sub-types →
- Potocki-Lupski syndrome 1 trial
- RNU4ATAC spectrum disorder 1 trial Sub-types →
- Rombo syndrome 1 trial
- Shashi-Pena syndrome 1 trial
- Snijders Blok-Campeau syndrome 1 trial
- TOR1AIP1-related nuclear envelopathy 0 trials · 1 incl. sub-types Sub-types →
- Taqi polymorphism 1 trial
- WFS1-related disorder 0 trials · 1 incl. sub-types Sub-types →
- X-linked dominant chondrodysplasia, Chassaing-Lacombe type 1 trial
- Y-linked disease 0 trials · 1 incl. sub-types Sub-types →
- Yao syndrome 1 trial
- Acrofacial dysostosis 0 trials · 1 incl. sub-types Sub-types →
- Aganglionosis, total intestinal 1 trial
- Anisocoria 1 trial
- Arcus senilis 1 trial
- Autoinflammatory-pancytopenia syndrome due to DNASE2 deficiency 1 trial
- Beta-aminoisobutyric acid, urinary excretion of 1 trial
- Central areolar choroidal dystrophy 1 trial Sub-types →
- Chromosome 15q24 deletion syndrome 1 trial
- Congenital bilateral absence of vas deferens 1 trial Sub-types →
- Congenital insensitivity to pain syndrome, Marsili type 1 trial
- Contractures, pterygia, and variable skeletal fusions syndrome 0 trials · 1 incl. sub-types Sub-types →
- Coracoclavicular joint, anomalous 1 trial
- Coxa vara 1 trial
- Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy 1 trial
- Dysautonomia-like disorder 1 trial
- Early repolarization associated with ventricular fibrillation 1 trial
- Electroencephalographic peculiarity: fronto-precentral beta wave groups 1 trial
- Eosinophilia, familial 1 trial
- Epilepsy, early-onset 0 trials · 1 incl. sub-types Sub-types →
- Esophagitis, eosinophilic, 1 1 trial
- Familial male-limited precocious puberty 1 trial
- Familial melanoma 1 trial Sub-types →
- Familial vesicoureteral reflux 0 trials · 1 incl. sub-types Sub-types →
- Fleck corneal dystrophy 1 trial
- Focal dermal hypoplasia 1 trial
- Foveal hypoplasia 1 trial Sub-types →
- Frontonasal dysplasia 1 trial Sub-types →
- Gastrointestinal defect and immunodeficiency syndrome 0 trials · 1 incl. sub-types Sub-types →
- Graying of hair, precocious 1 trial
- Growth delay due to insulin-like growth factor type 1 deficiency 1 trial
- Growth hormone insensitivity syndrome with immune dysregulation 0 trials · 1 incl. sub-types Sub-types →
- Hereditary arterial and articular multiple calcification syndrome 1 trial
- Hereditary gallbladder disorder 0 trials · 1 incl. sub-types Sub-types →
- Horizontal gaze palsy with progressive scoliosis 1 trial Sub-types →
- Hyperpigmentation of eyelid 1 trial
- Hypoparathyroidism-deafness-renal disease syndrome 1 trial
- Hypothyroidism, congenital, nongoitrous 0 trials · 1 incl. sub-types Sub-types →
- Ichthyosis prematurity syndrome 1 trial
- Immunodysregulation with variable immunodeficiency and autoimmunity 1 trial
- Infantile liver failure 0 trials · 1 incl. sub-types Sub-types →
- Isolated congenital breast hypoplasia/aplasia 0 trials · 1 incl. sub-types Sub-types →
- Isolated microphthalmia 0 trials · 1 incl. sub-types Sub-types →
- Levator-medial rectus synkinesis 1 trial
- Lumbar stenosis, familial 1 trial
- Megalodactyly 1 trial
- Microtia with meatal atresia and conductive deafness 1 trial
- Modifier, X-linked, for Neurofunctional defects 1 trial
- Myeloperoxidase deficiency 1 trial
- Nasal alar collapse, bilateral 1 trial
- Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset 0 trials · 1 incl. sub-types Sub-types →
- Neutropenia, chronic familial 1 trial
- Nocturnal enuresis, 2 1 trial
- Nonimmune chronic idiopathic neutropenia of adults 1 trial
- Pancreatic agenesis 0 trials · 1 incl. sub-types Sub-types →
- Papillomatosis, confluent and reticulated 1 trial
- Pernicious anemia 1 trial
- Platelet membrane fluidity 1 trial
- Posterior polymorphous corneal dystrophy 1 trial Sub-types →
- Premature centromere division 1 trial
- Progressive deafness with stapes fixation 1 trial
- Prolactin deficiency, isolated 1 trial
- Pulmonary atresia with ventricular septal defect 1 trial
- Pyropoikilocytosis, hereditary 1 trial
- Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency 1 trial
- Split hand-foot malformation 0 trials · 1 incl. sub-types Sub-types →
- Tarsal coalition 1 trial
- Taurodontism 1 trial
- Trichomegaly 1 trial Sub-types →
- Triphalangeal thumb, Nonopposable 1 trial
- Tune deafness 1 trial
- Urolithiasis, uric acid, autosomal dominant 1 trial
- Visceral heterotaxy 1 trial Sub-types →
- 3MC syndrome 0 trials Sub-types →
- 46,XX sex reversal 1 0 trials
- 46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency 0 trials
- 46,xx sex reversal 5 0 trials
- 5-hydroxytryptamine oxygenase regulator 0 trials
- 6-phosphogluconolactonase deficiency 0 trials
- ACCES syndrome 0 trials
- ACD-related telomere biology disorder 0 trials Sub-types →
- ADNP-related blepharophimosis-intellectual disability syndrome 0 trials
- AKT3-related overgrowth spectrum 0 trials Sub-types →
- Abruzzo-Erickson syndrome 0 trials
- Achard syndrome 0 trials
- Acrodysplasia with ossification abnormalities, short stature, and fibular hypoplasia 0 trials
- Adams-Oliver syndrome 0 trials Sub-types →
- Alazami-Yuan syndrome 0 trials
- Alfadhel syndrome 0 trials
- Alkuraya-Kucinskas syndrome 0 trials
- Amobarbital, deficient N-hydroxylation of 0 trials
- Aphalangy-hemivertebrae-urogenital-intestinal dysgenesis syndrome 0 trials
- Armfield syndrome 0 trials
- Atelis syndrome 0 trials Sub-types →
- Athrombia, essential 0 trials
- Axenfeld-Rieger anomaly with partially absent eye muscles, distinctive face, hydrocephaly, and skeletal abnormalities 0 trials
- Ayme-Gripp syndrome 0 trials
- B-cell immunodeficiency, distal limb anomalies, and urogenital malformations 0 trials
- BAFopathy 0 trials Sub-types →
- BMP4-related ocular growth disorder 0 trials Sub-types →
- Bamforth-Lazarus syndrome 0 trials
- Baralle-Macken syndrome 0 trials
- Basilicata-Akhtar syndrome 0 trials
- Beck-Fahrner syndrome 0 trials
- Birbeck granule deficiency 0 trials
- Boudin-Mortier syndrome 0 trials
- Bowen syndrome of multiple malformations 0 trials
- Brachmann-de Lange-like facial changes with microcephaly, metatarsus adductus, and developmental delay 0 trials
- Brachymetatarsus 4 0 trials
- Brachymorphism-onychodysplasia-dysphalangism syndrome 0 trials
- Braddock-Carey syndrome 0 trials Sub-types →
- Bryant-Li-Bhoj neurodevelopmental syndrome 0 trials Sub-types →
- Buratti-Harel syndrome 0 trials
- CCNK-related neurodevelopmental disorder-severe intellectual disability-facial dysmorphism syndrome 0 trials
- CEBALID syndrome 0 trials
- CHAND syndrome 0 trials
- CLAPO syndrome 0 trials
- CRYAB-related myofibrillar myopathy-cataract-cardiomyopathy spectrum disorder 0 trials Sub-types →
- Camptosynpolydactyly, complex 0 trials
- Car factor deficiency 0 trials
- Carabelli anomaly of maxillary molar teeth 0 trials
- Cardioneuromyopathy with hyaline masses and nemaline rods 0 trials
- Carey-Fineman-Ziter syndrome 0 trials Sub-types →
- Catifa syndrome 0 trials
- Charcot-Marie-Tooth peroneal muscular atrophy, X-linked, with aplasia cutis congenita 0 trials
- Chitayat syndrome 0 trials
- Chondronectin 0 trials
- Christianson syndrome 0 trials
- Chudley-McCullough syndrome 0 trials
- Cohen-Gibson syndrome 0 trials
- Crane-Heise syndrome 0 trials
- Cree intellectual disability syndrome 0 trials
- DEGCAGS syndrome 0 trials
- DNA, low-repetitive sequences of 0 trials
- DNA, satellite, 3 0 trials
- DONSON-related microcephaly-short stature-limb abnormalities spectrum 0 trials
- DOORS syndrome 0 trials
- Darwinian tubercle of pinna 0 trials
- Dauwerse-Peters syndrome 0 trials
- DeSanto-Shinawi syndrome due to WAC point mutation 0 trials
- Devriendt syndrome 0 trials
- Diamond-Blackfan anemia-like 0 trials
- Diets-Jongmans syndrome 0 trials
- Dohle bodies and leukemia 0 trials
- Dursun syndrome 0 trials
- Dyserythropoiesis, congenital, with ultrastructurally normal erythroblast heterochromatin 0 trials
- EDICT syndrome 0 trials
- EN1-related dorsoventral syndrome 0 trials Sub-types →
- EPHB4-associated vascular malformation spectrum 0 trials Sub-types →
- Elsahy-Waters syndrome 0 trials
- Emanuel syndrome 0 trials
- Eosinophilopenia 0 trials
- FDXR-related optic atrophy mitochondrial dysfunction syndrome 0 trials Sub-types →
- FG syndrome 0 trials Sub-types →
- FICUS syndrome 0 trials
- FRAXD syndrome 0 trials
- FRAXF syndrome 0 trials
- Fanconi-like syndrome 0 trials Sub-types →
- Faundes-Banka syndrome 0 trials
- Fliedner-Zweier syndrome 0 trials
- Floating-Harbor syndrome 0 trials
- Fowler syndrome 0 trials
- Fraser-like syndrome 0 trials
- Freesia Flowers, inability to smell 0 trials
- Friedreich ataxia and congenital glaucoma 0 trials
- Friedreich ataxia, so-called, with optic atrophy and sensorineural deafness 0 trials
- GATA1-Related X-Linked Cytopenia 0 trials Sub-types →
- GCGR-related hyperglucagonemia 0 trials
- GOMBO syndrome 0 trials
- GRACILE syndrome 0 trials
- Gabriele de Vries syndrome 0 trials
- Gamstorp-Wohlfart syndrome 0 trials
- Giacheti syndrome 0 trials
- Glucoglycinuria 0 trials
- Goldberg-Shprintzen syndrome 0 trials
- Grant syndrome 0 trials
- Guillouet-Gordon syndrome 0 trials
- Guttmacher syndrome 0 trials
- Halothane hepatitis 0 trials
- Hengel-Maroofian-Schols syndrome 0 trials
- Heyn-Sproul-Jackson syndrome 0 trials
- Hhhh syndrome 0 trials
- Hirschsprung disease with heart defects, laryngeal anomalies, and preaxial polydactyly 0 trials
- Hirschsprung disease with ulnar polydactyly, polysyndactyly of big toes, and ventricular septal defect 0 trials
- Hirschsprung disease, cardiac defects, and autonomic dysfunction 0 trials
- Hooft disease 0 trials
- Houge-Janssens syndrome 0 trials Sub-types →
- Hoxha-Aliu syndrome 0 trials
- Hunter-Macdonald syndrome 0 trials
- Huppke-Brendel syndrome 0 trials
- Hutterite cerebroosteonephrodysplasia syndrome 0 trials
- ICHAD syndrome 0 trials
- IVIC syndrome 0 trials
- Imagawa-Matsumoto syndrome 0 trials
- Jaberi-Elahi syndrome 0 trials
- Jalili syndrome 0 trials
- Jawad syndrome 0 trials
- Juberg-Hayward syndrome 0 trials
- Jumping Frenchmen of Maine 0 trials
- KLHL7-related Bohring-Opitz-like syndrome 0 trials
- Kallmann syndrome with spastic paraplegia 0 trials
- Karsch-Neugebauer syndrome 0 trials
- Kaya-Barakat-Masson syndrome 0 trials
- Keipert syndrome 0 trials
- Khan-Khan-Katsanis syndrome 0 trials
- Kifafa seizure disorder 0 trials
- Kleefstra syndrome 0 trials Sub-types →
- Kniest-like dysplasia with pursed lips and ectopia lentis 0 trials
- Kohlschutter-Tonz syndrome-like 0 trials
- Kury-Isidor syndrome 0 trials
- Kyrle disease 0 trials
- LTBP2-related ocular dysgenesis 0 trials Sub-types →
- Lamb-Shaffer syndrome 0 trials
- Lambotte syndrome 0 trials
- Lessel-Kreienkamp syndrome 0 trials
- Leydig cell hypoplasia, type 1 0 trials Sub-types →
- Li-Campeau syndrome 0 trials
- Li-Ghorbani-Weisz-Hubshman syndrome 0 trials
- Liang-Wang syndrome 0 trials
- Liberfarb syndrome 0 trials
- Lisch epithelial corneal dystrophy 0 trials
- Long-Olsen-Distelmaier syndrome 0 trials
- Lopes-Maciel-Rodan syndrome 0 trials
- Lui-Jee-Baron syndrome 0 trials
- Luo-Schoch-Yamamoto syndrome 0 trials
- Luscan-Lumish syndrome 0 trials
- MECOM-associated syndrome 0 trials Sub-types →
- MIRAGE syndrome 0 trials
- MOMO syndrome 0 trials
- MORM syndrome 0 trials
- MTOR-related overgrowth spectrum 0 trials
- Malan overgrowth syndrome 0 trials
- Mammastatin 0 trials
- Marinesco-Sjogren-like syndrome 0 trials
- Martinez-Frias syndrome 0 trials
- Meacham syndrome 0 trials
- Meckel diverticulum 0 trials
- Meesmann corneal dystrophy 0 trials Sub-types →
- Meester-Loeys syndrome 0 trials
- Megarbane syndrome 0 trials
- Megarbane-Jalkh syndrome 0 trials
- Melhem-Fahl syndrome 0 trials
- Menke-Hennekam syndrome 0 trials Sub-types →
- Monophalangy of great toe 0 trials
- Moynahan syndrome 0 trials
- Muggenthaler-Chowdhury-Chioza syndrome 0 trials
- Mullegama-Klein-Martinez syndrome 0 trials
- Mungan syndrome 0 trials
- N-acetylaspartate deficiency 0 trials
- NDUFB11-related disorders 0 trials Sub-types →
- NR2F2 related multiple congenital anomalies/dysmorphic syndrome 0 trials
- NR5A1-related sex development disorder 0 trials Sub-types →
- Nance-Horan syndrome 0 trials
- Nguyen syndrome 0 trials
- Nizon-Isidor syndrome 0 trials
- O'Donnell-Luria-Rodan syndrome 0 trials
- Okt4 epitope deficiency 0 trials
- Onychotrichodysplasia and neutropenia 0 trials
- Opitz G/BBB syndrome 0 trials Sub-types →
- Opticocochleodentate degeneration 0 trials
- Oroacral syndrome, Verloes-Koulischer type 0 trials
- Osebold skeletal dysplasia/osteolysis syndrome 0 trials
- PI4KA-related disorder 0 trials Sub-types →
- PIK3R1-related immunodeficiency and SHORT syndrome 0 trials Sub-types →
- PMP22-RAI1 contiguous gene duplication syndrome 0 trials
- POLR1C-related disorder 0 trials Sub-types →
- POLR3B-related disorder 0 trials Sub-types →
- PR interval, variation in 0 trials
- Paine syndrome 0 trials
- Pan-Chung-Bellen syndrome 0 trials
- Paramolar tubercle of bolk 0 trials
- Parotidomegaly, hereditary bilateral 0 trials
- Partington-Anderson syndrome 0 trials
- Passovoy factor defect 0 trials
- Pechet factor deficiency 0 trials
- Perlman syndrome 0 trials
- Pierre Robin syndrome-faciodigital anomaly syndrome 0 trials
- Pilotto syndrome 0 trials
- Polyosteolysis-hyperostosis syndrome 0 trials
- Prepapillary vascular loops 0 trials
- Primrose syndrome 0 trials
- Pseudoatrophoderma colli 0 trials
- Pseudopili annulati 0 trials
- Pseudouridinuria and mental defect 0 trials
- Rabin-Pappas syndrome 0 trials
- Rabson-Mendenhall syndrome 0 trials
- Radio-Tartaglia syndrome 0 trials
- Rahman syndrome 0 trials
- Ramon syndrome 0 trials
- Rauch-Steindl syndrome 0 trials
- Reese retinal dysplasia 0 trials
- Reynolds syndrome 0 trials
- Robin sequence-oligodactyly syndrome 0 trials
- Robinow-Sorauf syndrome 0 trials
- Roussy-Levy syndrome 0 trials
- Rowley-Rosenberg syndrome 0 trials
- SEC61A1 deficiency 0 trials Sub-types →
- STAD syndrome 0 trials
- SYCE1-related gametogenic failure 0 trials Sub-types →
- Sabinas brittle hair syndrome 0 trials
- Sakoda complex 0 trials
- Santos syndrome 0 trials
- Schnyder corneal dystrophy 0 trials
- Sener syndrome 0 trials
- Short stature, Dauber-Argente type 0 trials
- Shukla-Vernon syndrome 0 trials
- Siddiqi syndrome 0 trials
- Sifrim-Hitz-Weiss syndrome 0 trials
- Simpson-Golabi-Behmel syndrome type 1 0 trials
- Simpson-Golabi-Behmel syndrome type 2 0 trials
- Sjogren-Larsson-like ichthyosis without CNS or eye involvement 0 trials
- Skraban-Deardorff syndrome 0 trials
- Somatomedin, embryonic 0 trials
- Spondylospinal thoracic dysostosis 0 trials
- Stargardt macular degeneration, absent or hypoplastic corpus callosum, intellectual disability, and dysmorphic features 0 trials
- Stevenson-Carey syndrome 0 trials
- Stuve-Wiedemann syndrome 0 trials Sub-types →
- Suleiman-El-Hattab syndrome 0 trials
- Sweeney-Cox syndrome 0 trials
- T-cell Subgroups, non-HLA-linked 0 trials
- T-cell immunodeficiency with epidermodysplasia verruciformis 0 trials
- T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant 0 trials
- T-substance anomaly 0 trials
- THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome 0 trials
- TP63-related ectodermal dysplasia spectrum with limb and orofacial malformations 0 trials Sub-types →
- TPM4-related platelet disorder 0 trials
- TRAF3 haploinsufficiency 0 trials
- Tan-Almurshedi syndrome 0 trials
- Tayoun-Maawali syndrome 0 trials
- Teebi hypertelorism syndrome 0 trials Sub-types →
- Tenorio syndrome 0 trials
- Tented eyebrows 0 trials
- Tessadori-Van-Haaften neurodevelopmental syndrome 0 trials Sub-types →
- Thai symphalangism syndrome 0 trials
- Tn polyagglutination syndrome 0 trials
- Tolchin-Le Caignec syndrome 0 trials
- Tonoki syndrome 0 trials
- Tristichiasis 0 trials
- Tryptophanuria with dwarfism 0 trials
- Tuftsin deficiency 0 trials
- Tyrosinosis 0 trials
- Undritz anomaly 0 trials
- Upington disease 0 trials
- Usher syndrome, type 1M 0 trials
- Usmani-Riazuddin syndrome, autosomal dominant 0 trials
- Usmani-Riazuddin syndrome, autosomal recessive 0 trials
- VACTERL association, X-linked, with or without hydrocephalus 0 trials
- VISS syndrome 0 trials
- Valinemia 0 trials
- Ververi-Brady syndrome 0 trials Sub-types →
- Vissers-Bodmer syndrome 0 trials
- Warsaw breakage syndrome 0 trials
- Webb-Dattani syndrome 0 trials
- Weyers ulnar ray/oligodactyly syndrome 0 trials
- White-Kernohan syndrome 0 trials
- Wiedemann-Steiner syndrome 0 trials
- Wolfram syndrome 2 0 trials
- Woronets trait 0 trials
- X inactivation, familial skewed 0 trials Sub-types →
- X-linked complicated corpus callosum dysgenesis 0 trials
- Y chromosome infertility due to DAZ1 deletion 0 trials
- Yuksel-Vogel-Bauer syndrome 0 trials
- ZTTK syndrome 0 trials
- Zaki syndrome 0 trials
- Zimmermann-Laband syndrome 0 trials Sub-types →
- Ablepharon macrostomia syndrome 0 trials
- Absence deformity of leg-cataract syndrome 0 trials
- Absent radius-anogenital anomalies syndrome 0 trials
- Acetyl-CoA acetyltransferase-2 deficiency 0 trials
- Acetyl-coa carboxylase deficiency 0 trials
- Acetylation, slow 0 trials
- Achalasia, familial esophageal 0 trials
- Acinar dysplasia caused by mutation in FGF10 0 trials
- Acinar dysplasia caused by mutation in FGFR2 0 trials
- Acinar dysplasia caused by mutation in TBX4 0 trials
- Acroleukopathy, symmetric 0 trials
- Acromegaloid changes, cutis verticis gyrata, and corneal leukoma 0 trials
- Acromegaloid features, overgrowth, cleft palate, and hernia 0 trials
- Acromial dimples 0 trials
- Acroosteolysis-keloid-like lesions-premature aging syndrome 0 trials
- Acute insulin response 0 trials
- Adenosine triphosphatase deficiency, anemia due to 0 trials
- Advanced sleep phase syndrome 0 trials Sub-types →
- Agenesis of cerebral white matter 0 trials
- Agenesis of corpus callosum, cardiac, ocular, and genital syndrome 0 trials
- Agenesis of the corpus callosum and congenital lymphedema 0 trials
- Agnathia-otocephaly complex 0 trials
- Alar cleft, isolated 0 trials
- Alopecia - intellectual disability syndrome 0 trials Sub-types →
- Alopecia universalis congenita, 10Y gonadal dysgenesis, and laryngomalacia 0 trials
- Alopecia-epilepsy-pyorrhea-intellectual disability syndrome 0 trials
- Alpha-thalassemia-myelodysplastic syndrome 0 trials
- Amastia, bilateral, with ureteral triplication and dysmorphism 0 trials
- Amegakaryocytic thrombocytopenia, congenital, 2 0 trials
- Amelia and terminal transverse hemimelia 0 trials
- Amelia cleft lip palate hydrocephalus iris coloboma 0 trials
- Amenorrhea-galactorrhea syndrome 0 trials
- Amino aciduria with mental deficiency, dwarfism, muscular dystrophy, osteoporosis, and acidosis 0 trials
- Amyloidosis of gingiva and conjunctiva, with intellectual disability 0 trials
- Amyloidosis, cutaneous bullous 0 trials
- Amyotonia congenita 0 trials
- Amyotrophic dystonic paraplegia 0 trials
- Anal sphincter dysplasia 0 trials
- Anal sphincter myopathy, internal 0 trials
- Anemia, congenital hypoplastic, with multiple congenital anomalies/intellectual disability syndrome 0 trials
- Anemia, hypochromic microcytic with iron overload 0 trials Sub-types →
- Angiokeratoma corporis diffusum with arteriovenous fistulas 0 trials
- Angiomatosis, diffuse Corticomeningeal, of Divry and van Bogaert 0 trials
- Anhaptoglobinemia 0 trials
- Aniridia - intellectual disability syndrome 0 trials
- Aniridia, microcornea, and spontaneously Reabsorbed cataract 0 trials
- Aniridia-absent patella syndrome 0 trials
- Aniridia-renal agenesis-psychomotor retardation syndrome 0 trials
- Annular erythema 0 trials
- Anonychia-ectrodactyly 0 trials
- Anonychia-onychodystrophy with brachydactyly type b and ectrodactyly 0 trials
- Anosmia for isobutyric acid 0 trials
- Anterior chamber cleavage disorder, cerebellar hypoplasia, hypothyroidism, and tracheal stenosis 0 trials
- Antigen defined by monoclonal antibody Aj9 0 trials
- Antigen defined by monoclonal antibody T87 0 trials
- Antithrombin, familial hemorrhagic diathesis due to 0 trials
- Aortic arch interruption, facial palsy, and retinal coloboma 0 trials
- Aplasia of lacrimal and salivary glands 0 trials
- Apraxia of eyelid opening 0 trials
- Ariboflavinosis 0 trials Sub-types →
- Arms, malformation of 0 trials
- Arrhythmogenic cardiomyopathy with variable ectodermal abnormalities 0 trials
- Arteries, anomalies of 0 trials
- Arteriosclerosis, severe juvenile 0 trials
- Arteritis, familial granulomatous, with juvenile polyarthritis 0 trials
- Arthrogryposis multiplex with deafness, inguinal hernias, and early death 0 trials
- Arthrogryposis, Perthes disease, and upward gaze palsy 0 trials
- Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development 0 trials
- Arthrogryposis, congenital, lower limb, X-linked 0 trials
- Arthrogryposis, distal, with intellectual disability and characteristic facies 0 trials
- Aspirin resistance 0 trials
- Asthma, short stature, and elevated IgA 0 trials
- Asymmetric short stature syndrome 0 trials
- Ataxia with myoclonic epilepsy and presenile dementia 0 trials
- Ataxia, deafness, and cardiomyopathy 0 trials
- Ataxia, intention tremor, and hypotonia syndrome, childhood-onset 0 trials
- Ataxia, spastic, childhood-onset, autosomal recessive, with optic atrophy and intellectual disability 0 trials
- Ataxia-microcephaly-cataract syndrome 0 trials
- Atherosclerosis-deafness-diabetes-epilepsy-nephropathy syndrome 0 trials
- Atonic-astatic syndrome of Foerster 0 trials
- Atrial septal defect, secundum, with various cardiac and Noncardiac defects 0 trials
- Atrophia maculosa varioliformis cutis, familial 0 trials
- Aurocephalosyndactyly 0 trials
- Autoinflammation with arthritis and dyskeratosis 0 trials
- Autoinflammation with arthritis and vasculitis 0 trials
- Autoinflammation with episodic fever and immune dysregulation 0 trials
- Autoinflammation with episodic fever and lymphadenopathy 0 trials
- Autoinflammation with pulmonary and cutaneous vasculitis 0 trials
- Autoinflammation, immune dysregulation, and eosinophilia 0 trials
- Autoinflammation, panniculitis, and dermatosis syndrome 0 trials Sub-types →
- Autosomal dominant deafness - onychodystrophy syndrome 0 trials
- Autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome 0 trials
- Autosomal dominant wooly hair 0 trials
- Autosomal recessive leukoencephalopathy-ischemic stroke-retinitis pigmentosa syndrome 0 trials
- Autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity 0 trials
- Azoospermia, obstructive, with nephrolithiasis 0 trials
- Azotemia, familial 0 trials
- Baculum, congenital absence of 0 trials
- Berry aneurysm, cirrhosis, pulmonary emphysema, and cerebral calcification 0 trials
- Beta-amino acids, renal transport of 0 trials
- Bilateral microtia-deafness-cleft palate syndrome 0 trials
- Bile acid conjugation defect 1 0 trials
- Bile acid malabsorption, primary, 2 0 trials
- Bile and pancreatic ducts, complete absence of 0 trials
- Biliary malformation with renal tubular insufficiency 0 trials
- Biliary, renal, neurologic, and skeletal syndrome 0 trials
- Bipartite talus 0 trials
- Bladder diverticulum 0 trials Sub-types →
- Blepharochalasis, superior 0 trials
- Blepharophimosis - intellectual disability syndrome, SBBYS type 0 trials
- Blepharophimosis-impaired intellectual development syndrome 0 trials
- Blistering, acantholytic, of oral and laryngeal mucosa 0 trials
- Blue nevi, familial multiple 0 trials
- Bone marrow failure and diabetes mellitus syndrome 0 trials
- Bone pain, periodic 0 trials
- Brachial palsy, familial congenital 0 trials
- Brachycephaly, trichomegaly, and developmental delay 0 trials
- Brachydactyly 0 trials Sub-types →
- Brachydactyly, coloboma, and anterior segment dysgenesis 0 trials
- Brachydactyly, intraventricular septal defect, and deafness 0 trials
- Brachydactyly, type A1, with short stature, scoliosis, microcephaly, ptosis, hearing loss, and intellectual disability 0 trials
- Brachydactyly, type A2, with microcephaly 0 trials
- Brachymesomelia-renal syndrome 0 trials
- Brachyphalangy, polydactyly, and tibial aplasia/hypoplasia 0 trials
- Brain malformation renal syndrome 0 trials
- Branchial myoclonus with spastic paraparesis and cerebellar ataxia 0 trials
- Branchiootic syndrome 0 trials Sub-types →
- Broad terminal phalanges, familial 0 trials
- Bronchiectasis and nasal polyposis 0 trials
- Bullous dystrophy, macular type 0 trials
- Butyrylesterase 1 0 trials
- Calcific aortic disease with immunologic abnormalities, familial 0 trials
- Camera-Marugo-Cohen syndrome 0 trials
- Camptodactyly syndrome, Guadalajara 0 trials Sub-types →
- Camptodactyly, myopia, and fibrosis of the medial rectus muscle of eye 0 trials
- Camptodactyly-ichthyosis syndrome 0 trials
- Cancer, familial, with in vitro Radioresistance 0 trials
- Canine teeth, absence of upper permanent 0 trials
- Carboxypeptidase N deficiency 0 trials
- Cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies 0 trials
- Cardiac septal defects with coarctation of the aorta 0 trials
- Cardiac, facial, and digital anomalies with developmental delay 0 trials
- Cardiac-urogenital syndrome 0 trials
- Cardioacrofacial dysplasia 0 trials Sub-types →
- Cardioauditory syndrome of Sanchez Cascos 0 trials
- Cardiofacioneurodevelopmental syndrome 0 trials
- Cardiomyopathy associated with myopathy and sudden death 0 trials
- Cardiomyopathy, fatal fetal, due to myocardial calcification 0 trials
- Cardiomyopathy, infantile hypertrophic 0 trials
- Carnitine acetyltransferase deficiency 0 trials
- Carnitine deficiency, myopathic 0 trials
- Carpal displacement 0 trials
- Cataract, alopecia, oral mucosal disorder, and psoriasis-like syndrome 0 trials
- Cataract, ataxia, short stature, and intellectual disability 0 trials
- Cataract, congenital, with mental impairment and dentate gyrus atrophy 0 trials
- Cataracts, hearing impairment, nephrotic syndrome, and enterocolitis 0 trials Sub-types →
- Caudal duplication 0 trials
- Cavernous hemangiomas of face-supraumbilical midline raphe syndrome 0 trials
- Celiac disease-epilepsy-cerebral calcification syndrome 0 trials
- Central incisors, absence of 0 trials
- Cephalin lipidosis 0 trials
- Cerebellar ataxia and neurosensory deafness 0 trials
- Cerebellar ataxia, benign, with thermoanalgesia 0 trials
- Cerebellar ataxia, brain abnormalities, and cardiac conduction defects 0 trials
- Cerebellar atrophy with seizures and variable developmental delay 0 trials
- Cerebellar atrophy, developmental delay, and seizures 0 trials
- Cerebellar dysfunction, impaired intellectual development, and hypogonadotropic hypogonadism 0 trials
- Cerebellar hypoplasia-intellectual disability-congenital microcephaly-dystonia-anemia-growth retardation syndrome 0 trials
- Cerebellar, ocular, craniofacial, and genital syndrome 0 trials
- Cerebelloparenchymal disorder 0 trials Sub-types →
- Cerebral angiopathy, dysphoric 0 trials
- Cerebral malformation, seizures, hypertrichosis, and overlapping fingers 0 trials
- Cerebral sclerosis, diffuse, scholz type 0 trials
- Cerebrocortical degeneration of infancy 0 trials
- Cervical hypertrichosis with underlying kyphoscoliosis 0 trials
- Cervical rib disease 0 trials
- Cervical ribs, Sprengel anomaly, anal atresia, and urethral obstruction 0 trials
- Cervical vertebrae, agenesis of 0 trials
- Cervical vertebral Bridge 0 trials
- Cervical vertebral dysplasia 0 trials
- Chemodectoma, intraabdominal, with cutaneous angiolipomas 0 trials
- Chloramphenicol toxicity 0 trials
- Choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome 0 trials
- Choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome 0 trials
- Cholestasis with gallstone, ataxia, and visual disturbance 0 trials
- Cholestasis-pigmentary retinopathy-cleft palate syndrome 0 trials
- Cholesteatoma, congenital 0 trials
- Cholesterol pneumonia 0 trials
- Chondrodysplasia-pseudohermaphroditism syndrome 0 trials
- Chondroitin-6-sulfaturia, defective cellular immunity, nephrotic syndrome 0 trials
- Chorea, childhood-onset, with psychomotor retardation 0 trials
- Choroidal osteoma, bilateral 0 trials
- Chromosomal instability with tissue-specific radiosensitivity 0 trials
- Chromosome 16 inversion, 0.45-Mb 0 trials
- Chromosome 18 pericentric inversion 0 trials
- Chromosome 1p32-p31 deletion syndrome 0 trials
- Chromosome 1p35 deletion syndrome 0 trials
- Chromosome 1p36.33 duplication syndrome, atad3 gene cluster, autosomal dominant 0 trials
- Chromosome 4Q32.1-q32.2 triplication syndrome 0 trials
- Chronic atrial and intestinal dysrhythmia 0 trials
- Chronic mast cell leukemia 0 trials
- Circumvallate placenta syndrome 0 trials
- Citrulline transport defect 0 trials
- Clavicular hypoplasia, zygomatic arch hypoplasia, and micrognathia 0 trials
- Cleft palate, midfacial hypoplasia, triangular facies, and sensorineural hearing loss 0 trials
- Cleft palate, proliferative retinopathy, and developmental delay 0 trials
- Cleft palate-large ears-small head syndrome 0 trials
- Cocoon syndrome 0 trials
- Cognitive impairment with or without cerebellar ataxia 0 trials
- Colloid cysts of third ventricle 0 trials
- Coloboma, ocular, autosomal dominant 0 trials Sub-types →
- Coloboma, ocular, autosomal recessive 0 trials
- Coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness 0 trials
- Colobomatous optic disc-macular atrophy-chorioretinopathy syndrome 0 trials
- Colonic varices without portal hypertension 0 trials
- Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia 0 trials
- Combined low LDL and fibrinogen 0 trials
- Combined oxidative phosphorylation deficiency 49 0 trials
- Combined oxidative phosphorylation deficiency 50 0 trials
- Comedones, familial Dyskeratotic 0 trials
- Commissural lip pits 0 trials
- Complement factor b deficiency 0 trials
- Conductive deafness-malformed external ear syndrome 0 trials
- Cone-rod dystrophy and hearing loss 0 trials Sub-types →
- Cone-rod synaptic disorder syndrome, congenital nonprogressive 0 trials
- Congenital analbuminemia 0 trials
- Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay 0 trials
- Congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome 0 trials
- Congenital cataract-severe neonatal hepatopathy-global developmental delay syndrome 0 trials
- Congenital contractures of the limbs and face, hypotonia, and developmental delay 0 trials
- Congenital disorder of glycosylation, type i/IIx 0 trials
- Congenital enteropathy due to enteropeptidase deficiency 0 trials
- Congenital heart defects and ectodermal dysplasia 0 trials
- Congenital heart defects and skeletal malformations syndrome 0 trials
- Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder 0 trials
- Congenital heart defects, multiple types, 7 0 trials
- Congenital hypotonia, epilepsy, developmental delay, and digital anomalies 0 trials
- Congenital osteogenesis imperfecta-microcephaly-cataracts syndrome 0 trials
- Congenital pseudoarthrosis of clavicle 0 trials
- Congenital short bowel syndrome, autosomal recessive 0 trials
- Congenital smooth muscle hamartoma, with or without hemihypertrophy 0 trials
- Congenital stromal corneal dystrophy 0 trials
- Congenital vertical talus 0 trials Sub-types →
- Convulsive disorder, familial, with prenatal or early onset 0 trials
- Cornea guttata with anterior polar cataracts 0 trials
- Corneal degeneration, band-shaped spheroid 0 trials
- Corneal degeneration, ribbonlike, with deafness 0 trials
- Corneal dystrophy, punctiform and polychromatic pre-descemet 0 trials
- Corneal dystrophy-perceptive deafness syndrome 0 trials
- Corpus callosum agenesis-abnormal genitalia syndrome 0 trials
- Corticosteroid-binding globulin deficiency 0 trials
- Corticosterone methyloxidase type 2 deficiency 0 trials
- Coumarin resistance 0 trials
- Cranial dysinnervation disorder, congenital, with absent corneal reflex and developmental delay 0 trials
- Cranial nerves, congenital paresis of 0 trials
- Cranial nerves, recurrent paresis of 0 trials
- Cranioacrofacial syndrome 0 trials
- Craniofacial anomalies and anterior segment dysgenesis syndrome 0 trials
- Craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development syndrome 0 trials Sub-types →
- Craniofacial dysplasia - osteopenia syndrome 0 trials
- Craniofacial-deafness-hand syndrome 0 trials
- Craniofaciocardiohepatic syndrome 0 trials
- Craniolenticulosutural dysplasia 0 trials
- Craniometadiaphyseal osteosclerosis with hip dysplasia 0 trials
- Craniorhiny 0 trials
- Craniosynostosis with anomalies of the cranial base and digits 0 trials
- Craniosynostosis-intellectual disability syndrome of 51N and Gettig 0 trials
- Craniosynostosis-intellectual disability-clefting syndrome 0 trials
- Craniosynostosis-scoliosis syndrome 0 trials
- Creases, infra-auricular cutaneous, with tall stature and advanced bone age 0 trials
- Creatine phosphokinase, elevated serum 0 trials
- Crumpled helices and small mouth 0 trials
- Cryofibrinogenemia, familial primary 0 trials
- Cryptotia, familial 0 trials
- Curved nail of fourth toe 0 trials
- Cutis verticis gyrata and intellectual disability 0 trials
- Cutis verticis gyrata, thyroid aplasia, and intellectual disability 0 trials
- Cyanosis and hepatic disease 0 trials
- Cyanosis, transient neonatal 0 trials Sub-types →
- Cysteine Peptiduria 0 trials
- Dandy-walker malformation with occipital cephalocele, autosomal dominant 0 trials
- De Sanctis-Cacchione syndrome 0 trials
- Deafness with anhidrotic ectodermal dysplasia 0 trials
- Deafness with labyrinthine aplasia, microtia, and microdontia 0 trials
- Deafness, cataract, impaired intellectual development, and polyneuropathy 0 trials
- Deafness, cataract, retinitis pigmentosa, and sperm abnormalities 0 trials
- Deafness, congenital heart defects, and posterior embryotoxon 0 trials
- Deafness, congenital, and adult-onset progressive leukoencephalopathy 0 trials
- Deafness, congenital, and familial myoclonic epilepsy 0 trials
- Deafness, mid-tone neural 0 trials
- Deafness, neural, congenital moderate 0 trials
- Deafness, neural, with atypical atopic dermatitis 0 trials
- Deafness, sensorineural, with peripheral neuropathy and arterial disease 0 trials
- Deafness, unilateral, with delayed endolymphatic hydrops 0 trials
- Deafness-ear malformation-facial palsy syndrome 0 trials
- Deafness-epiphyseal dysplasia-short stature syndrome 0 trials
- Deafness-small bowel diverticulosis-neuropathy syndrome 0 trials
- Deafness-vitiligo-achalasia syndrome 0 trials
- Deeah syndrome 0 trials
- Dens evaginatus 0 trials
- Dens in dente and palatal invaginations 0 trials
- Dental radicular dysplasia 0 trials
- Dentin dysplasia type I 0 trials Sub-types →
- Dentin dysplasia type II 0 trials
- Dentin dysplasia-sclerotic bones syndrome 0 trials
- Dentinogenesis imperfecta type 2 0 trials Sub-types →
- Dentinogenesis imperfecta type 3 0 trials
- Deoxyribose-5-phosphate aldolase deficiency 0 trials
- Dermal Ridges, patternless 0 trials
- Developmental delay with dysmorphic facies and dental anomalies 0 trials
- Developmental delay with hypotonia, myopathy, and brain abnormalities 0 trials
- Developmental delay with or without dysmorphic facies and autism 0 trials
- Developmental delay with or without epilepsy 0 trials
- Developmental delay with or without intellectual impairment or behavioral abnormalities 0 trials
- Developmental delay with short stature, dysmorphic facial features, and sparse hair 0 trials Sub-types →
- Developmental delay with sleep apnea 0 trials
- Developmental delay with variable cardiac and renal congenital anomalies and dysmorphic facies 0 trials
- Developmental delay with variable intellectual disability and dysmorphic facies 0 trials
- Developmental delay with variable neurologic and brain abnormalities 0 trials
- Developmental delay, behavioral abnormalities, and neuropsychiatric disorders 0 trials
- Developmental delay, dysmorphic facies, and brain anomalies 0 trials
- Developmental delay, hypotonia, and impaired language 0 trials
- Developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalities 0 trials
- Developmental delay, impaired speech, and behavioral abnormalities 0 trials
- Developmental delay, impaired speech, and behavioral abnormalities, with or without seizures 0 trials
- Developmental delay, language impairment, and ocular abnormalities 0 trials
- Dextrocardia with unusual facies and microphthalmia 0 trials
- Diabetes mellitus, congenital autoimmune 0 trials
- Diabetes, deafness, developmental delay, and short stature syndrome 0 trials
- Diaminopentanuria 0 trials
- Diarrhea, glucose-stimulated secretory, with common variable immunodeficiency 0 trials
- Diencephalic-mesencephalic junction dysplasia 0 trials Sub-types →
- Diffuse idiopathic skeletal hyperostosis 0 trials
- Dilution, pigmentary 0 trials
- Disabling pansclerotic morphea of childhood 0 trials
- Discrimination, Two-point, reduction 1N 0 trials
- Dislocated elbows, bowed tibias, scoliosis, deafness, cataract, microcephaly, and intellectual disability 0 trials
- Disseminated sclerosis with narcolepsy 0 trials
- Distal monosomy 10p 0 trials Sub-types →
- Distal osteosclerosis 0 trials
- Distal symphalangism 0 trials
- Distichiasis with congenital anomalies of the heart and peripheral vasculature 0 trials
- Double fingernail of fifth finger 0 trials
- Double nail for fifth toe 0 trials
- Duodenal ulcer due to antral G-cell hyperfunction 0 trials
- Duodenal ulcer, hyperpepsinogenemic 1 0 trials
- Duodenojejunal atresia with volvulus, absent dorsal mesentery, and absent superior mesenteric artery 0 trials
- Dwarfism with stiff joints and ocular abnormalities 0 trials
- Dwarfism with tall vertebrae 0 trials
- Dwarfism, Levi type 0 trials
- Dwarfism, familial, with muscle spasms 0 trials
- Dwarfism, intellectual disability, and eye abnormality 0 trials
- Dwarfism, low-birth-weight type, with unresponsiveness to growth hormone 0 trials
- Dwarfism, proportionate, with hip dislocation 0 trials
- Dyschromatosis, ichthyosis, deafness, and atopic disease 0 trials
- Dysmorphism-cleft palate-loose skin syndrome 0 trials
- Dysmyelination with jaundice 0 trials
- Dysostosis multiplex, Ain-Naz type 0 trials
- Dysraphism-cleft lip/palate-limb reduction defects syndrome 0 trials
- Dystelephalangy 0 trials
- Dystonia with Ringbinden 0 trials
- Dystonia with cerebellar atrophy 0 trials
- Dystonia, early-onset, and/or spastic paraplegia 0 trials
- Ear antitragus, tag at base of 0 trials
- Ear exostoses 0 trials
- Ear folding 0 trials
- Ear pits, posterior helical 0 trials
- Early response to neural induction gene 0 trials
- Early-onset familial hypoaldosteronism 0 trials
- Eccrine syringofibroadenomatosis with eyelid abnormalities 0 trials
- Ectodermal dysplasia syndrome with distinctive facial appearance and preaxial polydactyly of feet 0 trials
- Ectodermal dysplasia with adrenal cyst 0 trials
- Ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies 0 trials
- Ectodermal dysplasia with intellectual disability and syndactyly 0 trials
- Ectodermal dysplasia, sensorineural hearing loss, and distinctive facial features 0 trials
- Ectopia lentis 1, isolated, autosomal dominant 0 trials
- Ectopia lentis 2, isolated, autosomal recessive 0 trials
- Ectopia lentis et pupillae 0 trials
- Ectopia pupillae 0 trials
- Ectrodactyly and ectodermal dysplasia without cleft lip/palate 0 trials
- Ectrodactyly of lower limbs, congenital heart defect, and micrognathia 0 trials
- Ectrodactyly-cleft palate syndrome 0 trials
- Edema, familial idiopathic, prepubertal 0 trials
- Electroencephalographic peculiarity: 14 and 6 per sec. positive spike phenomenon 0 trials
- Emphysema, congenital, with deafness, penoscrotal web, and intellectual disability 0 trials
- Emphysema, hereditary pulmonary 0 trials
- Enamel hypoplasia, cataracts, and aqueductal stenosis 0 trials
- Encephalitis, acute, infection-induced, susceptibility to, 12 0 trials
- Encephalomalacia, multilocular 0 trials
- Encephalomyopathy, mitochondrial, due to voltage-dependent anion channel deficiency 0 trials
- Endocardial fibroelastosis and coarctation of abdominal aorta 0 trials
- Endocrine-cerebro-osteodysplasia syndrome 0 trials
- Endothelial dystrophy, congenital hereditary, with nail hypoplasia 0 trials
- Enteropathy, familial, with villous edema and immunoglobulin G2 deficiency 0 trials
- Enuresis, nocturnal, 1 0 trials
- Epidermoid cysts 0 trials
- Epidermolysis bullosa with congenital localized absence of skin and deformity of nails 0 trials
- Epidermolysis bullosa with deficiency of galactosylhydroxylysyl glucosyltransferase 0 trials
- Epidermolysis bullosa with diaphragmatic hernia 0 trials
- Epilepsy, partial, with pericentral spikes 0 trials
- Epilepsy, photogenic, with spastic diplegia and intellectual disability 0 trials
- Epiphyseal dysplasia of femoral head, myopia, and deafness 0 trials
- Epiphyseal dysplasia, Baumann type 0 trials
- Episodic muscle weakness, X-linked 0 trials
- Epithelial basolateral chloride conductance regulator, rabbit, homolog of 0 trials
- Epithelial recurrent erosion dystrophy 0 trials
- Epithelial squamous dysplasia, keratinizing desquamative, of urinary tract 0 trials
- Erythema nodosum, familial 0 trials
- Erythema of acral regions 0 trials
- Esophageal ring, lower 0 trials
- Esophagitis, eosinophilic, 2 0 trials
- Estrogen resistance syndrome 0 trials
- Ethanolaminosis 0 trials
- Exchondrosis of pinna, posterior 0 trials
- Exercise intolerance, riboflavin-responsive 0 trials
- Exostoses-anetodermia-brachydactyly type E syndrome 0 trials
- Exostosis, Dupuytren subungual 0 trials
- Extraoral halitosis due to methanethiol oxidase deficiency 0 trials
- Facial abnormalities, kyphoscoliosis, and intellectual disability 0 trials
- Facial dysmorphism, cleft palate, hearing loss, and camptodactyly 0 trials
- Facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome 0 trials
- Facial dysmorphism, selective tooth agenesis, and choroid calcification 0 trials
- Facial dysmorphism-immunodeficiency-livedo-short stature syndrome 0 trials
- Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome 0 trials
- Facial palsy, congenital, with ptosis and velopharyngeal dysfunction 0 trials
- Facial paresis, hereditary congenital, 3 0 trials
- Facial spasm 0 trials
- Faciocardiomelic syndrome 0 trials
- Faciothoracogenital syndrome 0 trials
- Factor 9 and Factor XI, combined deficiency of 0 trials
- Factor VIII and Factor IX, combined deficiency of 0 trials
- Factors VIII, IX and XI, combined deficiency of 0 trials
- Familial caudal dysgenesis 0 trials Sub-types →
- Familial cavitary optic disk anomaly 0 trials
- Familial cervical artery dissection 0 trials
- Familial gestational hyperthyroidism 0 trials
- Familial glucocorticoid deficiency 0 trials Sub-types →
- Familial hyperthyroidism due to mutations in TSH receptor 0 trials
- Familial lipochrome histiocytosis 0 trials
- Familial monosomy 7 syndrome 0 trials Sub-types →
- Familial parathyroid adenoma 0 trials
- Familial partial paralysis 0 trials
- Familial progressive retinal dystrophy-iris coloboma-congenital cataract syndrome 0 trials
- Familial supernumerary nipples 0 trials
- Familial visceral myopathy 0 trials Sub-types →
- Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies 0 trials
- Fever, familial lifelong persistent 0 trials
- Fibromatosis, gingival, with hypertrichosis and intellectual disability 0 trials
- Fibromuscular dysplasia, multifocal 0 trials
- Fibrosclerosis, multifocal 0 trials
- Fibrosis, neurodegeneration, and cerebral angiomatosis 0 trials
- Fibula, recurrent dislocation of head of 0 trials
- Flushing of ears and somnolence 0 trials
- Focal epithelial hyperplasia 0 trials
- Focal epithelial hyperplasia of the oral mucosa 0 trials
- Focal segmental glomerulosclerosis and neurodevelopmental syndrome 0 trials
- Follicular atrophoderma, perioral pigmented, with milia and epidermoid cysts 0 trials
- Forsythe-wakeling syndrome 0 trials
- Fragile site 10Q23 0 trials
- Frontoocular syndrome 0 trials
- Fructose and galactose intolerance 0 trials
- Fucosidase regulator 0 trials
- Fucosyltransferase 6 deficiency 0 trials
- Fused mandibular incisors 0 trials
- Gamma-A-globulin, defect in assembly of 0 trials
- Gastric mucosal hypertrophy 0 trials
- Gastric volvulus, intrathoracic 0 trials
- Gelatinous drop-like corneal dystrophy 0 trials
- Genitourinary and/or brain malformation syndrome 0 trials
- Giant neutrophil leukocytes 0 trials
- Global developmental delay - lung cysts - overgrowth - Wilms tumor syndrome 0 trials
- Global developmental delay with speech and behavioral abnormalities 0 trials
- Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies 0 trials
- Global developmental delay, progressive ataxia, and elevated glutamine 0 trials
- Globulin anomaly involving beta (2A)-globulin 0 trials
- Glomuvenous malformation 0 trials
- Glucocorticoid therapy, response to 0 trials
- Glucose-6-phosphate dehydrogenase-like 0 trials
- Glutamic acid decarboxylase, brain, membrane form 0 trials
- Glutamyl ribose-5-phosphate storage disease 0 trials
- Glutathione transferase activity toward trans-stilbene oxide 0 trials
- Gluteal muscles, absence of 0 trials
- Glycosylphosphatidylinositol biosynthesis defect 21 0 trials
- Gonadal agenesis 0 trials
- Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy 0 trials
- Granddad syndrome 0 trials
- Grange syndrome 0 trials
- Granulocytopenia with immunoglobulin abnormality 0 trials
- Granulomas, congenital cerebral 0 trials
- Granulosis rubra nasi 0 trials
- Growth and developintellectual disability, ocular ptosis, cardiac defect, and anal atresia 0 trials
- Growth failure, microcephaly, intellectual disability, cataracts, large joint contractures, osteoporosis, cortical dysplasia, and cerebellar atrophy 0 trials
- Growth restriction, hypoplastic kidneys, alopecia, and distinctive facies 0 trials
- Growth retardation-mild developmental delay-chronic hepatitis syndrome 0 trials
- Guanylate cyclase 2E 0 trials
- Guanylate kinase 3 0 trials
- Hairy ears, Y-linked 0 trials
- Hairy nose tip 0 trials
- Hairy palms and soles 0 trials
- Hamartoma, Precalcaneal congenital fibrolipomatous 0 trials
- Hand clasping pattern 0 trials
- Headache associated with sexual activity 0 trials
- Hearing loss, noise-induced, susceptibility to 0 trials
- Heart and brain malformation syndrome 0 trials
- Heart-hand syndrome 0 trials Sub-types →
- Hemangiomatosis, cutaneous, with associated features 0 trials
- Hemifacial myohyperplasia 0 trials
- Hemoglobin--variants for which the chain carrying the mutation 1S unknown or uncertain 0 trials
- Hemolytic poikilocytic anemia due to reduced ankyrin binding sites 0 trials
- Hemopoietic proliferation 0 trials
- Hepatic adenomas, familial 0 trials
- Hepatic veno-occlusive disease-immunodeficiency syndrome 0 trials
- Hepatorenocardiac degenerative fibrosis 0 trials
- Hereditary fallopian tube carcinoma 0 trials
- Hereditary hyperferritinemia with congenital cataracts 0 trials
- Hereditary hypotrichosis with recurrent skin vesicles 0 trials
- Hereditary neuro-ophthalmological disease 0 trials
- Hereditary neuroendocrine tumor of small intestine 0 trials
- Hereditary neutrophilia 0 trials
- Hereditary sensory and autonomic neuropathy with deafness and global delay 0 trials
- Heterochromia iridis 0 trials
- High myopia-sensorineural deafness syndrome 0 trials
- Histiocytic dermatoarthritis 0 trials
- Holoprosencephaly, recurrent infections, and monocytosis 0 trials
- Humero-radio-ulnar synostosis 0 trials Sub-types →
- Humerofemoral hypoplasia with radiotibial ray deficiency 0 trials
- Humeroradial synostosis 0 trials Sub-types →
- Humerus trochlea aplasia 0 trials
- Hyaluronan metabolism, defect 1N 0 trials
- Hydrocephalus, congenital communicating, 1 0 trials
- Hydrops fetalis, nonimmune, with gracile bones and dysmorphic features 0 trials
- Hydroxyacyl glutathione hydrolase deficiency 0 trials
- Hydroxyprolinemia 0 trials
- Hymen, imperforate 0 trials
- Hyperbiliverdinemia 0 trials
- Hypercalciuria, absorptive, 2 0 trials
- Hyperglycinuria 0 trials
- Hyperheparinemia 0 trials
- Hyperimmunoglobulin G1(A1) syndrome 0 trials
- Hyperleucine-Isoleucinemia 0 trials
- Hyperlipoproteinemia, type II, and deafness 0 trials
- Hyperlysinuria with hyperammonemia 0 trials
- Hypermetabolism due to defect in mitochondria 0 trials
- Hypermetabolism due to uncoupled mitochondrial oxidative phosphorylation 2 0 trials
- Hyperopia, high 0 trials
- Hyperostosis cranialis interna 0 trials
- Hyperparathyroidism, neonatal self-limited primary, with hypercalciuria 0 trials
- Hyperphosphatemia, polyuria, and seizures 0 trials
- Hyperpigmentation of Fuldauer and Kuijpers 0 trials
- Hyperproglucagonemia 0 trials
- Hyperproinsulinemia 0 trials
- Hypersecretion of adrenal androgens, familial 0 trials
- Hypersulfaturia 0 trials
- Hypertelorism and other facial dysmorphism, brachydactyly, genital abnormalities, intellectual disability, and recurrent inflammatory episodes 0 trials
- Hypertelorism and tetralogy of fallot 0 trials
- Hypertelorism-preauricular sinus-punctual pits-deafness syndrome 0 trials
- Hyperthermia, cutaneous, with headaches and nausea 0 trials
- Hyperthyroxinemia, dystransthyretinemic 0 trials
- Hyperthyroxinemia, euthyroid, caused by generalized 5-prime-deiodinase deficiency 0 trials
- Hyperthyroxinemia, familial dysalbuminemic 0 trials
- Hypertrophia musculorum vera 0 trials
- Hypertrophic neuropathy and cataract 0 trials
- Hyperuricemia, infantile, with abnormal behavior and normal hypoxanthine guanine phosphoribosyltransferase 0 trials
- Hypoglycemia, leucine-induced 0 trials
- Hypogonadism with low-grade mental deficiency and microcephaly 0 trials
- Hypohidrosis with abnormal palmar dermal Ridges 0 trials
- Hypoinsulinemic hypoglycemia and body hemihypertrophy 0 trials
- Hypokalemic alkalosis, familial, with specific renal tubulopathy 0 trials
- Hypokalemic tubulopathy and deafness 0 trials
- Hypomagnesemia, hypertension, and hypercholesterolemia, mitochondrial 0 trials
- Hypophosphatemia, renal, with intracerebral calcifications 0 trials
- Hypophosphatemic bone disease 0 trials
- Hypophosphatemic rickets and hyperparathyroidism 0 trials
- Hypopigmentation, organomegaly, and delayed myelination and development 0 trials
- Hypopituitarism, congenital, with central diabetes insipidus 0 trials
- Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome 0 trials
- Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration 0 trials
- Hypotaurinemic retinal degeneration and cardiomyopathy 0 trials
- Hypotonia, ataxia, and delayed development syndrome 0 trials
- Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome 0 trials
- Hypotonia, congenital nystagmus, ataxia, and abnormal auditory brainstem responses 0 trials
- Hypotonia, hypoventilation, impaired intellectual development, dysautonomia, epilepsy, and eye abnormalities 0 trials
- Hypotonia, seizures, and precocious puberty 0 trials
- Hypotrichosis, progressive patterned scalp, with wiry hair, onycholysis, and cleft lip/palate 0 trials
- Hypoxanthine guanine phosphoribosyltransferase suppressor 0 trials
- Ichthyosis and male hypogonadism 0 trials
- Ichthyosis congenita with biliary atresia 0 trials
- Ichthyosis, split hairs, and amino aciduria 0 trials
- Ichthyosis-cheek-eyebrow syndrome 0 trials
- Ichthyosis-intellectual disability syndrome with large keratohyalin granules in the skin 0 trials
- Ichthyosis-intellectual disability-dwarfism-renal impairment syndrome 0 trials
- Ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facial features 0 trials
- Immune dysregulation with immunodeficiency due to AIOLOS haploinsufficiency 0 trials
- Immune dysregulation, autoimmunity, and autoinflammation 0 trials
- Immune dysregulation, neurodevelopmental defects, and colitis 0 trials
- Immunodeficiency 28 0 trials
- Immunodeficiency 37 0 trials Sub-types →
- Immunodeficiency 39 0 trials
- Immunodeficiency 47 0 trials
- Immunodeficiency with defective T-cell response to interleukin 1 0 trials
- Immunodeficiency, X-linked, with deficiency of 115,000 Dalton surface glycoprotein 0 trials
- Immunodeficiency, developmental delay, and hypohomocysteinemia 0 trials
- Immunoglobulin M, level of 0 trials
- Immunoglobulin d level in plasma, low 0 trials
- Imperforate oropharynx-costo vetebral anomalies syndrome 0 trials
- Imprinting gene related to retinoblastoma 0 trials
- Incisors, lower central, absence of 0 trials
- Incisors, rotation of upper central 0 trials
- Incisors, shovel-shaped 0 trials
- Indolylacroyl glycinuria with intellectual disability 0 trials
- Infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development 0 trials
- Inflammatory bowel disease, immunodeficiency, and encephalopathy 0 trials
- Inherited hypertrophic pyloric stenosis 0 trials Sub-types →
- Inherited isolated nail anomaly 0 trials Sub-types →
- Inherited oocyte maturation defect 0 trials Sub-types →
- Inosine phosphorylase deficiency, immune defect due to 0 trials
- Insensitivity to pain with hyperplastic Myelinopathy 0 trials
- Intellectual developmental disorder with abnormal behavior, microcephaly, and short stature 0 trials
- Intellectual developmental disorder with autism and dysmorphic facies 0 trials
- Intellectual developmental disorder with autistic features and language delay, with or without seizures 0 trials
- Intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures 0 trials
- Intellectual developmental disorder with cardiac defects and dysmorphic facies 0 trials
- Intellectual developmental disorder with hypertelorism and distinctive facies 0 trials
- Intellectual developmental disorder with hypotonia and behavioral abnormalities 0 trials
- Intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies 0 trials
- Intellectual developmental disorder with impaired language and dysmorphic facies 0 trials
- Intellectual developmental disorder with macrocephaly, seizures, and speech delay 0 trials
- Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects 0 trials
- Intellectual developmental disorder with nasal speech, dysmorphic facies, and variable skeletal anomalies 0 trials
- Intellectual developmental disorder with ocular anomalies and distinctive facial features 0 trials
- Intellectual developmental disorder with or without epilepsy or cerebellar ataxia 0 trials
- Intellectual developmental disorder with or without peripheral neuropathy 0 trials
- Intellectual developmental disorder with paroxysmal dyskinesia or seizures 0 trials
- Intellectual developmental disorder with poor growth and with or without seizures or ataxia 0 trials
- Intellectual developmental disorder with seizures and dysmorphic facies 0 trials
- Intellectual developmental disorder with seizures and language delay 0 trials
- Intellectual developmental disorder with short stature and behavioral abnormalities 0 trials
- Intellectual developmental disorder with short stature and variable skeletal anomalies 0 trials
- Intellectual developmental disorder with speech delay and axonal peripheral neuropathy 0 trials
- Intellectual developmental disorder with speech delay, autism, and dysmorphic facies 0 trials
- Intellectual developmental disorder, autosomal dominant 77 0 trials
- Intellectual developmental disorder, autosomal recessive 84 0 trials
- Intellectual disability and myopathy syndrome 0 trials
- Intellectual disability with optic atrophy, facial dysmorphism, microcephaly, and short stature 0 trials
- Intellectual disability, FRA12A type 0 trials
- Intellectual disability, anterior maxillary protrusion, and strabismus 0 trials
- Intellectual disability, keratoconus, febrile seizures, and sinoatrial block 0 trials
- Intellectual disability, microcephaly, growth retardation, joint contractures, and facial dysmorphism 0 trials
- Intellectual disability, severe, with spasticity and pigmentary tapetoretinal degeneration 0 trials
- Intellectual disability, short stature, facial anomalies, and joint dislocations 0 trials
- Intellectual disability-brachydactyly-Pierre Robin syndrome 0 trials
- Intellectual disability-strabismus syndrome 0 trials
- Interferon antiviral depressor 0 trials
- Internal carotid arteries, hypoplasia of 0 trials
- Internal carotid artery, spontaneous dissection of 0 trials
- Intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency 0 trials
- Intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linked 0 trials
- Iridogoniodysgenesis and skeletal anomalies 0 trials
- Iris pattern 0 trials
- Iris pigment epithelium anomalies 0 trials
- Iris pigment layer, cleavage of 0 trials
- Ischio-vertebral syndrome 0 trials
- Isolated aniridia 0 trials Sub-types →
- Isolated cryptophthalmia 0 trials Sub-types →
- Isolated hyperferritinemia 0 trials
- Isolated neonatal sclerosing cholangitis 0 trials
- Isolated right ventricular hypoplasia 0 trials
- Isoproterenol-mediated vasodilatation 0 trials
- Isovaleric acid, inability to smell 0 trials
- Jaundice, familial obstructive, of infancy 0 trials Sub-types →
- Jejunal atresia with renal adysplasia 0 trials
- Joint contractures, osteochondromas, and B-cell lymphoma 0 trials
- Kallikrein, decreased urinary activity of 0 trials
- Keloid formation 0 trials
- Keratitis fugax hereditaria 0 trials
- Keratoconus and congenital hip dysplasia 0 trials
- Keratoconus posticus circumscriptus 0 trials
- Keratoderma hereditarium mutilans 0 trials
- Keratoderma-ichthyosis-deafness syndrome, autosomal recessive 0 trials
- Keratosis, familial actinic 0 trials
- Knuckle pads 0 trials
- Labia minora, incomplete adhesion of 0 trials
- Lactic acidosis, chronic adult form 0 trials
- Language delay and attention deficit-hyperactivity disorder/cognitive impairment with or without cardiac arrhythmia 0 trials
- Laryngeal abductor paralysis with cerebellar ataxia and motor neuropathy 0 trials
- Laryngeal atresia, encephalocele, and limb deformities 0 trials
- Lateral semicircular canal malformation, familial, with external and middle ear abnormalities 0 trials
- Lattice degeneration of retina leading to retinal detachment 0 trials
- Leg ulcers, familial, of juvenile onset 0 trials
- Lentiginosis, centrofacial neurodysraphic 0 trials
- Lessel-kubisch syndrome 0 trials
- Lethal faciocardiomelic dysplasia 0 trials
- Lethal polymalformative syndrome, Boissel type 0 trials
- Lethal recessive chondrodysplasia 0 trials
- Leukemia, acute myelocytic, with polyposis coli and colon cancer 0 trials
- Leukocyte nuclear appendages, hereditary prevalence of 0 trials
- Leukodystrophy and acquired microcephaly with or without dystonia; 0 trials
- Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate 0 trials
- Leukoencephalopathy, arthritis, colitis, and hypogammaglobulinema 0 trials
- Leukoencephalopathy, developmental delay, and episodic neurologic regression syndrome 0 trials
- Leukoencephalopathy, motor delay, spasticity, and dysarthria syndrome 0 trials
- Leukoencephalopathy, progressive, infantile-onset, with or without deafness 0 trials
- Limb transversal defect-cardiac anomaly syndrome 0 trials
- Lip, hamartomatous 0 trials
- Lipodystrophy, partial, acquired, with low complement component c3, with or without glomerulonephritis 0 trials
- Lipoprotein types--Lt system 0 trials
- Lipoprotein, variant of beta 0 trials
- Lissencephaly, familial, with cleft palate and cerebellar hypoplasia 0 trials
- Lithium transport 0 trials
- Liver disease, severe congenital 0 trials
- Liver fibrocystic disease and polydactyly 0 trials
- Long chain fatty acids, defect in transport of 0 trials
- Low density lipoprotein, variation in molecular weight of 0 trials
- Lung disease, immunodeficiency, and chromosome breakage syndrome; 0 trials
- Lymphedema-posterior choanal atresia syndrome 0 trials
- Lymphoid system deterioration, progressive 0 trials
- Lymphopenic hypergammaglobulinemia, antibody deficiency, autoimmune hemolytic anemia, and glomerulonephritis 0 trials
- Lysine malabsorption syndrome 0 trials
- Macrocephaly, acquired, with impaired intellectual development 0 trials
- Macrocephaly, benign familial 0 trials
- Macrocephaly, dysmorphic facies, and psychomotor retardation 0 trials Sub-types →
- Macrocephaly, neurodevelopmental delay, lymphoid hyperplasia, and persistent fetal hemoglobin 0 trials
- Macrocephaly-developmental delay syndrome 0 trials
- Macrocytosis, familial 0 trials
- Macroepiphyseal dysplasia with osteoporosis, wrinkled skin, and aged appearance 0 trials
- Macrosomia adiposa congenita 0 trials
- Magnesium, elevated red cell 0 trials
- Maleylacetoacetate isomerase deficiency 0 trials
- Malocclusion and short stature 0 trials
- Mammary-digital-nail syndrome 0 trials
- Mandibulofacial dysostosis syndrome, Bauru type 0 trials
- Mandibulofacial dysostosis with alopecia 0 trials
- Mandibulofacial dysostosis with mental deficiency 0 trials
- Mandibulofacial dysostosis with ptosis, autosomal dominant 0 trials
- Mannose 6-phosphate receptor recognition defect, Lebanese type 0 trials
- Marfanoid habitus with situs inversus 0 trials
- Marfanoid hypermobility syndrome 0 trials
- Maxillofacial dysostosis 0 trials
- Mediosternal depigmentation line 0 trials
- Medium chain 3-ketoacyl-Coa thiolase deficiency 0 trials
- Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations 0 trials
- Megabladder, congenital 0 trials
- Megacystis-microcolon-intestinal hypoperistalsis syndrome 0 trials Sub-types →
- Megaepiphyseal dwarfism 0 trials
- Megalencephaly with dysmyelination 0 trials
- Megalencephaly-polydactyly syndrome 0 trials
- Megalocornea 0 trials Sub-types →
- Melanoma tumor antigen Gp90 0 trials
- Menstrual cycle-dependent periodic fever 0 trials
- Mental and growth retardation with amblyopia 0 trials
- Mesoaxial hexadactyly and cardiac malformation 0 trials
- Mesomelic dwarfism of hypoplastic tibia and radius type 0 trials
- Mesomelic dysplasia, camera type 0 trials
- Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression 0 trials
- Metachondromatosis 0 trials
- Metachromasia of fibroblasts 0 trials
- Metaphyseal chondrodysplasia with cone-shaped epiphyses, normal hair, and normal hands 0 trials
- Metaphyseal chondrodysplasia, Pena type 0 trials
- Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria 0 trials
- Metaphyseal dysplasia, anetoderma, and optic atrophy 0 trials
- Metaphyseal modeling abnormality, skin lesions, and spastic paraplegia 0 trials
- Metaphyseal undermodeling, spondylar dysplasia, and overgrowth 0 trials
- Metatarsus varus, type 1 0 trials
- Methionine malabsorption syndrome 0 trials
- Microcephaly, cataracts, impaired intellectual development, and dystonia with abnormal striatum 0 trials
- Microcephaly, corpus callosum dysgenesis, and cleft lip/palate 0 trials
- Microcephaly, developmental delay, and brittle hair syndrome 0 trials
- Microcephaly, epilepsy, and diabetes syndrome 0 trials Sub-types →
- Microcephaly, facial abnormalities, micromelia, and intellectual disability 0 trials
- Microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome 0 trials
- Microcephaly, growth deficiency, seizures, and brain malformations 0 trials
- Microcephaly, growth restriction and increased sister chromatid exchange 0 trials Sub-types →
- Microcephaly, growth retardation, cataract, hearing loss, and unusual appearance 0 trials
- Microcephaly, macrotia, and intellectual disability 0 trials
- Microcephaly, retinitis pigmentosa, and sutural cataract 0 trials
- Microcephaly, severe, with skeletal anomalies including posterior rib-Gap defects 0 trials
- Microcephaly, short stature, and impaired glucose metabolism 0 trials Sub-types →
- Microcephaly, short stature, and limb abnormalities 0 trials
- Microcephaly-brachydactyly-kyphoscoliosis syndrome 0 trials
- Microcephaly-capillary malformation syndrome 0 trials
- Microcephaly-facial dysmorphism-ocular anomalies-multiple congenital anomalies syndrome 0 trials
- Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome 0 trials
- Microcephaly-micromelia syndrome 0 trials
- Microcephaly-thin corpus callosum-intellectual disability syndrome 0 trials
- Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 1 0 trials
- Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 2 0 trials
- Microphthalmia with cyst, bilateral facial clefts, and limb anomalies 0 trials
- Microphthalmia with hyperopia, retinal degeneration, macrophakia, and dental anomalies 0 trials
- Microphthalmia, isolated, with corectopia 0 trials
- Microspherophakia with hernia 0 trials
- Microspherophakia-metaphyseal dysplasia syndrome 0 trials
- Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis 0 trials
- Midface hypoplasia, obesity, developmental delay, and neonatal hypotonia 0 trials
- Midline malformations, multiple, with limb abnormalities and hypopituitarism 0 trials
- Milia, multiple eruptive 0 trials
- Mitochondrial complex 1 deficiency, nuclear type 35 0 trials
- Mitochondrial import-stimulating factor 0 trials
- Mitochondrial intermembrane space protein Tim12, yeast, homolog of 0 trials
- Mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency 0 trials
- Monosodium glutamate sensitivity 0 trials
- Mucocutaneous ulceration, chronic 0 trials
- Mucus inspissation of respiratory tract 0 trials
- Mullerian aplasia and hyperandrogenism 0 trials
- Multiple congenital anomalies-hypotonia-seizures syndrome 0 trials Sub-types →
- Multiple congenital anomalies-neurodevelopmental syndrome, X-linked 0 trials
- Multiple exostoses with spastic tetraparesis 0 trials
- Multiple fibroadenoma of the breast 0 trials
- Multiple synostoses syndrome 0 trials Sub-types →
- Muscle cramps, familial 0 trials
- Muscular atrophy, malignant neurogenic 0 trials
- Muscular dystrophy, adult-onset, with leukoencephalopathy 0 trials
- Muscular dystrophy, congenital hearing loss, and ovarian insufficiency syndrome 0 trials
- Muscular dystrophy, congenital, with cerebellar atrophy 0 trials
- Muscular dystrophy, congenital, with or without seizures 0 trials
- Muscular dystrophy, congenital, with severe central nervous system atrophy and absence of large myelinated fibers 0 trials
- Muscular hypoplasia, congenital universal, of Krabbe 0 trials
- Musk, inability to smell 0 trials
- Myelinated optic nerve fibers 0 trials
- Myelodysplasia, immunodeficiency, facial dysmorphism, short stature, and psychomotor delay 0 trials
- Myelofibrosis, congenital, with anemia, neutropenia, developmental delay, and ocular abnormalities 0 trials
- Myeloid tumor suppressor 0 trials
- Myelolymphatic insufficiency 0 trials
- Myoclonic epilepsy, congenital deafness, macular dystrophy, and psychiatric disorders 0 trials
- Myopathy due to malate-aspartate shuttle defect 0 trials
- Myopathy with giant abnormal mitochondria 0 trials
- Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis 1 0 trials
- Myopathy with storage of glycoproteins and Glycosaminoglycans 0 trials
- Myopathy, congenital, with excess of muscle spindles 0 trials
- Myopathy, granulovacuolar lobular, with electrical myotonia 0 trials
- Nanophthalmia 0 trials Sub-types →
- Nasal bones, absence of 0 trials
- Nasal groove, familial transverse 0 trials
- Nasal hyperpigmentation, familial transverse 0 trials
- Nephropathy - deafness - hyperparathyroidism syndrome 0 trials
- Nephropathy, chronic tubulointerstitial 0 trials
- Nephropathy, progressive, with deafness 0 trials
- Neurocardiofaciodigital syndrome 0 trials
- Neurodegeneration, infantile-onset, with optic atrophy and brain abnormalities 0 trials
- Neurodevelopmental, jaw, eye, and digital syndrome 0 trials
- Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities 0 trials
- Neuroectodermal melanolysosomal disease 0 trials
- Neuroendocrine carcinoma of salivary glands, sensorineural hearing loss, and enamel hypoplasia 0 trials
- Neurofacioskeletal syndrome with or without renal agenesis 0 trials
- Neurofibromatosis-pheochromocytoma-duodenal carcinoid syndrome 0 trials
- Neurologic disease, infantile multisystem, with osseous fragility 0 trials
- Neuromuscular disease and ocular or auditory anomalies with or without seizures 0 trials
- Neurooculocardiogenitourinary syndrome 0 trials
- Neurooculorenal syndrome 0 trials
- Neuropathy, congenital, with arthrogryposis multiplex 0 trials
- Neuropathy, hereditary motor and sensory, with excessive myelin folding complex, autosomal recessive 0 trials
- Neuropathy, hereditary sensory and autonomic, adult-onset, with anosmia 0 trials
- Neuropathy, with paraprotein in serum, cerebrospinal fluid and urine 0 trials
- Nevus anemicus 0 trials
- Nevus flammeus of nape of neck 0 trials
- Nipples inverted 0 trials
- Noduli Cutanei, multiple, with urinary tract abnormalities 0 trials
- Nondisjunction 0 trials
- Nuclear ribonucleic acid 0 trials
- Obesity and hypopigmentation 0 trials
- Obesity, hyperphagia, and developmental delay 0 trials
- Occipital hair, white lock of 0 trials
- Ocular myopathy with curare sensitivity 0 trials
- Ocular pterygium-digital keloid dysplasia syndrome 0 trials
- Oculocerebrofacial syndrome, Kaufman type 0 trials
- Oculogastrointestinal-neurodevelopmental syndrome 0 trials
- Oculomaxillofacial dysostosis 0 trials Sub-types →
- Oculomotor-abducens synkinesis 0 trials
- Oculopharyngeal myopathy with leukoencephalopathy 1 0 trials
- Oculorenocerebellar syndrome 0 trials
- Oculotrichoanal syndrome 0 trials
- Oculovertebral syndrome 0 trials
- Odontoid hypoplasia 0 trials
- Oligodontia-cancer predisposition syndrome 0 trials
- Olivopontocerebellar atrophy II, autosomal recessive 0 trials
- Omphalocele, X-linked 0 trials
- Omphalocele, autosomal 0 trials
- Omphalocele, diaphragmatic hernia, and radial ray defects 0 trials
- Onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome 0 trials
- Onychogryposis, pedal, with keratosis plantaris and coarse hair 0 trials
- Ophthalmomandibulomelic dysplasia 0 trials
- Ophthalmoplegia totalis with ptosis and miosis 0 trials
- Ophthalmoplegia, external, and myopia 0 trials
- Ophthalmoplegia, external, with rib and vertebral anomalies 0 trials
- Ophthalmoplegia, familial static 0 trials
- Ophthalmoplegia, familial total, with iris transillumination 0 trials
- Ophthalmoplegic neuromuscular disorder with abnormal mitochondria 0 trials
- Optic atrophy, hearing loss, and peripheral neuropathy, autosomal recessive 0 trials
- Optic atrophy--spastic paraplegia syndrome 0 trials
- Oral sensibility, disturbance of 0 trials
- Orofaciodigital syndrome 0 trials Sub-types →
- Oromandibular-limb hypogenesis syndrome 0 trials Sub-types →
- Orthostatic hypotensive disorder, Streeten type 0 trials
- Ossicular malformations, familial 0 trials
- Ossified ear cartilages 0 trials
- Osteochondrodysplasia, brachydactyly, and overlapping malformed digits 0 trials
- Osteochondrodysplasia, rhizomelic, with callosal agenesis, thrombocytopenia, hydrocephalus, and hypertension 0 trials
- Osteochondrodysplatic nanism-deafness-retinitis pigmentosa syndrome 0 trials
- Osteodysplasty, precocious, of Danks, Mayne, and Kozlowski 0 trials
- Osteoma of cranial vault, familial 0 trials
- Osteoma of middle ear 0 trials
- Osteootohepatoenteric syndrome 0 trials
- Osteoporosis, childhood- or juvenile-onset, with developmental delay 0 trials
- Osteoporosis-oculocutaneous hypopigmentation syndrome 0 trials
- Osteosclerosis with ichthyosis and fractures 0 trials
- Osteosclerotic chondrodysplasia, lethal, with intracellular inclusions 0 trials
- Otofaciocervical syndrome 0 trials Sub-types →
- Otofacioosseous-gonadal syndrome 0 trials
- Otoonychoperoneal syndrome 0 trials
- Ovalocytosis, hereditary hemolytic, with defective erythropoiesis 0 trials
- Ovarian dysgenesis, hypergonadotropic, with short stature and recurrent metabolic acidosis 0 trials
- Pachydermodactyly, familial 0 trials
- Pachygyria, microcephaly, developmental delay, and dysmorphic facies, with or without seizures 0 trials
- Palant cleft palate syndrome 0 trials
- Palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome 0 trials
- Palmaris longus muscle, absence of 0 trials
- Pancreatic beta cell agenesis with neonatal diabetes mellitus 0 trials
- Pancreatic hypoplasia-diabetes-congenital heart disease syndrome 0 trials
- Pancreatic lymphoma, familial 0 trials
- Pancreatitis, sclerosing cholangitis, and sicca complex 0 trials
- Pancytopenia and occlusive vascular disease 0 trials
- Papillomatosis, florid, of nipple 0 trials
- Parotid salivary glands, polycystic dysgenetic disease of 0 trials
- Parotitis, juvenile recurrent 0 trials
- Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome 0 trials
- Patella aplasia/hypoplasia 0 trials Sub-types →
- Patent ductus venosus 0 trials
- Peeling skin-leukonuchia-acral punctate keratoses-cheilitis-knuckle pads syndrome 0 trials
- Pellagra-like syndrome 0 trials
- Pelvic lipomatosis with crossed renal ectopia 0 trials
- Periodic fever, immunodeficiency, and thrombocytopenia syndrome 0 trials
- Peripapillary atrophy, beta type 0 trials
- Peripheral cone dystrophy 0 trials
- Peripheral neuropathy, ataxia, focal necrotizing encephalopathy, and spongy degeneration of brain 0 trials
- Peripheral neuropathy, autosomal recessive, with or without impaired intellectual development 0 trials
- Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome 0 trials
- Peroneal nerve, accessory deep 0 trials
- Peroneus tertius muscle, absence of 0 trials
- Peroxidase, salivary 0 trials
- Phagocytosis, plasma-related defect 1N 0 trials
- Phenformin 4-hydroxylation 0 trials
- Pheochromocytoma-islet cell tumor syndrome 0 trials
- Phlebectasia of lips 0 trials
- Phocomelia-ectrodactyly-deafness-sinus arrhythmia syndrome 0 trials
- Phosphatase, acid, of tissues 0 trials
- Phosphoglucomutase 4 0 trials
- Phosphoglycoprotein 1 0 trials
- Phosphohydroxylysinuria 0 trials
- Phosphoribosylaminoimidazole carboxylase deficiency 0 trials
- Photomyoclonus, diabetes mellitus, deafness, nephropathy, and cerebral dysfunction 0 trials
- Pigmented purpuric eruption 0 trials
- Pituitary dwarfism with large sella turcica 0 trials
- Plasma clot retraction factor, deficiency of 0 trials
- Plasma fibronectin deficiency 0 trials
- Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease 0 trials
- Platelet adenylate cyclase activity 0 trials
- Platelet disorder, undefined 0 trials
- Platelet factor 3 deficiency 0 trials
- Platelet prostacyclin receptor defect 0 trials
- Platelet responsiveness to adrenaline, depressed 0 trials
- Platelet signal processing defect 0 trials
- Platelet-activating factor acetylhydrolase deficiency 0 trials
- Pleoconial myopathy with salt craving 0 trials
- Polycystic bone disease 0 trials
- Polycystic kidney, cataract, and congenital blindness 0 trials
- Polydactyly-macrocephaly syndrome 0 trials
- Polyhydramnios, chronic idiopathic 0 trials
- Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome 0 trials
- Polymyoclonus, infantile 0 trials
- Polyneuropathy, lethal neonatal, axonal sensorimotor, autosomal recessive 0 trials
- Polyposis of gastric fundus without polyposis coli 0 trials
- Polyposis, intestinal, scattered and discrete 0 trials
- Polyposis, intestinal, with multiple exostoses 0 trials
- Polyps, multiple and recurrent inflammatory fibroid, gastrointestinal 0 trials
- Polysaccharide, storage of unusual 0 trials
- Pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal 0 trials Sub-types →
- Porencephaly-microcephaly-bilateral congenital cataract syndrome 0 trials
- Postaxial tetramelic oligodactyly 0 trials
- Posterior column ataxia 0 trials
- Preauricular fistulae, congenital 0 trials
- Preauricular tag, isolated, autosomal dominant, 1 0 trials
- Premature chromatid separation trait 0 trials
- Presenile dementia, Kraepelin type 0 trials
- Priapism, familial idiopathic 0 trials
- Primary hypertrophic osteoarthropathy 0 trials Sub-types →
- Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection 0 trials
- Primary intraosseous venous malformation 0 trials
- Primordial dwarfism-immunodeficiency-lipodystrophy syndrome 0 trials
- Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome 0 trials
- Progressive non-infectious anterior vertebral fusion 0 trials
- Prolactin deficiency with obesity and enlarged testes 0 trials
- Pronation-supination of the forearm, impairment of 0 trials
- Properdin deficiency, X-linked 0 trials
- Prostate cancer aggressiveness quantitative trait locus on chromosome 19 0 trials
- Protein Z deficiency 0 trials
- Proteinuria, chronic benign 0 trials
- Proteolytic capacity of plasma 0 trials
- Protocadherin 3 0 trials
- Prune belly syndrome with pulmonic stenosis, intellectual disability, and deafness 0 trials
- Pruritus, hereditary localized 0 trials
- Pseudoacromegaly with severe insulin resistance 0 trials
- Pseudoarthrogryposis 0 trials
- Pseudohyperaldosteronism type 2 0 trials
- Pseudomonilethrix 0 trials
- Pseudoxanthoma elasticum, forme fruste 0 trials
- Psychomotor retardation, epilepsy, and craniofacial dysmorphism 0 trials
- Pterygium colli, isolated 0 trials
- Pubic bone dysplasia 0 trials
- Pulmonary alveolar microlithiasis 0 trials
- Pulmonary alveolar proteinosis with hypogammaglobulinemia 0 trials
- Pulmonary bullae causing pneumothorax 0 trials
- Pulmonary venoocclusive disease 0 trials Sub-types →
- Pulmonic stenosis and congenital nephrosis 0 trials
- Pulmonic stenosis and deafness 0 trials
- Pulmonic stenosis, atrial septal defect, and unique electrocardiographic abnormalities 0 trials
- Pupillary membrane, persistence of 0 trials
- Purpura simplex 0 trials
- Pyloric atresia 0 trials
- Radial deficiency-tibial hypoplasia syndrome 0 trials
- Radial heads, posterior dislocation of 0 trials
- Radial ray deficiency, X-linked 0 trials
- Radiation sensitivity of natural killer activity 0 trials
- Radiculoneuropathy, fatal neonatal 0 trials
- Radio-renal syndrome 0 trials
- Radioulnar synostosis, radial ray abnormalities, and severe malformations in the male 0 trials
- Radius, aplasia of, with cleft lip/palate 0 trials
- Raindrop hypopigmentation 0 trials
- Recombinant 8 syndrome 0 trials
- Recurrent infections associated with rare immunoglobulin isotypes deficiency 0 trials
- Red cell permeability defect 0 trials
- Red cell phospholipid defect with hemolysis 0 trials
- Red skin pigment anomaly of new guinea 0 trials
- Renal and mullerian duct hypoplasia 0 trials
- Renal tubular acidosis, distal, with nephrocalcinosis, short stature, intellectual disability, and distinctive facies 0 trials
- Renal-hepatic-pancreatic dysplasia 0 trials Sub-types →
- Respiratory infections, recurrent, and failure to thrive with or without diarrhea 0 trials
- Respiratory papillomatosis, juvenile recurrent, congenital 0 trials
- Respiratory underresponsiveness to hypoxia and hypercapnia 0 trials
- Restrictive dermopathy 0 trials Sub-types →
- Reticuloendotheliosis, X-linked 0 trials
- Retinal degeneration and epilepsy 0 trials
- Retinal dystrophy and microvillus inclusion disease 0 trials
- Retinal dystrophy with leukodystrophy 0 trials
- Retinal dystrophy with or without macular staphyloma 0 trials
- Retinal telangiectasia and hypogammaglobulinemia 0 trials
- Retinal venous beading 0 trials
- Retinitis pigmentosa 89 0 trials
- Retinitis pigmentosa and erythrocytic microcytosis 0 trials
- Retinitis pigmentosa inversa with deafness 0 trials
- Retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome 0 trials
- Retinitis pigmentosa-intellectual disability-deafness-hypogenitalism syndrome 0 trials
- Retinitis pigmentosa-juvenile cataract-short stature-intellectual disability syndrome 0 trials
- Retinopathy, pigmentary, and intellectual disability 0 trials
- Rhabdomyosarcoma, embryonal, 2 0 trials
- Rhiny 0 trials
- Rhizomelic dysplasia, scoliosis, and retinitis pigmentosa 0 trials
- Rhizomelic limb shortening with dysmorphic features 0 trials
- Ribbing disease 0 trials
- Right pulmonary artery, anomalous origin of, familial 0 trials
- Ring dermoid of cornea 0 trials
- Rod-cone dystrophy, sensorineural deafness, and Fanconi-type renal dysfunction 0 trials
- Salivary duct calculi 0 trials
- Salivary substance, Clostridium botulinum type 0 trials
- Sandestig-stefanova syndrome 0 trials
- Scimitar anomaly, multiple cardiac malformations, and craniofacial and central nervous system abnormalities 0 trials
- Sebaceous gland hyperplasia, familial presenile 0 trials
- Second metatarsal-metacarpal syndrome 0 trials
- Secretory diarrhea, myopathy, and deafness 0 trials
- Seizures, early-onset, with neurodegeneration and brain calcifications 0 trials
- Sella turcica, bridged 0 trials
- Senile plaque formation 0 trials
- Sensorineural hearing loss, retinal pigment epithelium lesions, discolored teeth 0 trials
- Serpinopathy 0 trials
- Setting-Sun phenomenon, familial benign 0 trials
- Severe dermatitis-multiple allergies-metabolic wasting syndrome 0 trials
- Severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome 0 trials
- Sex-linked disease 0 trials
- Short stature and Facioauriculothoracic malformations 0 trials
- Short stature and microcephaly with genital anomalies 0 trials
- Short stature due to GHSR deficiency 0 trials
- Short stature due to primary acid-labile subunit deficiency 0 trials
- Short stature with nonspecific skeletal abnormalities 0 trials Sub-types →
- Short stature, Brussels type 0 trials
- Short stature, amelogenesis imperfecta, and skeletal dysplasia with scoliosis 0 trials
- Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 0 trials Sub-types →
- Short stature, impaired intellectual development, microcephaly, hypotonia, and ocular anomalies 0 trials
- Short stature, intellectual disability, callosal agenesis, Heminasal hypoplasia, microphthalmia, and atypical clefting 0 trials
- Short stature, oligodontia, dysmorphic facies, and motor delay 0 trials
- Short stature, rhizomelic, with microcephaly, micrognathia, and developmental delay 0 trials
- Short stature-obesity syndrome 0 trials
- Shoulder and thorax deformity-congenital heart disease syndrome 0 trials
- Sister chromatid exchange, frequency of 0 trials
- Skeletal defects, genital hypoplasia, and intellectual disability 0 trials
- Skeletal dysplasia and progressive central nervous system degeneration, lethal 0 trials
- Skeletal dysplasia with delayed epiphyseal and carpal bone ossification 0 trials
- Skeletal dysplasia, mild, with joint laxity and advanced bone age 0 trials
- Skeletal dysplasia, rhizomelic, with retinitis pigmentosa 0 trials
- Snijders blok-fisher syndrome 0 trials
- Sodium-potassium-ATPase activity of red cell 0 trials
- Spastic diplegia and intellectual disability 0 trials
- Spastic paraparesis-cataracts-speech delay syndrome 0 trials
- Spastic paraparesis-deafness syndrome 0 trials
- Spastic paraplegia and Evans syndrome 0 trials
- Spastic paraplegia with associated extrapyramidal signs 0 trials
- Spastic paraplegia with myoclonic epilepsy 0 trials
- Spastic paraplegia, ataxia, and intellectual disability 0 trials
- Spastic paraplegia, mitochondrial 0 trials
- Spastic paraplegia, optic atrophy, and dementia 0 trials
- Spastic paraplegia, optic atrophy, microcephaly, and 10Y sex reversal 0 trials
- Spastic tetraplegia and axial hypotonia, progressive 0 trials
- Spastic tetraplegia-retinitis pigmentosa-intellectual disability syndrome 0 trials
- Specific granule deficiency 0 trials Sub-types →
- Sperm protamine P4 0 trials
- Sperm-specific antigen 1 0 trials
- Spinal dysplasia, Anhalt type 0 trials
- Spinal muscular atrophy with intellectual disability 0 trials
- Spinal muscular atrophy with microcephaly and mental subnormality 0 trials
- Spinal muscular atrophy, infantile, James type 0 trials
- Spinocerebellar ataxia with rigidity and peripheral neuropathy 0 trials
- Spinocerebellar atrophy with pupillary paralysis 0 trials
- Splenogonadal fusion-limb defects-micrognathia syndrome 0 trials
- Splenomegaly syndrome with splenic Germinal center hypoplasia and reduced circulating T helper cells 0 trials
- Splenoportal vascular anomalies 0 trials
- Split lower lip 0 trials
- Split-foot malformation-mesoaxial polydactyly syndrome 0 trials
- Split-hand and split-foot with hypodontia 0 trials
- Spondylocostal dysostosis-anal and genitourinary malformations syndrome 0 trials
- Spondylocostal dysostosis-hypospadias-intellectual disability syndrome 0 trials
- Spondylomegaepiphyseal dysplasia with upper limb mesomelia, punctate calcifications, and deafness 0 trials
- Spondylometaphyseal dysplasia with corneal dystrophy 0 trials
- Sternum, premature obliteration of sutures of 0 trials
- Storm syndrome 0 trials
- Streptococcus, group A, severity of infection by 0 trials
- Structural brain anomalies with impaired intellectual development and craniosynostosis 0 trials
- Structural heart defects and renal anomalies syndrome 0 trials
- Subaortic stenosis, membranous 0 trials
- Succinic acidemia 0 trials
- Sucrosuria, hiatus hernia and intellectual disability 0 trials
- Sudden cardiac failure, alcohol-induced 0 trials
- Sudden cardiac failure, infantile 0 trials
- Sudden infant death-dysgenesis of the testes syndrome 0 trials
- Superior transverse scapular ligament, calcification of, familial 0 trials
- Supernumerary der(22)t(8;22) syndrome 0 trials
- Suppressor of tumorigenicity 3 0 trials
- Surface antigen, glycoprotein 75 0 trials
- Surface polypeptides, anonymous 0 trials
- Symphalangism of toes 0 trials
- Symphalangism with multiple anomalies of hands and feet 0 trials
- Symphalangism, C. S. Lewis type 0 trials
- Symphalangism, distal, with microdontia, dental pulp stones, and narrowed zygomatic arch 0 trials
- Syndesmodysplasic dwarfism 0 trials
- Syndromic multisystem autoimmune disease due to ITCH deficiency 0 trials
- Syngnathia multiple anomalies 0 trials
- Syngnathia-cleft palate syndrome 0 trials
- Synovial chondromatosis, familial, with dwarfism 0 trials
- Syringomas, multiple 0 trials
- Tall stature-intellectual disability-renal anomalies syndrome 0 trials
- Talonavicular coalition 0 trials
- Taurodontism, microdontia, and dens invaginatus 0 trials
- Tear protein, anodal 0 trials
- Teeth present at birth 0 trials
- Teeth, fused 0 trials
- Teeth, odd shapes of 0 trials
- Telangiectasia, impaired intellectual development, microcephaly, metaphyseal dysplasia, eye abnormalities, and short stature 0 trials
- Temperature-sensitive lethal mutation 0 trials
- Temtamy syndrome 0 trials
- Testes, rudimentary 0 trials
- Testicular anomalies with or without congenital heart disease 0 trials
- Testicular microlithiasis 0 trials
- Tetraamelia with ectodermal dysplasia and lacrimal duct abnormalities 0 trials
- Tetraamelia-multiple malformations syndrome 0 trials Sub-types →
- Tetralogy of fallot and glaucoma 0 trials
- Tetralogy of fallot syndrome, autosomal recessive 0 trials
- Tetramelic monodactyly 0 trials
- Tetrasomy 18p 0 trials
- Thalamic degeneration, symmetric infantile 0 trials
- Thickened earlobes-conductive deafness syndrome 0 trials
- Thoracic dysostosis, isolated 0 trials
- Thrombocytopenia with elevated serum IgA and renal disease 0 trials
- Thrombocytopenia, anemia, and myelofibrosis 0 trials
- Thrombocytopenia-Robin sequence syndrome 0 trials
- Thumb deformity 0 trials
- Thumb, distal hyperextensibility of 0 trials
- Thumbs, congenital Clasped 0 trials
- Thymic aplasia with fetal death 0 trials
- Thymoma, familial 0 trials
- Thyroid hormone metabolism, abnormal 0 trials Sub-types →
- Thyroid hormone plasma membrane transport defect 0 trials
- Tibia, absence of, with congenital deafness 0 trials
- Tibial aplasia-ectrodactyly syndrome 0 trials Sub-types →
- Tibial torsion, bilateral medial 0 trials
- Tiglic acidemia 0 trials
- Toe, fifth, number of phalanges 1N 0 trials
- Toe, misshapen 0 trials
- Toe, rotated fifth 0 trials
- Toes, relative length of first and second 0 trials
- Toes, space between first and second 0 trials
- Tongue, pigmented fungiform papillae of 0 trials
- Torus palatinus and torus mandibularis 0 trials
- Transient infantile hypertriglyceridemia and hepatosteatosis 0 trials
- Tremor of intention, ataxia, and lipofuscinosis 0 trials
- Tremor, hereditary essential, and idiopathic normal pressure hydrocephalus 0 trials
- Trichilemmal cyst 0 trials
- Trichoepitheliomas, multiple desmoplastic 0 trials
- Trichohepatoneurodevelopmental syndrome 0 trials
- Trichoscyphodysplasia 0 trials
- Triokinase and FMN cyclase deficiency syndrome 0 trials
- Triphalangeal thumb with double phalanges 0 trials
- Triphalangeal thumb-polysyndactyly syndrome 0 trials
- Trisomy 18-like syndrome 0 trials
- Trypsinogen deficiency 0 trials
- Tuberculin skin test reactivity, absence of 0 trials
- Tubulin, beta 0 trials
- Tumor suppressor gene on chromosome 11 0 trials
- Turnpenny-fry syndrome 0 trials
- Ubiquitin-activating enzyme, Y-linked 0 trials
- Ulna hypoplasia-intellectual disability syndrome 0 trials
- Ulnar agenesis and endocardial fibroelastosis 0 trials
- Ulnar hypoplasia-split foot syndrome 0 trials
- Ulnar ray dysgenesis with postaxial polydactyly and renal cystic dysplasia 0 trials
- Umbilicus, familial flat 0 trials
- Uncombable hair syndrome 1 0 trials
- Uncombable hair syndrome 2 0 trials
- Uncombable hair syndrome 3 0 trials
- Unique green phenomenon 0 trials
- Ureter, bifid or double 0 trials
- Ureterocele 0 trials
- Urogenital adysplasia 0 trials
- Uveal coloboma-cleft lip and palate-intellectual disability 0 trials
- Vacuolar Neuromyopathy 0 trials
- Van Bogaert-Hozay syndrome 0 trials
- Van Maldergem syndrome 0 trials Sub-types →
- Varicella, severe recurrent 0 trials
- Vascular helix of umbilical cord 0 trials
- Vascular hyalinosis 0 trials
- Vasculitis, lymphocytic, cutaneous small vessel 0 trials
- Veins, pattern of, on anterior thorax 0 trials
- Ventriculomegaly and arthrogryposis 0 trials
- Ventriculomegaly with defects of the radius and kidney 0 trials
- Ventriculomegaly-cystic kidney disease 0 trials
- Venular insufficiency, systemic 0 trials
- Vertebral anomalies and variable endocrine and T-cell dysfunction 0 trials
- Vertebral hypersegmentation and orofacial anomalies 0 trials
- Vertebral hypoplasia with lumbar kyphosis 0 trials
- Vertebral, cardiac, tracheoesophageal, renal, and limb defects 0 trials
- Vestibulocochlear dysfunction, progressive 0 trials
- Visceral neuropathy, familial 0 trials Sub-types →
- Visual impairment and progressive phthisis bulbi 0 trials
- Vitamin D-dependent rickets, type 3 0 trials
- Vitiligo, progressive, with intellectual disability and urethral duplication 0 trials
- Vitreoretinopathy with phalangeal epiphyseal dysplasia 0 trials
- Warburg-cinotti syndrome 0 trials
- Widow's peak syndrome 0 trials
- Woolly hair-skin fragility syndrome 0 trials
- Wooly hair, autosomal recessive 3 0 trials
- Wormian bone-multiple fractures-dentinogenesis imperfecta-skeletal dysplasia 0 trials
- Xerosis and growth failure with immune and pulmonary dysfunction syndrome 0 trials
- Xylosidase deficiency 0 trials
- Yakut short stature syndrome 0 trials
- Zinc deficiency, transient neonatal 0 trials
-
Chromosomal disorder 13 trials · 278 incl. sub-types
18 sub-types
- Autosomal anomaly 0 trials · 195 incl. sub-types Sub-types →
- Syndrome caused by partial chromosomal deletion 0 trials · 57 incl. sub-types Sub-types →
- Aneuploidy 14 trials · 36 incl. sub-types Sub-types →
- Prader-Willi syndrome 32 trials Sub-types →
- Syndrome caused by partial chromosomal duplication 0 trials · 32 incl. sub-types Sub-types →
- Gonosome anomaly 6 trials · 20 incl. sub-types Sub-types →
- Silver-Russell syndrome 7 trials Sub-types →
- Chromosome inversion disorder 1 trial Sub-types →
- Polyploidy 0 trials · 1 incl. sub-types Sub-types →
- Uniparental disomy 0 trials · 1 incl. sub-types Sub-types →
- Bloom syndrome 0 trials
- FRAXD syndrome 0 trials
- Chromosome 16q12 duplication syndrome 0 trials
- Chromosome 1p36 deletion syndrome, proximal 0 trials
- Chromosome Xq13 duplication syndrome 0 trials
- Duplication/inversion 15q11 0 trials
- Mosaic variegated aneuploidy syndrome 0 trials Sub-types →
- Ring chromosome disorder 0 trials Sub-types →
Most studied deeper sub-types
Showing the 400 most recently updated of 3513 trials in this tab.
-
Rewriting the code: a One-Time gene fix for a rare immune disease?
Cure By invitation onlyThis trial tests a one-time gene therapy for WHIM syndrome, a rare inherited immune disorder that causes severe infections. Doctors collect a person's own blood stem cells, use base editing to correct the faulty CXCR4 gene, and return the edited cells to the body. The goal is to …
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Cure
Last updated Sep 21, 2026 20:00 UTC
-
Missing Iron-Carrying protein replaced in rare blood disorder
Cure OngoingAtransferrinemia is a rare inherited condition in which the body cannot make enough transferrin, a protein that moves iron through the blood. Without it, iron builds up in organs and red blood cells cannot form properly. Researchers are testing intravenous infusions of apotransfe…
Phase 2 • Sponsor: Prothya Biosolutions • Aim: Cure
Last updated Sep 18, 2026 00:00 UTC
-
Could a Half-Matched donor cure a rare immune disease?
Cure OngoingThis early-phase trial tests whether a bone marrow transplant from a partially matched relative can safely cure chronic granulomatous disease (CGD), a condition that causes severe infections and inflammation. Four people aged 4 to 65 with CGD and no perfect donor will receive che…
Early phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Cure
Last updated Sep 18, 2026 00:00 UTC
-
Can a Precision-Engineered transplant rebuild immunity in babies born without it?
Cure OngoingInfants with severe combined immunodeficiency (SCID) lack working immune cells and face life-threatening infections. A matched sibling donor transplant is the standard cure, but most babies do not have one. This trial tests a refined transplant using a parent or other partially m…
Phase 1/2 • Sponsor: St. Jude Children's Research Hospital • Aim: Cure
Last updated Sep 18, 2026 00:00 UTC
-
Can a One-Time gene therapy fix the root cause of rett syndrome?
Cure By invitation onlyRett syndrome is a rare genetic disorder that mostly affects girls and stems from mutations in the MECP2 gene. This trial tests GCB-002, an experimental gene therapy given as a single injection into the spinal fluid, in 6 to 9 girls aged 2 to 10 who have a confirmed MECP2 mutatio…
Sponsor: Genecombio Ltd. • Aim: Cure
Last updated Sep 17, 2026 00:00 UTC
-
One-Time gene therapy for fatal childhood brain disease: does it last?
Cure OngoingResearchers are following 64 people with cerebral adrenoleukodystrophy (CALD) for 15 years after they received a one-time gene therapy called eli-cel in earlier studies. The therapy uses the patient's own stem cells, modified to carry a working copy of the gene that is faulty in …
Sponsor: Genetix Biotherapeutics Inc. • Aim: Cure
Last updated Sep 16, 2026 00:00 UTC
-
One-Shot gene therapy aims to restore movement in children with SMA
Cure By invitation onlyResearchers test GCB-001, a gene therapy given as a single injection into the spinal fluid, in children aged 2 to 12 with type 2 spinal muscular atrophy who can sit alone but cannot walk. The trial checks safety and whether the treatment improves motor skills over 12 months. It i…
Sponsor: Genecombio Ltd. • Aim: Cure
Last updated Sep 13, 2026 00:00 UTC
-
Can a calming drug make cord blood transplants safer?
Cure PausedResearchers are testing whether adding abatacept to standard immune-suppressing drugs can prevent severe graft-versus-host disease after a double umbilical cord blood transplant. The trial enrolls people with blood cancers such as leukemia, lymphoma, and myelodysplastic syndromes…
Phase 2 • Sponsor: Leland Metheny • Aim: Cure
Last updated Sep 12, 2026 00:00 UTC
-
Can a milder transplant cure sickle cell and thalassemia in adults?
Cure OngoingResearchers are testing a stem cell transplant that uses low-dose radiation and two immune-suppressing drugs instead of high-dose chemotherapy. The goal is to cure severe sickle cell disease and beta-thalassemia in adults up to age 65 who have a matched sibling donor. Participant…
Phase 1/2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Cure
Last updated Sep 11, 2026 00:00 UTC
-
New combo aims to cure hodgkin lymphoma without harsh chemo or transplant
Cure OngoingThis study tests whether combining the drug pembrolizumab with a precise form of radiation can cure people with early-stage Hodgkin lymphoma that has returned or not responded to initial treatment. About 22 participants will receive this combination, with the goal of avoiding the…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Cure
Last updated Sep 04, 2026 00:00 UTC
-
Can a softer transplant cure sickle cell disease?
Cure OngoingThis trial tests a stem cell transplant method that uses lower doses of chemotherapy and radiation, aiming to reduce side effects while still replacing the faulty blood cells that cause sickle cell disease. Children and young adults up to age 25 with severe sickle cell disease ca…
Phase 2 • Sponsor: St. Jude Children's Research Hospital • Aim: Cure
Last updated Sep 03, 2026 00:00 UTC
-
Stick to a schedule to beat Pre-Diabetes?
Disease control OngoingThis study tests whether keeping a consistent daily routine—like eating and sleeping at the same times—can improve blood sugar control and reduce body fat in people with pre-diabetes. Researchers will enroll 34 adults and ask half to follow a fixed schedule for 12 weeks. The goal…
Sponsor: Columbia University • Aim: Disease control
Last updated Sep 21, 2026 20:00 UTC
-
New drug SAT-3247 tested for long-term muscle protection in duchenne MD
Disease control By invitation onlyThis study looks at the long-term safety and effects of a drug called SAT-3247 in 10 people with Duchenne muscular dystrophy who were in a previous trial. Participants take the drug by mouth five days a week for about 11 months. Researchers will check for side effects and measure…
Phase 2 • Sponsor: Satellos Bioscience, Inc. • Aim: Disease control
Last updated Sep 21, 2026 20:00 UTC
-
New enzyme therapy aims to reach the brain in hunter syndrome
Disease control OngoingResearchers are testing a new enzyme replacement therapy called GNR-055 in people with Hunter syndrome (MPS II), a rare inherited disorder that causes harmful sugar molecules to build up in the body. The trial enrolls about 32 patients, including those who have never had enzyme t…
Phase 2/3 • Sponsor: AO GENERIUM • Aim: Disease control
Last updated Sep 21, 2026 20:00 UTC
-
Modified vitamin a pill tested against inherited blindness
Disease control OngoingResearchers are testing whether a daily pill called ALK-001 can slow the progression of Stargardt disease, a rare inherited condition that causes vision loss in children and young adults. The trial enrolls people aged 8 and older who have a clinical diagnosis of Stargardt disease…
Phase 2 • Sponsor: Alkeus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 21, 2026 20:00 UTC
-
New hope for kids with tough cancers: targeted drug attacks gene flaw
Disease control OngoingThis study tests a drug called ulixertinib in children and teens whose advanced cancers have a specific genetic change in the MAPK pathway. The goal is to see if the drug can shrink or control the tumor. About 20 participants with various solid tumors, lymphomas, or related disor…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 21, 2026 20:00 UTC
-
Could keytruda tame tough prostate cancers?
Disease control OngoingThis phase 2 study tests pembrolizumab (Keytruda) in 40 men with metastatic castration-resistant prostate cancer that has specific genetic flaws (mismatch repair deficiency or CDK12 inactivation). The goal is to see if the drug can shrink tumors or slow the cancer. Researchers wi…
Phase 2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Sep 21, 2026 20:00 UTC
-
New combo shows promise for tough kidney cancers
Disease control OngoingThis study tests two drugs, nivolumab and cabozantinib, together in 60 people with advanced or metastatic non-clear cell kidney cancer. The goal is to see how well the combination shrinks tumors. Participants take cabozantinib daily and receive nivolumab infusions every two weeks…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Sep 21, 2026 20:00 UTC
-
New pill could tame tough psoriasis
Disease control OngoingThis phase 3 trial tests an oral drug called JNJ-77242113 in 774 adults with moderate to severe plaque psoriasis. Participants receive either the new drug, a placebo, or an active comparator (deucravacitinib) to see how well it clears skin lesions. The main goal is to measure imp…
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Sep 21, 2026 20:00 UTC
-
Immunotherapy drug blinatumomab aims to boost leukemia survival in major trial
Disease control OngoingThis Phase III trial is testing whether adding the immunotherapy drug blinatumomab to standard chemotherapy helps adults with a newly diagnosed type of acute lymphoblastic leukemia (ALL) live longer and stay cancer-free longer. About 488 participants are randomly assigned to rece…
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 21, 2026 20:00 UTC
-
Could a common diabetes drug help manage cystic Fibrosis-Related diabetes?
Disease control OngoingThis pilot study tests the safety and feasibility of empagliflozin (Jardiance) in 8 overweight or obese adults with cystic fibrosis-related diabetes (CFRD) who are already on insulin. Participants will receive either the drug or a placebo in a crossover design. The goal is to gat…
Phase 2/3 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Sep 21, 2026 20:00 UTC
-
New hope for kids with tough brain tumors: targeted drug shows promise
Disease control OngoingThis study tests a drug called selumetinib in children and young adults with low grade glioma that has come back or not responded to other treatments. The drug works by blocking certain enzymes that help tumor cells grow. The goal is to find the best dose and see if it can shrink…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 21, 2026 20:00 UTC
-
New pill targets genetic form of polycystic kidney disease
Disease control OngoingThis study tests an experimental drug called VX-407 in 24 adults with autosomal dominant polycystic kidney disease (ADPKD) who have specific changes in the PKD1 gene. The goal is to see if the drug can slow kidney growth and is safe. Participants take VX-407 tablets by mouth and …
Phase 2 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated Sep 21, 2026 20:00 UTC
-
Vitamin a derivative eyed to halt inherited blindness
Disease control OngoingResearchers are testing a daily oral drug called ALK-001 in people aged 8 to 70 with Stargardt disease, an inherited condition that causes progressive vision loss. The trial compares ALK-001 to a placebo over 24 months to see if the drug is safe and can slow damage to the retina.…
Phase 2 • Sponsor: Alkeus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 21, 2026 20:00 UTC
-
New drug cocktail takes on glioblastoma in early trial
Disease control OngoingThis early-stage study tests whether adding an experimental drug called OKN-007 to standard chemoradiotherapy is safe and tolerable for people with newly diagnosed glioblastoma, a fast-growing brain cancer. About 27 participants will receive the combination after surgery. The mai…
Phase 1 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can special glasses stop Kids' eyesight from getting worse?
Disease control OngoingThis study tests whether new spectacle lenses can safely slow the progression of myopia (nearsightedness) in children. About 249 kids will wear either the novel lenses or standard single vision glasses for 36 months. Researchers will measure changes in eye length and prescription…
Sponsor: HOYA Lens Thailand LTD. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Real-World lupus drug study launches in poland
Disease control OngoingThis study follows 100 Polish adults with systemic lupus erythematosus (SLE) who are receiving anifrolumab as part of their routine care. Researchers will track changes in disease activity and overall response over time. The goal is to see how well the drug works outside of contr…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug aims to stop brain bleeds in rare disease
Disease control OngoingThis study tests an experimental drug called ALN-APP in 200 adults with cerebral amyloid angiopathy (CAA), a condition that causes bleeding in the brain. The drug is given via spinal injection and aims to slow disease progression and reduce new brain bleeds. Participants will be …
Phase 2 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug cocktail aims to shrink Hard-to-Treat carcinoid tumors
Disease control OngoingThis Phase II trial tests whether combining lenvatinib and everolimus can shrink or slow advanced carcinoid tumors that cannot be removed by surgery. The study enrolls 36 adults with confirmed unresectable carcinoid tumors. Both drugs are taken orally and work by blocking enzymes…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Brain pacemaker tested for Musician's hand cramps
Disease control OngoingThis study tests deep brain stimulation (DBS) surgery for people with severe focal hand dystonia, including musician's dystonia, that hasn't improved with botulinum toxin. Five participants will have electrodes placed in brain areas that control movement, connected to a stimulato…
Phase 1/2 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Immunotherapy combo shows promise in preventing High-Risk uterine cancer return
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy (with or without radiation) after surgery can help prevent high-risk endometrial cancer from coming back. About 990 participants who had surgery to remove their uterus and ovaries will r…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New study aims to boost growth and health in kids with thalassemia
Disease control OngoingThis study looks at growth problems in children with thalassemia, a blood disorder. Researchers will test a program that includes health education, nutrition plans, exercise, and support to help kids grow better. The goal is to improve height, weight, and overall well-being in 36…
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug aims to slow kidney failure in rare genetic disease
Disease control OngoingThis study tests an experimental drug called BAY 3401016 in 60 adults aged 18 to 45 with Alport syndrome, a rare genetic condition that damages kidneys, hearing, and eyes. The drug works by blocking a protein thought to cause kidney injury, with the goal of slowing the loss of ki…
Phase 2 • Sponsor: Bayer • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New antibody takes aim at Hard-to-Treat blood cancers
Disease control OngoingThis early-stage trial tests a new antibody drug called Hu8F4 in 72 people with advanced blood cancers like leukemia and myelodysplastic syndrome. The goal is to find the safest dose and see if it can slow or stop cancer growth. Researchers will also track how long patients live …
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New psoriasis drug shows promise for kids in Head-to-Head trial
Disease control OngoingThis study tests a new medicine called bimekizumab against an existing one (ustekinumab) for children and teens aged 6 to 17 with moderate to severe plaque psoriasis. The goal is to see if bimekizumab works better at clearing skin symptoms. About 168 participants will receive inj…
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Higher-Dose eye injection shows promise for two leading causes of vision loss
Disease control OngoingThis study tests a higher dose of the drug aflibercept (8 mg) given as an eye injection every 4 weeks to people with wet age-related macular degeneration (nAMD) or diabetic macular edema (DME). The goal is to see if this dosing schedule is safe and works well for those who have a…
Phase 3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New daily shot could help kids with hemophilia avoid bleeds
Disease control OngoingThis study tests a daily injection called concizumab in children under 12 with hemophilia A or B, with or without inhibitors. The goal is to see if it safely prevents bleeding episodes. Participants receive daily shots under the skin for at least 2 years, and the study tracks how…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug shows promise for Crohn's sufferers in Mid-Stage trial
Disease control OngoingThis study tests a new drug called AZD7798 in 120 people with moderate to severe Crohn's disease. The goal is to see if it can reduce symptoms and improve the appearance of the gut lining. Participants are randomly assigned to receive either the drug or a placebo, and neither the…
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New combo aims to deepen remission in early CML
Disease control OngoingThis study tests whether adding ASTX727 to the standard drug dasatinib can better control chronic myeloid leukemia (CML) in newly diagnosed patients. About 70 adults with a specific genetic marker (Philadelphia chromosome) will receive both pills. The goal is to see if the combin…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New lupus drug tested for Long-Term safety in large trial
Disease control By invitation onlyThis study is checking the long-term safety of a drug called dapirolizumab pegol for people with systemic lupus erythematosus (lupus). It involves 760 participants who have already completed earlier studies of the drug. Researchers will monitor side effects over time to see if th…
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can Device-Preserved donor lungs boost transplant success?
Disease control By invitation onlyThis registry collects data on lung transplant patients whose donor lungs were preserved and transported using the LUNGguard or BAROguard devices. Researchers track outcomes such as primary graft dysfunction, rejection, survival, ICU and hospital stays, readmissions, and time on …
Sponsor: Paragonix Technologies • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New gene therapy targets Parkinson's in patients with specific gene flaw
Disease control OngoingThis study tests a new gene therapy called LY3884961 in 32 people with moderate to severe Parkinson's disease who have a specific genetic change (GBA1 mutation). The treatment is given as a single injection into the fluid around the brain and spinal cord. The main goal is to chec…
Phase 1/2 • Sponsor: Prevail Therapeutics • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for lupus skin lesions: drug trial targets stubborn cases
Disease control OngoingThis study tests a drug called litifilimab for people with lupus-related skin disease that didn't get better with standard antimalarial pills. About 450 adults with active skin lesions will receive either the drug or a placebo every 4 weeks for 24 weeks, then everyone gets the dr…
Phase 2/3 • Sponsor: Biogen • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New combo therapy shows promise for Radioiodine-Resistant thyroid cancer
Disease control OngoingThis phase 2 trial tests a combination of the immunotherapy drug PDR001 with either trametinib or dabrafenib in 19 patients with thyroid cancer that no longer responds to radioiodine treatment. The goal is to see if the combination can shrink tumors. The study is active but no lo…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New cocktail of drugs tested for Tough-to-Treat lymphoma
Disease control OngoingThis phase 2 trial is testing several new drug combinations for people with aggressive B-cell lymphoma that has come back or not responded to standard therapy. About 129 participants will receive one of several experimental combinations, including drugs like ibrutinib and selinex…
Phase 2 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New hope for kids with pompe: enzyme combo trial underway
Disease control OngoingThis study tests a new treatment called cipaglucosidase alfa/miglustat in children (0 to under 18 years) with late-onset Pompe disease. The goal is to see if it is safe and how well it works. Participants either have never had enzyme therapy before or have been on it for at least…
Phase 3 • Sponsor: Amicus Therapeutics • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Gene therapy shot aims to tame autoimmune diseases in early trial
Disease control OngoingThis early-phase study tests a single injection of a gene therapy called V001-BCMA for people with autoimmune diseases like lupus that have not responded to standard treatments. The therapy targets and modifies specific immune cells to reduce disease activity. The main goal is to…
Early phase 1 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Two biologics go head to head in ulcerative colitis
Disease control OngoingResearchers compare two biologic drugs, ustekinumab and infliximab, in adults with moderate to severe ulcerative colitis who have not previously tried biologic therapy. The trial measures how well each drug reduces inflammation, controls symptoms, and improves quality of life, wh…
Sponsor: Helwan University • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New study tests everolimus for kidney tumors in TSC patients
Disease control OngoingThis study looks at how safe and effective the drug everolimus is for Taiwanese adults with tuberous sclerosis complex (TSC) who have kidney tumors called angiomyolipomas. Four participants will take the drug and be monitored for side effects and tumor shrinkage. The goal is to c…
Phase 4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New oil therapy could slash Life-Threatening events in kids with rare metabolic disease
Disease control OngoingThis study tests whether triheptanoin, a special oil, can reduce major clinical events (like severe low blood sugar or heart problems) in children with long-chain fatty acid oxidation disorders (LC-FAOD), a rare condition where the body can't break down certain fats for energy. A…
Phase 3 • Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Lifeline for ALK cancer patients: continued access to ceritinib
Disease control OngoingThis study offers continued treatment with the drug ceritinib to people with ALK-positive cancers who were already benefiting from it in a previous Novartis study. The main goal is to track safety and side effects over time. About 233 participants will receive the drug as long as…
Phase 4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Hope for becker MD: new drug shows promise in Long-Term trial
Disease control By invitation onlyThis study looks at the long-term safety and effects of a drug called EDG-5506 (sevasemten) in people with Becker muscular dystrophy, a muscle-weakening disease. About 260 adults and teens who were in earlier EDG-5506 studies will take the drug and be monitored for side effects a…
Phase 2 • Sponsor: Edgewise Therapeutics, Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New eye injection aims to slow genetic blindness
Disease control OngoingThis study tests a new medicine called PYC-001, given as an injection into the eye, for people with a genetic condition that damages the optic nerve (OPA1 optic atrophy). The main goal is to check if the treatment is safe and tolerable. About 18 adults will receive a single dose,…
Phase 1 • Sponsor: PYC Therapeutics • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New hope for dravet syndrome: phase 3 trial of LP352 aims to cut seizure frequency
Disease control OngoingThis study tests whether the drug LP352 can safely reduce seizures in children and adults with Dravet syndrome, a severe form of epilepsy. About 160 participants will receive either LP352 or a placebo, and researchers will track changes in seizure frequency over several months. T…
Phase 3 • Sponsor: Longboard Pharmaceuticals • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can special lenses plus eye drops stop Kids' myopia from getting worse?
Disease control OngoingThis study tests whether combining special glasses (that create optical defocus) with low-dose atropine eye drops can better control myopia (nearsightedness) in children aged 7 to 12. Over 18 months, researchers will measure changes in eye prescription and eye length. The goal is…
Sponsor: The Hong Kong Polytechnic University • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a daily injection save your sight? new trial for dry AMD
Disease control OngoingThis phase 3 trial tests whether a daily injection of elamipretide can slow vision loss in people with dry age-related macular degeneration (AMD). About 313 adults aged 55 and older with early dry AMD will receive either the drug or a placebo for 96 weeks. The main goal is to see…
Phase 3 • Sponsor: Stealth BioTherapeutics Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Promising drug may shrink inoperable tumors in kids with rare genetic condition
Disease control OngoingThis study tests a drug called selumetinib in children and young adults (ages 3-18) with neurofibromatosis type 1 (NF1) who have nerve tumors that cannot be removed by surgery. The goal is to see if the drug can shrink or slow the growth of these tumors. Participants take the dru…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New drug aims to tame rare bleeding disorder
Disease control OngoingThis study tests a new medicine called ALN-6400 for people with hereditary hemorrhagic telangiectasia (HHT), a condition that causes abnormal blood vessels and frequent nosebleeds. First, healthy volunteers will receive a single dose to check safety. Then, HHT patients will recei…
Phase 1/2 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for Crohn's: experimental drug targets gut inflammation
Disease control OngoingThis study tests an experimental drug called RO7790121 in about 21 adults with moderate to severe Crohn's disease who haven't responded well to other treatments. The goal is to see if the drug can reduce gut inflammation and improve symptoms like diarrhea and stomach pain. Partic…
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Could a simple ketone drink reduce the need for surgery in FAP patients?
Disease control By invitation onlyThis study tests whether a daily ketone supplement (BHB) is safe and tolerable for people with Familial Adenomatous Polyposis (FAP), a genetic condition that causes many colon polyps and often leads to surgery. Twenty participants will take the supplement for two weeks to see if …
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New drug shows promise for Long-Term control of rare immune disorders
Disease control OngoingThis study is testing the long-term safety of a drug called leniolisib in people with primary immunodeficiency disorders linked to PI3K signaling. Participants are 12 people who already took leniolisib in a previous study and may benefit from continuing it. The goal is to see if …
Phase 2 • Sponsor: Pharming Technologies B.V. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hip implant aims to fix cartilage without replacement
Disease control OngoingThis early study is testing a new device called the ReNew Hip Implant in 15 people aged 14 to 64 with hip cartilage damage from conditions like osteoarthritis or hip impingement. The implant is surgically placed to repair the cartilage. Researchers are checking if it is safe and …
Sponsor: Cytex Therapeutics, Inc. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New daily injection could cut bleeding episodes in hemophilia
Disease control OngoingThis study tests a medicine called concizumab for people with hemophilia A or B who do not have inhibitors. The goal is to see if a daily shot under the skin can prevent bleeding episodes safely. About 156 participants, aged 12 and older, will either start concizumab right away o…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Blood test showdown: MCV vs. ferritin in iron overload treatment
Disease control OngoingThis study looks at whether the MCV test (which measures red blood cell size) is as good as or better than the standard ferritin test for guiding phlebotomy (blood removal) therapy in people with hereditary hemochromatosis, a condition causing too much iron absorption. About 622 …
Phase 2 • Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a pill that starves tumors of oxygen help fight advanced cancer?
Disease control OngoingThis early-stage trial is testing an experimental drug called belzutifan in people with advanced solid tumors that have not responded to standard treatments. Belzutifan works by blocking a protein (HIF-2α) that tumors use to survive in low-oxygen conditions. The main goal is to f…
Phase 1 • Sponsor: Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for tough hodgkin lymphoma: immune drugs tested alone or together
Disease control OngoingThis study tests two immune-boosting drugs, ipilimumab and nivolumab, in people with classic Hodgkin lymphoma that has returned or not responded to prior therapy. The goal is to see if giving these drugs alone or together can shrink tumors. The trial involves 13 adults with measu…
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New study tests aggressive BP management to protect heart and kidneys in cancer patients
Disease control OngoingThis phase II trial tests whether intensive blood pressure management (targeting systolic BP below 120 mmHg) is better than standard care (below 140 mmHg) for patients with advanced kidney or thyroid cancer starting anti-angiogenic TKI therapy. The study enrolls 61 participants a…
Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for hard-to-treat lung cancer: experimental drug targets MET gene
Disease control OngoingThis study tests an experimental drug called REGN5093 in people with advanced non-small cell lung cancer that has a specific change in the MET gene. The first part finds a safe dose, and the second part checks if the drug can shrink tumors. About 231 participants will take part.
Phase 1/2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New stem cell approach aims to cure rare immune disease
Disease control OngoingThis study tests a high-dose stem cell transplant for people with chronic granulomatous disease (CGD), a condition that weakens the immune system. Participants receive donor stem cells along with drugs to prevent rejection and graft-versus-host disease. The goal is to improve tra…
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a daily pill boost blood counts in fanconi anemia?
Disease control OngoingFanconi anemia is a genetic condition that can damage bone marrow and lead to low blood cell counts, causing anemia, bleeding, or infections. Researchers are testing whether a daily pill called eltrombopag can improve blood counts in people with this condition. The trial enrolls …
Phase 2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
PET scans guide Nivolumab-Chemo combo in relapsed hodgkin lymphoma
Disease control OngoingResearchers test a treatment plan for adults with Hodgkin lymphoma that has come back or stopped responding to initial therapy. Participants receive nivolumab, an immunotherapy, plus three chemotherapy drugs. PET scans help doctors decide how much treatment each person needs. The…
Phase 1/2 • Sponsor: St. Petersburg State Pavlov Medical University • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Spinal gene injection aims to slow duchenne in toddlers
Disease control OngoingThis early-stage study tests a single injection of a gene therapy called INS1201, given into the spinal fluid of young boys (ages 2 to 5) with Duchenne muscular dystrophy who can still walk. The main goal is to check if the treatment is safe and to see how it spreads in the body.…
Phase 1 • Sponsor: Insmed Gene Therapy LLC • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Smart scans guide tailored therapy for hodgkin lymphoma patients
Disease control OngoingThis study tests a personalized approach for people with early-stage Hodgkin lymphoma. Doctors use PET scans to decide if standard chemotherapy alone is enough or if adding immunotherapy drugs can improve results. The goal is to boost survival while limiting unnecessary treatment…
Phase 2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New oral drug balinatunfib tested for long-term control of Crohn's and colitis
Disease control OngoingThis study looks at the long-term safety and effectiveness of balinatunfib, an oral tablet, in adults with Crohn's disease or ulcerative colitis. Participants have already completed a one-year treatment in a previous study. The trial will last up to 107 weeks and includes both do…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New hope for Hard-to-Treat seizures: phase 3 trial launches
Disease control OngoingThis study tests an experimental drug called LP352 to see if it can safely reduce seizures in children and adults with developmental and epileptic encephalopathies (DEE), a group of severe epilepsy syndromes. About 320 participants will receive either LP352 or a placebo, and rese…
Phase 3 • Sponsor: Longboard Pharmaceuticals • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Parkinson's patients get brain transplants of their own cells
Disease control By invitation onlyThis early-stage trial tests whether transplanting dopamine neurons made from a patient's own stem cells into the brain is safe for Parkinson's disease. Six people aged 55 to 80 with Parkinson's for at least 5 years will receive the cells in a single surgery. The main goal is to …
Phase 1 • Sponsor: Penelope J. Hallett, Ph.D. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Immunotherapy boost may wipe out stubborn leukemia cells
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab to standard tyrosine kinase inhibitors (TKIs) can eliminate tiny amounts of leftover leukemia cells in people with chronic myeloid leukemia (CML). About 40 adults with CML who still have detectable cancer marker…
Phase 2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New hope for duchenne: experimental drug targets genetic glitch
Disease control OngoingThis study tests an experimental drug called NS-089/NCNP-02 (Brogidirsen) in 20 boys with Duchenne muscular dystrophy whose genetic mutation can be fixed by skipping exon 44. The drug is given as a weekly IV infusion and aims to help the body produce a working version of the dyst…
Phase 2 • Sponsor: NS Pharma, Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New acne gel put to the test for Year-Long safety
Disease control OngoingThis study is testing whether a new gel applied daily for up to 52 weeks is safe for people with acne. About 400 participants will use the gel on their face and upper body and visit the clinic regularly for checkups. The main goal is to track any side effects, not to measure how …
Phase 3 • Sponsor: PPM Services S.A. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Brain implant shows promise for Hard-to-Treat seizures in rare epilepsy
Disease control OngoingThis study tests a brain-responsive neurostimulation system in 24 people aged 12 and older with Lennox-Gastaut syndrome whose seizures are not controlled by medication. The device detects and responds to seizure activity in the brain to reduce drop seizures. The goal is to see if…
Phase 2 • Sponsor: NeuroPace • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Can a Two-Drug chemo combo shrink BRCA breast tumors before surgery?
Disease control OngoingResearchers test whether giving mitomycin plus carboplatin before surgery helps people with BRCA1 or BRCA2 mutations and locally advanced triple-negative breast cancer. The trial compares this combination, followed by paclitaxel, against standard chemotherapy. About 30 adults wit…
Sponsor: N.N. Petrov National Medical Research Center of Oncology • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug duo aims to control rare lymphoma without chemotherapy
Disease control OngoingThis study tests whether combining zanubrutinib (a targeted pill) with rituximab (an antibody infusion) can shrink or control MALT lymphoma, a slow-growing cancer of the lymph nodes and organs. About 42 adults with newly diagnosed advanced disease or lymphoma that returned after …
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New hope for rare inflammatory disease: pacritinib trial begins
Disease control OngoingThis study tests a drug called pacritinib for people with VEXAS syndrome, a rare genetic disease that causes severe inflammation. About 78 adults will receive either the drug or a placebo to see if it controls symptoms and reduces flare-ups. The goal is to find a safe and effecti…
Phase 2 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Hope for rare disease: new drug shows promise in Long-Term study
Disease control By invitation onlyThis study is for people with PMM2-CDG, a rare genetic disorder, who have already taken the experimental drug GLM101 in a previous trial. The goal is to see if GLM101 is safe and effective over a longer period. Participants will receive weekly infusions of GLM101 at the same dose…
Phase 2 • Sponsor: Glycomine, Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Head-to-Head safety check: which Clot-Reversal drug is safer before emergency surgery?
Disease control OngoingThis observational study compares the safety of two drugs, BALFAXAR and KCENTRA, used to reverse the effects of vitamin K antagonist blood thinners (like warfarin) in adults who need urgent surgery or an invasive procedure. The main goal is to see how often blood clots (thromboem…
Sponsor: Octapharma • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New antibody aims to block muscle wasting in rare disease
Disease control OngoingThis Phase 2 trial tests a drug called RO7204239 in 51 adults with facioscapulohumeral muscular dystrophy (FSHD), a genetic condition that causes progressive muscle weakness. The drug is an antibody that blocks myostatin, a protein that normally limits muscle growth, to help pres…
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New pill shows promise for rare tumor in japanese patients
Disease control OngoingThis phase 2 study tests the drug nirogacestat in 20 Japanese adults with desmoid tumors that are growing. The goal is to see if the drug can shrink tumors or stop them from getting worse. Participants take nirogacestat as an oral tablet, and researchers will monitor tumor respon…
Phase 2 • Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Can a supplement duo quiet PCOS-Linked inflammation?
Disease control OngoingResearchers are testing whether a daily combination of myo-inositol and folic acid can lower two markers of inflammation, NLR and CRP, in overweight women aged 25 to 35 with polycystic ovarian syndrome. The trial compares this supplement pair with metformin plus folic acid over t…
Sponsor: Khyber Medical University Peshawar • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New antibody cocktail aims to tame ulcerative colitis for good
Disease control By invitation onlyThis study is testing three long-acting antibodies, alone or in combination, in 645 people with ulcerative colitis. The goal is to see if they are safe and can improve bowel inflammation over 48 weeks. Participants are joining from a previous study and may have already seen some …
Phase 2 • Sponsor: Spyre Therapeutics, Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New pill aims to tame rare immune diseases
Disease control OngoingThis early-stage trial tests an experimental drug called BI 3000202 in 16 adults with rare type 1 interferonopathies, such as Aicardi-Goutières syndrome. Participants take a low dose for 4 weeks, then a higher dose for 36 weeks. The main goal is to see if the drug is safe and how…
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New pill could tame lupus flares in major trial
Disease control OngoingThis phase 3 trial tests whether adding cenerimod, a daily pill, to standard lupus treatments can reduce symptoms in adults with moderate-to-severe systemic lupus erythematosus (SLE). About 470 participants will receive either cenerimod or a placebo for 12 months. Researchers wil…
Phase 3 • Sponsor: Viatris Innovation GmbH • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New hope for NF1 patients: drug shows promise against inoperable tumors
Disease control OngoingThis study tests a drug called selumetinib in adults with neurofibromatosis type 1 (NF1) who have nerve tumors that cannot be removed by surgery. The goal is to see if the drug can shrink these tumors or slow their growth. Participants take the drug twice daily and are monitored …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug targets Sugar-Coated proteins on cancer cells
Disease control OngoingResearchers are testing an experimental oral drug called PhOx430 in people with advanced solid tumors, including glioblastoma and triple-negative breast cancer. The trial has two parts: first, they give increasing doses to small groups to find a safe dose and watch for side effec…
Phase 1 • Sponsor: Phost'In Therapeutics • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug combo targets tough cancers in early trial
Disease control OngoingThis early-phase study tests a combination of two oral drugs, olaparib and ASTX727, in adults with advanced solid tumors that have mutations in genes like BRCA1, BRCA2, PALB2, ATM, or CHEK2. The main goals are to find the safest dose and to check for side effects. About 18 partic…
Phase 1 • Sponsor: Varun Monga, MBBS • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Immunotherapy combo aims to boost hodgkin lymphoma response in slow responders
Disease control OngoingThis phase 2 trial tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy can help children and young adults (ages 3-25) with newly diagnosed classical Hodgkin lymphoma who did not respond well to initial chemo. About 340 participants will receive pemb…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New gene therapy aims to fix immune system in rare disease
Disease control By invitation onlyThis study tests a new gene therapy for people with chronic granulomatous disease (CGD), a genetic disorder that weakens the immune system and makes them prone to serious infections. The treatment takes the patient's own blood stem cells, adds a missing gene in the lab, and puts …
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug LP352 aims to control seizures in severe epilepsy over the long term
Disease control By invitation onlyThis phase 3 study is testing the long-term safety and effectiveness of LP352 (Bexicaserin) in 324 children and adults with developmental and epileptic encephalopathy (DEE), including Dravet and Lennox-Gastaut syndromes. Participants who completed earlier studies will receive LP3…
Phase 3 • Sponsor: Longboard Pharmaceuticals • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Engineered donor cells aim to beat blood cancer without severe side effects
Disease control OngoingThis study tests a new way to treat children and young adults with high-risk blood cancers like leukemia and lymphoma. Doctors take blood cells from a family donor, remove certain T cells that can cause a harmful immune reaction, and then transplant the modified cells. The goal i…
Phase 2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New lupus pill shows promise in major trial
Disease control OngoingThis Phase 3 study tests whether adding cenerimod to standard lupus treatments can better control moderate-to-severe lupus symptoms. About 451 adults will receive either cenerimod or a placebo for 12 months. The main goal is to see if more people improve on a lupus disease activi…
Phase 3 • Sponsor: Viatris Innovation GmbH • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug combo shows promise in controlling Early-Stage leukemia
Disease control OngoingThis study tests a combination of two drugs, dasatinib and venetoclax, in people with early chronic phase chronic myeloid leukemia (CML). The goal is to see if the combination can better control the disease by blocking enzymes that help cancer cells grow. About 155 participants w…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Triple-Target CAR T-Cells take on tough lymphomas
Disease control By invitation onlyThis early-phase trial is testing a new type of immunotherapy called tri-specific CAR T-cells that target three proteins (CD19, CD20, CD22) on cancer cells. It is for adults with B-cell lymphomas that have come back or not responded to standard treatments. The study will enroll 1…
Phase 1 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New hope for ulcerative colitis: phase 3 trial of afimkibart underway
Disease control OngoingThis Phase 3 trial tests whether the drug Afimkibart can help people with moderate-to-severe ulcerative colitis achieve remission. About 400 adults who have not responded well to other treatments will receive either Afimkibart or a placebo. The study measures remission at 12 and …
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Nasal spray shows promise against deadly brain cancer
Disease control OngoingThis study tests a nasal spray drug called NEO100 (perillyl alcohol) in people with aggressive brain tumors (grade III or IV gliomas) that have come back or worsened. The trial has two phases: first to find the safest dose, then to see if it helps patients live longer. About 49 p…
Phase 1/2 • Sponsor: Neonc Technologies, Inc. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug aims to cut sickle cell pain crises in half
Disease control OngoingThis phase 3 study tests two doses of crizanlizumab against a placebo in 255 adolescents and adults with sickle cell disease who have frequent pain crises. The goal is to see if the drug can reduce the number of severe pain episodes that require a hospital or clinic visit. Partic…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug shows promise for rare blood cancer
Disease control OngoingThis phase 2 study tests acalabrutinib, a targeted drug, in 107 people with Waldenström macroglobulinemia, a rare blood cancer. The goal is to see how well the drug shrinks tumors and controls the disease. Participants either had prior treatment or are new to therapy and cannot t…
Phase 2 • Sponsor: Acerta Pharma BV • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Immunotherapy before surgery shows promise for certain colorectal cancers
Disease control OngoingThis trial is testing whether giving the immunotherapy drug pembrolizumab before surgery can improve outcomes for people with high-risk stage 2 or stage 3 colorectal cancer that has a specific genetic feature called mismatch repair deficiency. About 88 participants will receive p…
Phase 2 • Sponsor: University College, London • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Real-World check: is talzenna safe for advanced breast cancer?
Disease control CancelledThis study will track 600 people in Korea with advanced breast cancer who are already being prescribed Talzenna. Researchers will watch for side effects and see how well the drug works in everyday medical practice, not in a strict research setting. The goal is to confirm the drug…
Sponsor: Pfizer • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New MRI technique could revolutionize cystic fibrosis care
Disease control OngoingThis study tests a special MRI technique that uses inhaled gas to create detailed images of lung function in people with cystic fibrosis. Researchers want to see how a new triple-combination therapy changes lung ventilation over time. The study involves 64 participants and aims t…
Phase 4 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New laser method could make glaucoma treatment easier
Disease control By invitation onlyThis study tests if a new, automated laser treatment (DSLT) works as well as the standard laser treatment (SLT) for lowering eye pressure in people with open-angle glaucoma. About 51 adults will receive one of the two treatments and be followed for 12 months. The goal is to see i…
Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Can a Twice-Daily hormone pill match standard care for CAH?
Disease control CancelledResearchers are testing whether Chronocort, a modified-release hydrocortisone taken twice daily, controls hormones as well as standard glucocorticoid therapy in people aged 16 and over with congenital adrenal hyperplasia. The trial assigns participants to either Chronocort or the…
Phase 3 • Sponsor: Neurocrine UK Limited • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Eye drops face off to halt Kids' worsening nearsightedness
Disease control OngoingResearchers compare two strengths of atropine eye drops, 0.05% and 0.5%, in Dutch children aged 6 to 11 with progressive nearsightedness. About 550 children use the drops for three years, then researchers follow them for two more years. The goal is to see which strength better sl…
Phase 3 • Sponsor: Erasmus Medical Center • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Dialysis upgrade could protect bones in kidney patients
Disease control OngoingThis study tests whether a newer type of dialysis filter (medium cut-off membrane) can better manage bone and mineral problems common in people with end-stage kidney disease. Thirty adults on maintenance dialysis will try both the new and standard filters for three months each. R…
Sponsor: Gazi University • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Cornea transplant showdown: which surgery gives sharper sight?
Disease control OngoingThis study compares two types of cornea transplant surgery—DSAEK and DMEK—in 220 adults with corneal swelling or Fuchs' dystrophy. The goal is to see which procedure leads to better vision and patient satisfaction one year after surgery. Participants will be randomly assigned to …
Sponsor: University Hospital, Antwerp • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New epilepsy drug XEN1101 tested for long-term seizure control
Disease control By invitation onlyThis study tests the long-term safety and effectiveness of XEN1101 (azetukalner) in 880 adults with focal or tonic-clonic seizures. Participants who completed earlier studies will take XEN1101 capsules for up to 6 years. Researchers will track side effects and changes in monthly …
Phase 3 • Sponsor: Xenon Pharmaceuticals Inc. • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New drug cocktail shows promise for tough childhood brain cancers
Disease control OngoingThis trial is testing whether adding hydroxychloroquine to two targeted cancer drugs (dabrafenib and trametinib) can help children and young adults with certain brain tumors that have come back or not responded to treatment. The study includes patients with specific genetic chang…
Phase 1/2 • Sponsor: Pediatric Brain Tumor Consortium • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can early PET scans guide a gentler, more effective attack on hodgkin lymphoma?
Disease control OngoingThis phase 2 trial tests whether adjusting treatment based on a very early PET scan can improve outcomes and reduce side effects for people with advanced Hodgkin lymphoma. Participants receive brentuximab vedotin plus chemotherapy, with the regimen modified according to how well …
Phase 2 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New pill could tame severe ulcerative colitis Flare-Ups
Disease control OngoingThis study tests an experimental drug called SAR441566 in about 204 adults with moderate-to-severe ulcerative colitis, a chronic bowel disease causing inflammation and symptoms like diarrhea and bleeding. Participants will receive either the drug or a placebo for up to 52 weeks t…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New bone graft material could improve spine surgery outcomes
Disease control OngoingThis study is testing a material called Orthoss®, made from granules, to help bones in the spine fuse together after surgery. The trial includes 65 adults with lower back problems like slipped discs or narrowing of the spine canal. Doctors will check if the bones fuse properly an…
Sponsor: Geistlich Pharma AG • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can a Drug-Radiation combo outsmart Treatment-Resistant colorectal cancer?
Disease control CancelledThis phase 2 trial is testing whether combining an experimental drug called S-531011 with a precise radiation technique known as RadScopal can help control metastatic colorectal cancer that has not responded to prior treatments. The study enrolls about 30 adults with advanced dis…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New implant could replace eye drops after corneal surgery
Disease control By invitation onlyThis study tests whether a tiny steroid-releasing implant (Dextenza) placed in the tear duct works as well as standard steroid eye drops after corneal crosslinking surgery for keratoconus. About 20 people aged 13 and older with progressive keratoconus will receive either the impl…
Phase 1/2 • Sponsor: Maanasa Indaram, MD • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New lupus drug tested for Long-Term safety in 680 patients
Disease control By invitation onlyThis study looks at the long-term safety of cenerimod in adults with moderate-to-severe lupus. About 680 participants who were in a previous study will take cenerimod for up to 3 years, along with their usual lupus medications. Researchers will track side effects and see how well…
Phase 3 • Sponsor: Viatris Innovation GmbH • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New stem cell transplant trial aims to control tough lymphoma
Disease control OngoingThis study tests a stem cell transplant to control peripheral T-cell lymphoma in people whose cancer has not responded to standard treatments. Participants receive a donor's stem cells after chemotherapy or antibody therapy to prepare their body. The goal is to see if this approa…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New pill could tame ulcerative colitis Flare-Ups
Disease control OngoingThis study tests an experimental oral drug called GS-5290 (tilpisertib fosmecarbil) in 176 adults with moderate to severe ulcerative colitis. Participants are randomly assigned to receive either the drug or a placebo for 12 weeks. The main goal is to see if the drug can improve s…
Phase 2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New lupus drug shows promise in Long-Term safety trial
Disease control By invitation onlyThis study looks at the long-term safety of a drug called litifilimab for people with active lupus. About 864 adults who finished earlier studies will continue taking the drug for up to 3 years, along with their usual treatments. The goal is to see how safe it is and how well it …
Phase 3 • Sponsor: Biogen • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New eye injection aims to slow vision loss from Age-Related macular degeneration
Disease control OngoingThis study tests the safety of a drug called ASP3021 (avacincaptad pegol) for people in Japan with geographic atrophy, an advanced form of age-related macular degeneration that causes vision loss. Twenty participants will receive monthly injections into the affected eye for 12 mo…
Phase 4 • Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Myopia glasses may keep working even after kids take them off
Disease control OngoingResearchers are studying whether the benefit of a special spectacle lens for slowing nearsightedness lasts after children stop wearing it. The trial follows 91 children who took part in an earlier three-year study, where some wore the innovative lenses and others wore regular sin…
Sponsor: Essilor International • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Could an antibody slow Parkinson's? new trial hopes to find out
Disease control OngoingThis study tests an experimental drug called prasinezumab in 316 people with early Parkinson's disease. The drug is an antibody designed to target and remove clumps of a protein linked to Parkinson's. Participants receive either the drug or a placebo for 52 weeks, with an option …
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New hope for Crohn's: experimental drug aims to heal the gut
Disease control OngoingThis study tests an experimental drug called SAR441566 in 260 adults with moderate to severe Crohn's disease. Participants will receive different doses of the drug or a placebo for up to 52 weeks to see if it reduces gut inflammation and improves symptoms. The goal is to find a s…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New drug could cut transfusions for rare blood disorder
Disease control OngoingThis phase 2 trial tests luspatercept (Reblozyl) in adults and adolescents with alpha-thalassemia, a genetic blood disorder that causes anemia. The goal is to see if the drug can reduce the need for blood transfusions and raise hemoglobin levels. About 189 participants will recei…
Phase 2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Gene therapy hope for duchenne boys in first human test
Disease control OngoingThis early-stage trial tests a single dose of a gene therapy called JWK007 in 3 boys aged 5-10 with Duchenne muscular dystrophy. The main goal is to check safety and tolerability, while also looking at whether it helps muscle function. It is a very small, first-in-human study, so…
Phase 1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Can tailoring bypass length improve weight loss surgery results?
Disease control By invitation onlyResearchers are studying how the length of bypassed intestine during gastric bypass affects weight loss, complications, and metabolic changes in people with severe obesity. Participants will have different lengths of intestine bypassed and will provide blood and stool samples bef…
Sponsor: University of Missouri-Columbia • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Gene therapy shot could end frequent eye injections for wet AMD
Disease control OngoingThis early-stage trial tests a one-time gene therapy injection (NG101) for wet age-related macular degeneration. The therapy uses a harmless virus to deliver a gene that makes a drug inside the eye, aiming to reduce the need for repeated anti-VEGF injections. About 20 adults aged…
Phase 1/2 • Sponsor: Elisigen, Inc. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Ketogenic diet vs mediterranean diet: which better reshapes metabolism?
Disease control OngoingResearchers compare a very low calorie ketogenic diet with a Mediterranean-style low-calorie diet in 40 adults who have type 2 diabetes, obesity, and non-alcoholic fatty liver disease. Participants follow one of the two diets for several weeks. The study measures changes in weigh…
Sponsor: Azienda Ospedaliero Universitaria Maggiore della Carita • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New combo shows promise for rare adrenal cancers
Disease control OngoingThis study tests whether adding olaparib to the standard chemotherapy temozolomide helps control advanced pheochromocytoma or paraganglioma—rare neuroendocrine tumors that have spread or can't be removed surgically. About 46 adults with these cancers will be randomly assigned to …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Could skipping Face-Down recovery be safe for macular hole surgery?
Disease control OngoingThis trial tests whether people with large macular holes (over 400 micrometres) can heal without the usual face-down positioning after surgery. All participants undergo a procedure called inverted flap vitrectomy with gas tamponade, and half are asked to avoid face-down posturing…
Sponsor: Lahore General Hospital • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New drug bitopertin offers hope for sunlight pain relief in rare blood disorders
Disease control By invitation onlyThis long-term study tests the safety and effectiveness of bitopertin (DISC-1459) in people with erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP), rare conditions that cause severe pain from sunlight exposure. About 230 participants who previously took bitoper…
Phase 2/3 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Brain implant that learns: new hope for Parkinson's?
Disease control OngoingThis study tests an adaptive deep brain stimulation (aDBS) system that automatically adjusts stimulation based on real-time brain signals. It aims to improve symptom control for 62 people with Parkinson's disease in China who already have a compatible brain implant. The main goal…
Sponsor: MedtronicNeuro • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Could dead donors provide Life-Saving bone marrow?
Disease control OngoingThis early study is testing whether bone marrow from deceased donors can be safely used for transplants in people with blood cancers like leukemia and lymphoma. Twelve patients will receive the transplant along with chemotherapy or radiation. The main goal is to see if the new ma…
Phase 1/2 • Sponsor: Ossium Health, Inc. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New triple therapy shows promise for cystic fibrosis in Long-Term trial
Disease control OngoingThis study tests a triple-combination drug (VX-121/TEZ/D-IVA) for people with cystic fibrosis, a genetic condition that affects the lungs and digestion. The goal is to see if the treatment is safe and works well over a long period. About 822 participants who completed earlier stu…
Phase 3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Trikafta's long-term safety tested in cystic fibrosis patients with rare mutations
Disease control OngoingThis study looks at the long-term safety and effectiveness of the drug combination Trikafta (elexacaftor/tezacaftor/ivacaftor) in people with cystic fibrosis who have certain non-F508del gene mutations. About 297 participants who completed a prior study will continue taking the m…
Phase 3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Lung cancer hope: drug combo aims to boost survival in Early-Stage disease
Disease control OngoingThis phase 3 trial tests whether adding pembrolizumab (an immunotherapy) and olaparib (a targeted drug) to standard chemotherapy and radiation can help people with limited-stage small cell lung cancer live longer. About 672 participants will receive either the drug combo or a pla…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Tailored Three-Drug combo targets Myeloma's toughest genetic weak spot
Disease control OngoingResearchers are testing whether a combination of daratumumab, pomalidomide and dexamethasone can help people whose multiple myeloma has come back and carries a genetic change called del(17p). This change, found in about 10% of patients at diagnosis, makes the cancer harder to tre…
Phase 2 • Sponsor: Fondazione EMN Italy Onlus • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New hope for Drug-Resistant stomach cancer? sorafenib trial underway
Disease control OngoingThis phase 2 trial tests the drug sorafenib in 38 patients with gastrointestinal stromal tumor (GIST) that has worsened despite treatment with imatinib and sunitinib. Sorafenib works by blocking enzymes that help tumors grow and by cutting off blood supply to the cancer. The stud…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New pill hopes to tame rare blood cancer in japanese patients
Disease control OngoingThis study tests a cancer pill called venetoclax in 14 Japanese adults with a rare blood cancer (Waldenström macroglobulinemia) that has come back or not responded to treatment. Participants take the drug by mouth daily, with doses slowly increased. The main goal is to see how ma…
Phase 2 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New drug Mim8 shows promise for Long-Term bleeding prevention in hemophilia a
Disease control OngoingThis study tests Mim8, a drug that helps blood clot by mimicking a missing protein, in people with hemophilia A (with or without inhibitors). Over 450 participants will receive injections for up to 5.5 years to see if it safely prevents bleeding episodes. The goal is to provide a…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Hope for rare muscle disease: new drug enters final testing phase
Disease control OngoingThis study tests a drug called BBP-418 (Ribitol) in 81 people aged 12 to 60 with limb girdle muscular dystrophy type 2I (LGMD2I), a genetic condition that causes progressive muscle weakness. Participants receive either the drug or a placebo for 36 months to see if it slows the di…
Phase 3 • Sponsor: ML Bio Solutions, Inc. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New oral drug shows promise for rare sun allergy conditions
Disease control OngoingThis study is for people with erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP), rare conditions that cause severe pain and skin reactions to sunlight. The purpose is to check the long-term safety of an oral medication called dersimelagon. About 301 participant…
Phase 3 • Sponsor: Tanabe Pharma America, Inc. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New hope for angelman syndrome: experimental drug enters Mid-Stage trial
Disease control OngoingThis study tests an experimental drug called GTX-102 (apazunersen) in 60 people with Angelman syndrome, a genetic disorder causing developmental delays and seizures. Participants range from 1 to 65 years old and are grouped by age and genetic type. The goal is to see if the drug …
Phase 2 • Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New injection aims to tame lupus when standard treatments fail
Disease control OngoingThis early-stage study tests an injection called GC012F in 20 adults with refractory systemic lupus erythematosus (SLE) — a type of lupus that hasn't responded to standard treatments. The goal is to see if the therapy is safe and can reduce disease activity. Participants receive …
Phase 1/2 • Sponsor: Gracell Biotechnologies (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
SMA drug risdiplam under Long-Term watch: will it hold up?
Disease control OngoingThis study follows 403 adults and children with spinal muscular atrophy who are already taking risdiplam (Evrysdi) as prescribed by their doctor. Researchers will track side effects and how well the drug works over about two years. The goal is to see if risdiplam remains safe and…
Phase 4 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Gene therapy aims to tame rare metabolic disorder
Disease control OngoingThis Phase 3 trial tests a gene therapy called DTX301 for people with late-onset OTC deficiency, a rare genetic disorder that causes dangerous ammonia buildup. The study involves 37 participants and compares the gene therapy to a placebo. The goal is to see if the treatment can h…
Phase 3 • Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New drug aims to control angelman syndrome long-term
Disease control OngoingThis phase 3 trial tests the long-term safety of GTX-102 (apazunersen) in 255 people with Angelman syndrome, a genetic disorder causing developmental delays and seizures. Participants have already completed an earlier GTX-102 study and will continue receiving the drug. The main g…
Phase 3 • Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New Muscle-Boosting drug combo tested for SMA
Disease control OngoingThis study tests whether adding an experimental drug (RO7204239) to an existing SMA medicine (risdiplam) can help people with spinal muscular atrophy build stronger muscles and move better. The trial includes about 259 children and young adults, ages 2 to 25, who can walk. Resear…
Phase 2/3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Pompe disease patients get continued enzyme therapy in Long-Term safety study
Disease control OngoingThis study follows 17 people with Pompe disease who have already taken part in earlier trials of avalglucosidase alfa (Nexviadyme). It aims to check the drug's long-term safety and effectiveness by giving it every two weeks as an IV infusion. The study will continue until the dru…
Phase 4 • Sponsor: Genzyme, a Sanofi Company • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Triple therapy under the microscope: does it transform cystic fibrosis care?
Disease control OngoingResearchers are observing how elexacaftor/tezacaftor/ivacaftor triple combination therapy affects people with cystic fibrosis in routine care. The study follows two groups: children aged 6 to 11 and people aged 12 and older. Over seven years, they measure lung function, inflammat…
Phase 4 • Sponsor: Royal College of Surgeons, Ireland • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can focused radiation replace surgery for inherited pancreatic tumors?
Disease control OngoingPeople with MEN1 syndrome inherit a high risk of developing multiple pancreatic neuroendocrine tumors. Surgery is the only curative option but causes major complications. Researchers are testing high-dose, high-precision MR-guided radiotherapy to see if it can shrink these tumors…
Sponsor: J.M. de Laat • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New daily injection could cut bleeding in Tough-to-Treat hemophilia
Disease control OngoingThis study tests a drug called concizumab, given as a daily shot under the skin, to prevent bleeding in people with hemophilia A or B who have inhibitors (antibodies that block standard treatment). About 134 participants either start concizumab right away or continue their usual …
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New hope for kids with rare kidney disease: crovalimab trial underway
Disease control OngoingThis phase 3 trial tests crovalimab in 41 children with atypical hemolytic uremic syndrome (aHUS), a rare disease that causes blood clots and kidney damage. The drug is given first through a vein, then as a shot under the skin every four weeks. The goal is to see if it can stop d…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New pill combo aims to slash cholesterol in High-Risk patients
Disease control OngoingThis Phase 3 study tests whether a daily pill combining obicetrapib and ezetimibe, or obicetrapib alone, can lower LDL (bad) cholesterol more than placebo in 300 people with type 2 diabetes or metabolic syndrome. Participants continue their standard cholesterol medications. The m…
Phase 3 • Sponsor: NewAmsterdam Pharma • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Gene therapy trial targets duchenne in toddlers
Disease control OngoingThis study tests a gene therapy called delandistrogene moxeparvovec in 13 children under age 4 with Duchenne muscular dystrophy. The goal is to see if it is safe and can help produce a key muscle protein. The children will be followed for about 5 years.
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Daily Bone-Growth drug tested for taller stature in hypochondroplasia
Disease control By invitation onlyResearchers are studying whether daily injections of vosoritide can safely improve long-term growth in children with hypochondroplasia, a genetic condition that causes short stature. The trial enrolls about 140 children who have already taken vosoritide in earlier studies and who…
Phase 3 • Sponsor: BioMarin Pharmaceutical • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Sound waves open brain barrier to attack deadly tumor
Disease control PausedThis early study tests a combination approach for recurrent glioblastoma, an aggressive brain cancer. The treatment uses focused ultrasound (NaviFUS) to temporarily open the blood-brain barrier, allowing the drug Avastin (bevacizumab) to reach the tumor more effectively. Ten adul…
Phase 1/2 • Sponsor: NaviFUS Corporation • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New enzyme therapy aims to reach the brain in MPS II
Disease control OngoingResearchers are testing tividenofusp alfa (DNL310), an experimental enzyme replacement therapy, against the standard treatment idursulfase in children and young adults with mucopolysaccharidosis type II (MPS II). The study includes participants with and without brain involvement,…
Phase 2/3 • Sponsor: Denali Therapeutics Inc. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New clotting factor aims to stop bleeding in severe hemophilia a
Disease control OngoingThis phase 3 trial tests a new drug called FRSW107, a lab-made clotting factor VIII fused with a protein that helps it last longer in the body. The study enrolls males aged 12 to 65 with severe hemophilia A who have had at least 150 prior exposure days to factor VIII products. Pa…
Phase 3 • Sponsor: Hangzhou Gensciences Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Gene fix trial aims to tame rare immune disease
Disease control By invitation onlyThis study tests a gene therapy for people with X-linked chronic granulomatous disease (X-CGD), a genetic condition that weakens the immune system and leads to severe infections. Researchers take the patient's own stem cells, add a working copy of the faulty gene, and return the …
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Raspberry diet shows promise for gut health and metabolism
Disease control OngoingThis study looks at whether eating 2 cups of frozen raspberries daily for 8 weeks can improve blood sugar, cholesterol, and gut health in overweight or obese adults with early signs of metabolic syndrome. Researchers want to see if the berries' natural compounds help by changing …
Sponsor: Laval University • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New hope for men with Hard-to-Treat prostate cancer?
Disease control OngoingThis phase 3 trial compares a new drug, BMS-986365, against standard treatments (docetaxel or other hormone therapies) in 960 men with metastatic castration-resistant prostate cancer that has stopped responding to hormone therapy. The main goal is to see if the new drug delays ca…
Phase 3 • Sponsor: Celgene • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
One-Time infusion aims to build cancer killers inside the body
Disease control OngoingThis early study tests a new gene therapy called INT2104 in 10 adults with B-cell cancers that have come back or not responded to treatment. The therapy is given as a single IV infusion and works by instructing the body to create its own cancer-fighting T cells and natural killer…
Phase 1 • Sponsor: Kite, A Gilead Company • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New vaccine combo aims to slow Alzheimer's by targeting tau tangles
Disease control By invitation onlyThis study tests a vaccine called AADvac1, which targets tau tangles in the brain, a hallmark of Alzheimer's. It will be given alone or with another drug (donanemab) to 450 adults aged 50-80 with very early Alzheimer's. The goal is to see if this approach can reduce tau buildup a…
Phase 2 • Sponsor: Paul S. Aisen • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New mRNA inhalation therapy offers hope for Hard-to-Treat cystic fibrosis
Disease control OngoingThis early-stage trial tests an inhaled mRNA therapy called VX-522, combined with an existing drug (ivacaftor), in 26 adults with cystic fibrosis who have genetic mutations that do not respond to current modulator treatments. The main goals are to check safety and tolerability, a…
Phase 1/2 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Eye size may reveal which kids benefit most from myopia lenses
Disease control OngoingThis study tests whether pupil size changes can predict how well peripheral defocus spectacle lenses slow myopia progression in children. Researchers will measure pupil responses and track eye growth over 24 months in 14 kids with progressive myopia. The goal is to see if a simpl…
Sponsor: Bambino Gesù Hospital and Research Institute • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New drug cocktail targets rare bone cancer that spreads
Disease control OngoingThis study tests two drug combinations (belinostat plus either guadecitabine or ASTX727) in 19 adults with a rare bone cancer called chondrosarcoma that has spread or cannot be removed surgically. The goal is to see if the drugs can shrink tumors or stop them from growing. Partic…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a new enzyme therapy tame MPS II over time?
Disease control OngoingThis study tests the long-term safety and effects of JR-141, an enzyme replacement therapy, in people with mucopolysaccharidosis II (MPS II), a rare genetic disorder. Participants who completed an earlier JR-141 trial receive the drug again by IV infusion. Researchers track side …
Phase 2 • Sponsor: JCR Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Could a short pill course save hand function in advanced MS?
Disease control OngoingThis UK trial tests whether cladribine tablets, taken for just 8-10 days a year over two years, can slow the loss of hand function in people with advanced multiple sclerosis (MS). The study includes 204 participants with significant disability (EDSS 6.5-8.5). Half receive cladrib…
Phase 2/3 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a direct brain infusion slow sanfilippo syndrome?
Disease control OngoingThis trial tests an experimental enzyme replacement called GC1130A in children with Sanfilippo syndrome type A, a rare genetic disease that damages the brain. The enzyme is given through a small device placed under the scalp that delivers it directly into the fluid around the bra…
Phase 1 • Sponsor: GC Biopharma Corp • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New drug hope for rare kidney disease: daratumumab trial launches
Disease control OngoingThis study tests a drug called daratumumab in 40 people with a rare kidney condition called PGNMID, where abnormal proteins damage the kidneys. Participants receive weekly injections for 8 weeks, then every two weeks for another 8 weeks. The goal is to see if the drug can reduce …
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a brain implant let paralyzed people control computers with their minds?
Disease control OngoingThis study tests a device called a motor neuroprosthesis, an implantable brain computer interface designed to help people with severe paralysis control digital devices like computers or tablets. The device aims to bypass damaged motor pathways and transmit brain signals directly …
Sponsor: Synchron Medical, Inc. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Blueberry powder may tame metabolic syndrome by boosting gut bacteria
Disease control OngoingThis study tests whether taking 50 grams of blueberry powder daily for 8 weeks can improve gut bacteria and metabolic health in overweight or obese adults. Researchers will measure changes in blood sugar, cholesterol, and gut microbes. The goal is to see if blueberries can help m…
Sponsor: Laval University • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a weekly infusion reach the brain to fight a rare childhood disease?
Disease control OngoingThis trial tests an experimental drug called JR-441 in children with mucopolysaccharidosis type IIIA (MPS IIIA), a rare genetic condition that harms the brain and body. Researchers give the drug as a weekly intravenous infusion to see if it is safe and tolerable. They also measur…
Phase 1/2 • Sponsor: JCR Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New drug aims to slow Parkinson's progression in early stages
Disease control OngoingThis phase 2 trial tests whether prasinezumab, given as an IV infusion every 4 weeks, can slow motor decline in people with early Parkinson's disease. The study includes 586 participants who are already on stable Parkinson's medication. Researchers are measuring how long it takes…
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Could an arthritis drug help kids with duchenne MD? new trial aims to find out
Disease control OngoingThis study tests satralizumab, a drug that calms inflammation, in 30 children aged 8 to 17 with Duchenne muscular dystrophy. The goal is to see if it improves bone density and muscle function. Participants receive injections for several months while continuing standard steroid th…
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New study aims to help smokers with HIV kick the habit for good
Disease control OngoingThis study tests whether a smoking cessation medication (varenicline) combined with tools to help people stick with treatment can improve quit rates for smokers living with HIV. About 340 participants will be followed for 6 months to see if they stop smoking, confirmed by breath …
Phase 3 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a new injection tame hereditary swelling attacks?
Disease control ApprovedThis program provides access to an investigational drug called donidalorsen for people with hereditary angioedema (HAE), a genetic condition that causes sudden, painful swelling in various body parts. The drug is given as a monthly or every-other-month injection under the skin. I…
Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New clotting factor aims to cut bleeding episodes in severe hemophilia a
Disease control OngoingThis phase 3 trial tests a new drug called FRSW107, a long-lasting version of clotting factor VIII, in people with severe hemophilia A. The study enrolls males aged 12 to 65 who have had at least 150 prior exposure days to factor VIII products. Participants receive regular inject…
Phase 3 • Sponsor: Hangzhou Gensciences Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a single injection drug calm the immune attack on kidneys?
Disease control OngoingThis phase 2 trial tests an experimental drug called SGB-9768 in adults with three related kidney diseases: IgA nephropathy, C3 glomerulopathy, and immune complex-mediated membranoproliferative glomerulonephritis. These conditions occur when the immune system deposits proteins in…
Phase 2 • Sponsor: Suzhou Sanegene Bio Inc. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New pill aims to keep ulcerative colitis in check for a year
Disease control OngoingThis study looks at the safety and effectiveness of Velsipity tablets taken daily for up to 52 weeks by people with moderate to severe ulcerative colitis. About 553 participants will be followed in real-world medical settings. The goal is to see if the drug can help control sympt…
Sponsor: Pfizer • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Lupus drug anifrolumab put to the test in Real-World study
Disease control OngoingThis study follows 551 people with lupus who are starting anifrolumab for the first time. Researchers will track how well the drug controls disease activity, reduces flares, and improves quality of life over time. The goal is to see if the benefits seen in clinical trials hold up…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a tiny metal plug fix painful ankle defects?
Disease control OngoingThis trial tests whether a small metal implant, called the Episealer Talus, can relieve pain and improve function in people with a specific type of ankle cartilage damage. The study will enroll 20 adults aged 18 to 65 who have a focal defect on the talus bone and have not improve…
Sponsor: Stefano Zaffagnini • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
AI Doctor's helper: could a smart system improve heart and diabetes care?
Disease control OngoingThis study will test whether an artificial intelligence (AI) system can help community doctors better manage patients who have high blood pressure along with diabetes or high cholesterol. About 6,800 adults will be split into two groups: one where doctors use the AI tool to guide…
Sponsor: First Hospital of China Medical University • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Contact lens showdown: which lens slows Kids' nearsightedness best?
Disease control OngoingThis study compares two special contact lenses (MiSight 1 Day and Abiliti 1-Day) to see which one better slows the worsening of nearsightedness in Chinese children aged 6-12 living in New Zealand. Each child will wear a different lens in each eye for 6 months. The goal is to find…
Phase 3 • Sponsor: Aston University • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New eye drug could slash injection frequency for wet AMD patients
Disease control OngoingThis phase 3 trial tests EYP-1901, a new eye injection that may last longer than current treatments for wet age-related macular degeneration (AMD). About 400 participants will receive either EYP-1901 or the standard drug aflibercept. The goal is to see if EYP-1901 can maintain or…
Phase 3 • Sponsor: EyePoint Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New Gene-Targeting drug could change how we treat high blood pressure
Disease control OngoingThis early-stage study tests a new drug called ADX-850 in 28 people with mild to moderate high blood pressure. The drug uses siRNA technology to target genes involved in blood pressure regulation. The main goal is to check safety and how the drug moves through the body, with a se…
Phase 1 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a less invasive reflux surgery match the standard one?
Disease control OngoingThis trial compares two surgical procedures for people with gastroesophageal reflux disease (GERD) and a hiatal hernia. One procedure, called transoral incisionless fundoplication (TIF), is done through the mouth without cuts. The other, laparoscopic Nissen fundoplication (LNF), …
Sponsor: Mayo Clinic • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New lupus drug RO7507062 enters first human safety trial
Disease control OngoingThis early-stage study tests a new drug called RO7507062 in 70 people with systemic lupus erythematosus (SLE). The main goal is to check its safety and how the body processes it. Participants receive the drug as a shot under the skin, and the study will look for side effects and …
Phase 1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New program aims to tackle obesity in kids with down syndrome
Disease control OngoingThis study tests a 6-month family-based program called HomeGrown, designed to help parents of young children (ages 2-6) with Down syndrome create healthier home environments. Families get online tools, resources, and monthly coaching calls to improve nutrition and physical activi…
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New eye drug aims to cut injection frequency for wet AMD patients
Disease control OngoingThis phase 3 trial tests EYP-1901, a new eye injection that may last longer than current treatments for wet age-related macular degeneration (AMD). About 400 people with wet AMD will receive either EYP-1901 or standard aflibercept injections over 2 years. The main goal is to see …
Phase 3 • Sponsor: EyePoint Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a leukemia drug slow Parkinson's disease?
Disease control OngoingResearchers are testing whether radotinib, a drug used for leukemia, can help people with Parkinson's disease. The trial will give the drug or a placebo to about 43 adults aged 40 to 80 who were diagnosed within the past three years. The study measures safety, how the drug moves …
Phase 2 • Sponsor: Il-Yang Pharm. Co., Ltd. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New cocktail aims to boost remission in rare blood cancer
Disease control OngoingThis phase II trial tests whether adding the targeted drug acalabrutinib to standard chemotherapy (bendamustine and rituximab) improves outcomes for people with untreated Waldenstrom's macroglobulinemia, a rare blood cancer. About 63 participants will receive the three-drug combo…
Phase 2 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Gene therapy trial for rare muscle disease halted after severe side effects
Disease control OngoingThis trial tested a gene therapy called AT132 for X-linked myotubular myopathy (XLMTM), a rare muscle disease present at birth that causes severe breathing problems. The therapy aimed to deliver a healthy copy of the MTM1 gene to improve muscle function. However, the study was st…
Phase 2/3 • Sponsor: Astellas Gene Therapies • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Could removing certain immune cells prevent a deadly transplant complication?
Disease control OngoingThis study tests whether removing a specific type of immune cell (naive T cells) from donor stem cells can prevent chronic graft-versus-host disease (GVHD) in children and young adults with blood cancers. GVHD occurs when donor cells attack the patient's body after a stem cell tr…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a lower dose of a leukemia drug keep the disease in check?
Disease control OngoingThis study tests whether reducing the dose of the cancer drug radotinib can still control chronic myeloid leukemia in its early phase while possibly easing side effects. Adults newly diagnosed with this blood cancer take a lower dose twice daily for up to a year. Researchers meas…
Sponsor: Il-Yang Pharm. Co., Ltd. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a newer drug outperform the standard for chronic myeloid leukemia?
Disease control OngoingThis phase III trial compares two oral drugs, radotinib and imatinib, in adults newly diagnosed with chronic myeloid leukemia in its chronic phase. Researchers want to see if radotinib, taken twice daily, achieves a deeper molecular response at 12 months than imatinib, taken once…
Phase 3 • Sponsor: Il-Yang Pharm. Co., Ltd. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Children's trial launches for Friedreich's ataxia drug
Disease control OngoingThis study tests omaveloxolone, a drug already approved for adults with Friedreich's ataxia, in children aged 2 to 15. Researchers want to see how the drug moves through children's bodies and whether it is safe. The study involves two parts: a single dose followed by daily dosing…
Phase 1 • Sponsor: Biogen • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
When waters break early, does acting fast beat waiting?
Disease control By invitation onlyThis trial studies women whose water breaks before labor starts, a condition called premature rupture of membranes, at 37 to 42 weeks of pregnancy. Half the participants will have labor induced within 24 hours using a vaginal gel, while the other half will wait up to 24 hours for…
Sponsor: Pakistan Institute of Medical Sciences • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Bubble boy disease gets a gene fix: new trial offers hope
Disease control By invitation onlyThis study tests a new gene therapy for X-linked severe combined immunodeficiency (X-SCID), a rare immune disorder. Doctors take a person's own stem cells, fix a faulty gene using a technique called base editing, and return the cells to the body. The goal is to rebuild the immune…
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a weekly infusion slow the toll of a rare genetic disease?
Disease control OngoingThis trial tests whether JR-141, an enzyme replacement therapy given as a weekly IV infusion, can safely manage mucopolysaccharidosis type II (MPS II) over the long term. Researchers will follow about 27 people who completed an earlier JR-141 study, tracking side effects, develop…
Phase 2/3 • Sponsor: JCR Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New Bone-Boosting shot tested for first time in humans
Disease control OngoingThis early-stage study tests a new injectable drug called LYN101 in 44 people. First, healthy volunteers get a single dose to check safety. Then, postmenopausal women with low bone mass get multiple doses to see how the drug affects bone turnover markers. The main goal is safety,…
Phase 1 • Sponsor: Shanghai TTM-Bio Technology Co., Ltd • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New Huntington's drug enters first human tests
Disease control OngoingThis early-stage study tests a new drug called RG6496 in people who carry the gene for Huntington's disease. The main goal is to check if the drug is safe and how the body handles it. About 40 participants will receive a single dose injected into the spine, with some getting a pl…
Phase 1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Old asthma drug shows promise for rare genetic disorder
Disease control OngoingThis phase 2 trial tests whether theophylline, a drug used for asthma, can help people with pseudohypoparathyroidism lose weight and improve blood sugar control. The study includes 29 obese participants aged 13 and older. Researchers will measure changes in body mass index and gl…
Phase 2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Sound waves aimed at the brain: a new approach to OCD?
Disease control OngoingThis trial tests whether low intensity focused ultrasound (LIFU), a non-invasive technique that uses sound waves to stimulate deep brain regions, can safely ease symptoms of obsessive-compulsive disorder (OCD). Researchers will target the ventral striatum, an area linked to OCD, …
Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a cancer drug stop the body from making extra bone?
Disease control OngoingThis phase 2 trial tests whether saracatinib, an oral drug originally developed for cancer, can prevent new abnormal bone growth in adults with fibrodysplasia ossificans progressiva (FOP), a rare genetic condition where muscle and soft tissue turn into bone. Twenty adults with ac…
Phase 2 • Sponsor: Amsterdam UMC, location VUmc • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Small study tests plerixafor for gene therapy in sickle cell
Disease control OngoingThis early-phase trial is testing whether the drug plerixafor can safely and effectively collect enough stem cells from people with sickle cell disease for a future gene therapy. Only 5 participants are enrolled, and the main goal is to check for side effects. If it works, it cou…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New pill could let Sun-Sensitive patients enjoy the outdoors
Disease control OngoingThis Phase 3 trial tests whether bitopertin, a daily pill, can help people with erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP) spend more time in sunlight without pain. About 183 participants aged 12 and older will take bitopertin or a placebo for 6 months. …
Phase 3 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New 'Sandwich' strategy aims to stop leukemia relapse
Disease control OngoingThis study tests a new treatment plan for adults with B-cell acute lymphoblastic leukemia (B-ALL) who cannot or choose not to have a donor stem cell transplant. The approach uses a 'sandwich' strategy: first, patients receive two types of CAR T-cells (targeting CD22 and CD19), th…
Phase 2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a daily zinc pill tame insulin resistance in polyendocrine ovarian syndrome?
Disease control By invitation onlyThis trial tests whether taking 50 mg of zinc daily for 12 weeks, alongside standard treatment, improves insulin resistance and other features of polyendocrine metabolic ovarian syndrome (PMOS) in women aged 18 to 45. PMOS is a common hormone condition linked to insulin resistanc…
Sponsor: Bangladesh Medical University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Gene therapy trial hopes to treat rare muscle disease
Disease control OngoingThis early-stage study tests a gene therapy called AT845 for adults with late-onset Pompe disease, a condition that weakens muscles. The treatment aims to deliver a working copy of the GAA gene to muscle cells. Eleven participants who have been on standard enzyme replacement ther…
Phase 1/2 • Sponsor: Astellas Gene Therapies • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Could a common asthma drug help treat a rare genetic disorder?
Disease control By invitation onlyThis study tests whether theophylline, a drug used for asthma, can help children and young adults with pseudohypoparathyroidism—a rare genetic condition causing early obesity, hormone problems, and short stature. Researchers will check for weight loss, better blood sugar control,…
Phase 2 • Sponsor: Jaclyn Tamaroff • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a brain implant learn to sense OCD distress and respond in real time?
Disease control OngoingThis trial tests an adaptive deep brain stimulation system for people with severe obsessive-compulsive disorder (OCD) that has not improved with standard treatments. The device, implanted in the brain, aims to detect brain signals linked to OCD distress and adjust its stimulation…
Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New drug combo targets tough cancers in early trial
Disease control OngoingThis early-phase study tests a new drug called MK-2870, either alone or with the immunotherapy pembrolizumab, in Japanese patients with advanced solid tumors or a type of lung cancer. The main goal is to check the safety and side effects of these treatments. About 30 people will …
Phase 1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New hip implant aims to cut repeat surgeries
Disease control OngoingThis study is testing a new hip implant called the OR3O Dual Mobility System in 177 people who need hip replacement surgery. The goal is to see if the implant is safe and lasts longer without needing another surgery. Researchers will follow participants for up to 10 years to chec…
Sponsor: Smith & Nephew, Inc. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
One-Time cell therapy could tame tough lupus
Disease control OngoingThis study tests a one-time treatment called rapcabtagene autoleucel, made from a patient's own immune cells, for people with active lupus or lupus kidney disease that hasn't improved with standard therapies. About 179 adults will receive the treatment after a short chemotherapy …
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Which DBS setting works best for Parkinson's? a trial puts anodic vs cathodic to the test
Disease control OngoingThis trial tests three deep brain stimulation (DBS) settings in people with Parkinson's disease who already have a Boston Scientific Vercise system implanted. The settings are pure anodic, pure cathodic, and a mix of both. Researchers want to see which setting offers the best sym…
Sponsor: University of South Florida • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a single infusion stop GPP flares in their tracks?
Disease control OngoingThis study is testing whether the drug spesolimab can safely and effectively treat repeated flares of generalized pustular psoriasis (GPP), a serious skin condition. Adults with GPP who have had a flare will receive a single intravenous dose of spesolimab, with a possible second …
Phase 4 • Sponsor: LEO Pharma • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Could a One-Time immune cell infusion help older leukemia patients avoid harsh chemo?
Disease control OngoingThis early-phase trial tests a personalized cell therapy for adults aged 60 and older with B-cell acute lymphoblastic leukemia (ALL) who are in first remission. Researchers take a patient's own immune cells, modify them in the lab to recognize and attack leukemia cells, and infus…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New eye lens could let you focus without glasses after cataract surgery
Disease control OngoingThis study is testing a new type of intraocular lens (IOL) that can be adjusted after cataract surgery using laser energy, potentially allowing the eye to focus at different distances. Researchers will enroll 85 adults with cataracts in both eyes to check safety and how well the …
Sponsor: Alcon Research • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a collagen patch replace a palate graft for Better-Looking dental implants?
Disease control OngoingThis trial tests whether a collagen matrix can match the standard tissue graft for improving gum shape around a single dental implant in the front upper jaw. Thirty adults with one missing tooth will receive an implant and then either a graft taken from their palate or a collagen…
Sponsor: Damascus University • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a single gene therapy calm Parkinson's for years?
Disease control OngoingThis study follows people with Parkinson's disease who previously received AAV-GAD, a gene therapy infused into a brain region that helps control movement. The goal is to check how safe the treatment remains over many years, watching for any drug-related side effects. Researchers…
Phase 1/2 • Sponsor: MeiraGTx, LLC • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New pill combo aims to crush bad cholesterol
Disease control OngoingThis study tests whether adding a new drug called AZD0780 to the common statin rosuvastatin can lower 'bad' LDL cholesterol more than rosuvastatin alone. About 76 adults with high cholesterol will take either AZD0780 or a placebo pill, plus rosuvastatin, for 12 weeks. Neither par…
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
A daily eye drop might slow childhood nearsightedness. a trial puts it to the test.
Disease control OngoingThis phase 3 trial tests whether an experimental eye drop called CTO0308 can slow the progression of myopia, or nearsightedness, in children aged 5 to 12. Participants receive either the active drop or a placebo once daily in each eye for 12 months. Researchers measure changes in…
Phase 3 • Sponsor: Taejoon Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New hope for rare blood disorder: drug targets overactive immune cells
Disease control OngoingThis phase 2 trial is testing the drug ruxolitinib in people with hypereosinophilic syndrome, a rare condition where the body produces too many eosinophils (a type of white blood cell), causing organ damage. The study aims to see if ruxolitinib can normalize blood cell counts and…
Phase 2 • Sponsor: Stanford University • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Video diet coaching may cut heart risks after spinal cord injury
Disease control OngoingThis trial tests whether nutrition counseling delivered over video calls can help people with spinal cord injury eat healthier and lower their risk of obesity, high cholesterol, and diabetes. Participants, who are at least one year post-injury and overweight, will receive six ses…
Sponsor: Santa Clara Valley Health & Hospital System • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New hope for rare liver disease: drug shows promise in reducing damage and symptoms
Disease control OngoingThis study tests a new drug called elafibranor in people with primary biliary cholangitis (PBC), a rare liver disease that can lead to scarring and liver failure. Participants either did not get enough help from or could not take the standard medicine. The goal is to see if elafi…
Phase 3 • Sponsor: Ipsen • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Could brain pacemakers slow Alzheimer's? new trial tests DBS
Disease control By invitation onlyThis study tests whether deep brain stimulation (DBS) can improve thinking and memory in people with early Alzheimer's disease. Two participants will have electrodes implanted in a brain area that produces a key chemical for memory. The goal is to see if daily, one-hour stimulati…
Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Eye implant could replace monthly shots for blinding disease
Disease control OngoingThis study tests a small, refillable implant placed in the eye that slowly releases medication for wet age-related macular degeneration (nAMD). It aims to see if refilling the implant every 24 weeks works as well as getting a standard eye injection every 4 weeks. About 68 Chinese…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New drug shows promise for rare skin disease over nearly 5 years
Disease control OngoingThis study looks at the long-term safety and effectiveness of spesolimab in people with generalized pustular psoriasis (GPP), a rare and severe skin condition. All 131 participants had already taken spesolimab in a previous study and will continue treatment for up to 5 years. Res…
Phase 2 • Sponsor: LEO Pharma • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New hope for advanced stomach cancer: experimental combo targets HER2-positive tumors
Disease control OngoingThis study tests whether a new drug called zanidatamab, combined with chemotherapy and sometimes another drug (tislelizumab), works better than the current standard treatment for advanced HER2-positive stomach and esophageal cancers. About 920 adults whose cancer has spread or ca…
Phase 3 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New drug cocktail shows promise for rare cancers
Disease control OngoingThis phase 2 trial is testing whether a combination of two drugs, talazoparib and temozolomide, can shrink tumors in people with rare cancers that have spread. The study includes 14 participants with advanced rare solid tumors, such as pheochromocytoma or paraganglioma, who have …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New study tests belimumab to tame early lupus
Disease control OngoingThis study is testing the drug belimumab (Benlysta) in 350 adults who were diagnosed with systemic lupus erythematosus (SLE) within the last two years and still have active disease despite standard treatment. The goal is to see if adding belimumab helps more people reach a state …
Phase 4 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New fluid lens could sharpen vision after cataract surgery
Disease control OngoingThis study tests a new type of lens implant for people having cataract surgery. The lens uses fluid to adjust focus, aiming to improve vision compared to a standard fixed-focus lens. About 175 participants will receive either the new lens or a standard one, and their vision and a…
Sponsor: Alcon Research • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a muscle-boosting antibody help people with spinal muscular atrophy over the long haul?
Disease control OngoingThis trial tests the long-term safety and effectiveness of apitegromab, an investigational antibody that blocks myostatin, a protein that limits muscle growth. People with type 2 or type 3 spinal muscular atrophy who completed earlier apitegromab studies can join. Researchers wil…
Phase 3 • Sponsor: Scholar Rock, Inc. • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New study tests video coaching to help older adults shed pounds and prevent disease
Disease control OngoingThis study tests a video-based healthy lifestyle program for adults aged 50 to 74 who are overweight and have conditions like prediabetes, type 2 diabetes, or high blood pressure. Participants use a tablet, scale, and activity tracker at home, and some get extra support from a co…
Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New drug guselkumab aims to tame Crohn's Flare-Ups
Disease control OngoingThis study tests whether guselkumab, given as a shot under the skin, can help people with moderate to severe Crohn's disease achieve remission and heal their gut lining. About 350 adults who have not responded well to other treatments will receive either guselkumab or a placebo. …
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New drug guselkumab aims to tame Crohn's Flare-Ups
Disease control OngoingThis large study tests whether guselkumab, an injected drug, can control symptoms and heal the gut lining in people with moderate to severe Crohn's disease. About 1,400 participants will receive guselkumab, an existing treatment (ustekinumab), or a placebo. The goal is to see if …
Phase 2/3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New pill could tame tough psoriasis
Disease control OngoingThis phase 3 study tests an experimental oral drug, JNJ-77242113, in about 731 adults with moderate to severe plaque psoriasis. Participants receive either the new drug, a placebo, or an active comparator (deucravacitinib) to see how well it clears skin lesions. The main goal is …
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New hope for liver disease: drug shows promise in reducing damage
Disease control OngoingThis study tests a daily pill called elafibranor in about 18 Japanese adults with primary biliary cholangitis (PBC), a rare liver disease that can lead to scarring and liver failure. Participants had not responded well to standard treatment. The main goal is to see if the drug im…
Phase 3 • Sponsor: Ipsen • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New pill shows promise for rare, severe psoriasis
Disease control OngoingThis phase 3 trial tests an oral drug called JNJ-77242113 in 19 people with two rare and severe forms of psoriasis: generalized pustular psoriasis and erythrodermic psoriasis. The study measures how many participants see improvement after 16 weeks of treatment. It is an open-labe…
Phase 3 • Sponsor: Janssen Pharmaceutical K.K. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New drug guselkumab shows promise for ulcerative colitis in large trial
Disease control OngoingThis study tests guselkumab, a drug that targets inflammation, in over 1,000 people with moderate to severe ulcerative colitis. Participants receive either guselkumab or a placebo to see if the drug can improve symptoms and lead to remission. The goal is to find a new treatment o…
Phase 2/3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Could your own nerves help treat Parkinson's? early trial tests idea
Disease control OngoingThis study is testing whether implanting a small piece of a patient's own nerve tissue into the brain during deep brain stimulation (DBS) surgery is safe and doable for people with Parkinson's disease. The nerve tissue contains cells that produce growth factors, which might help …
Phase 1 • Sponsor: Craig van Horne, MD, PhD • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a One-Stop clinic solve the mystery of functional disorders?
Diagnosis OngoingFunctional somatic disorders cause persistent physical symptoms that doctors cannot explain by other diseases. The DISTRESS trial evaluates a new clinic where internal medicine doctors, trained to recognize these disorders, examine patients and provide guidance to their general p…
Sponsor: Regionshospitalet Silkeborg • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Glow-in-the-Dark mouth scans could catch cancer early
Diagnosis OngoingThis study tests whether special lights and cameras can help find early signs of mouth cancer in people at high risk. About 338 participants with precancerous spots or conditions like Fanconi anemia will have their mouths examined with fluorescence imaging, which makes abnormal c…
Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Sep 16, 2026 00:00 UTC
-
Can AI learn to spot kidney disease in biopsy images?
Diagnosis OngoingResearchers are building deep learning models that analyze digital images of kidney biopsy tissue to classify kidney diseases such as IgA nephropathy and membranous nephropathy. The study uses pathology images and clinical data from thousands of patients who had kidney biopsies a…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Diagnosis
Last updated Sep 16, 2026 00:00 UTC
-
AI chest X-Rays could catch hidden lung disease in zambia
Diagnosis OngoingThis project tests an integrated approach to lung health in Zambia. Community and primary care clinics screen people with cough, breathlessness or other respiratory symptoms for TB, post-TB lung disease, COPD, silicosis and pneumonia. All participants get a symptom check and a di…
Sponsor: Centre for Infectious Disease Research in Zambia • Aim: Diagnosis
Last updated Sep 13, 2026 00:00 UTC
-
Simple scan mistakes may skew osteoporosis diagnoses
Diagnosis OngoingResearchers at a Turkish hospital are studying how errors in bone density scans (DXA) affect doctors' decisions about osteoporosis. They will review scans from 530 adults, identify common positioning mistakes, correct them, and compare the original and corrected results. The goal…
Sponsor: Ankara Etlik City Hospital • Aim: Diagnosis
Last updated Sep 12, 2026 00:00 UTC
-
AI plus ultrasound could catch heart and lung decline before it turns critical
Diagnosis By invitation onlyResearchers are testing whether artificial intelligence can combine ultrasound images with routine health data to track changes in a person's physiology over time. The study enrolls adults with heart, lung, kidney, or blood vessel conditions, as well as healthy volunteers. The go…
Sponsor: Truway Health, Inc. • Aim: Diagnosis
Last updated Sep 12, 2026 00:00 UTC
-
Can a simple checklist predict how well dental treatment will go for people with down syndrome?
Diagnosis CancelledResearchers are testing a form that dentists fill out to score how cooperative a person with Down syndrome is likely to be during dental and orthodontic treatment. The form is completed at the first visit and updated later. The goal is to see whether the score helps dentists choo…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Diagnosis
Last updated Sep 06, 2026 00:00 UTC
-
Can AI turn routine scans into a bone health check?
Diagnosis OngoingThis trial tests whether an AI tool called DeepBMD can identify people at high risk for osteoporosis using CT scans they've already had for other reasons. Researchers will compare the AI's findings with the standard bone density test (DXA) to see if it's accurate. If it works, th…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Diagnosis
Last updated Sep 05, 2026 00:00 UTC
-
Monthly HIV prevention pill could replace daily dose
Prevention OngoingThis large phase 3 trial is testing whether a new oral pill called MK-8527, taken just once a month, can prevent HIV infection as well as the standard daily PrEP pill. About 4,390 people at risk of HIV will be randomly assigned to receive either the monthly pill or daily Truvada …
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
Village health workers lead new HIV prevention effort in lesotho
Prevention CancelledThis study tests a new program where trained village health workers use tablet-based tools to provide HIV prevention services, including PrEP and emergency PEP, to people at high risk in rural Lesotho. About 380 participants will be enrolled to see if this approach increases mont…
Sponsor: University Hospital, Basel, Switzerland • Aim: Prevention
Last updated Sep 18, 2026 00:00 UTC
-
Aspirin shows promise in blocking ovarian cancer for High-Risk women
Prevention OngoingThis study tests whether taking aspirin can prevent ovarian cancer in women with BRCA1 or BRCA2 gene mutations, who are at high risk. About 117 participants will take either aspirin or a placebo daily for up to 2 years before their scheduled risk-reducing surgery. Researchers wil…
Phase 2 • Sponsor: Canadian Cancer Trials Group • Aim: Prevention
Last updated Sep 18, 2026 00:00 UTC
-
Can diet and exercise programs cut cancer risk? new study tests lifestyle changes
Prevention OngoingThis study tests different programs to help people at high risk for cancer (such as those with BRCA or Lynch syndrome) or cancer survivors increase their physical activity and eat healthier. The goal is to see which programs work best to reduce cancer risk. About 337 participants…
Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated Sep 18, 2026 00:00 UTC
-
Can cutting alcohol help stop HIV? vietnam trial tests clinic strategies
Prevention OngoingThis study looks at how to best help HIV clinics in Vietnam offer a short alcohol counseling program to patients who drink heavily. The goal is to reduce risky drinking and lower the chance of spreading HIV. Over 3,200 people living with HIV and clinic staff are taking part to se…
Sponsor: University of North Carolina, Chapel Hill • Aim: Prevention
Last updated Sep 16, 2026 00:00 UTC
-
New drug aims to stop dangerous gut infection from returning
Prevention OngoingThis study tests an experimental drug called LMN-201 to see if it can prevent C. difficile infection from coming back after standard antibiotic treatment. About 375 adults with a recent C. diff infection will receive either LMN-201 or a placebo. The main goal is to see if more pe…
Phase 2/3 • Sponsor: Lumen Bioscience, Inc. • Aim: Prevention
Last updated Sep 13, 2026 00:00 UTC
-
Banking on health: savings accounts may cut HIV risk in kenyan men
Prevention OngoingThis study tests whether offering lottery-based rewards for saving money can help Kenyan men reduce behaviors that raise their risk for HIV and other STIs. About 1,500 men aged 18-39 who drink alcohol and have paid for sex in the past will be split into two groups. One group gets…
Sponsor: University of Pennsylvania • Aim: Prevention
Last updated Sep 12, 2026 00:00 UTC
-
Eye drops may shield the cornea after cataract surgery
Prevention By invitation onlyResearchers are testing whether netarsudil eye drops can protect the cornea in people with Fuchs endothelial corneal dystrophy and glaucoma who have cataract surgery. The study enrolls 50 adults aged 40 to 90. Participants use either netarsudil or a placebo drop daily for four we…
Sponsor: University Hospital Dubrava • Aim: Prevention
Last updated Sep 11, 2026 00:00 UTC
-
Can a common heart drug stop rhythm problems after a Stroke-Related heart repair?
Prevention OngoingResearchers test whether flecainide, an antiarrhythmic drug, can prevent atrial arrhythmias in adults who have a patent foramen ovale (PFO) closed after a cryptogenic stroke. Participants receive flecainide or standard care for 3 to 6 months. An insertable cardiac monitor records…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Prevention
Last updated Sep 11, 2026 00:00 UTC
-
Early Gluten-Free diet or probiotics: a new strategy to prevent celiac disease?
Prevention OngoingResearchers are testing whether a gluten-free diet during the first three years of life, or daily probiotic supplements, can prevent celiac disease in children with a high genetic risk. The trial enrolls infants before they start eating gluten and randomly assigns them to one of …
Sponsor: Lund University • Aim: Prevention
Last updated Sep 10, 2026 00:00 UTC
-
A simple fix for myopia could change education for millions
Prevention OngoingThis trial tests whether giving free glasses to short-sighted middle school children in rural China helps more of them continue to academic high school. Researchers will randomly assign 111 schools to either provide glasses with teacher support or just give prescriptions. The mai…
Sponsor: Queen's University, Belfast • Aim: Prevention
Last updated Sep 10, 2026 00:00 UTC
-
Could exercise be the key to stronger bones in women?
Prevention OngoingThis trial tests whether a year of twice-weekly supervised exercise can improve bone mineral density in women. Researchers will measure bone density and blood markers linked to bone turnover. The goal is to see if regular physical activity can help prevent osteoporosis and relate…
Sponsor: Poznan University of Physical Education • Aim: Prevention
Last updated Sep 06, 2026 00:00 UTC
-
Could 10 minutes of daily mindfulness shield children from anxiety?
Prevention OngoingThis trial tests whether 5-10 minutes of daily mindfulness and compassion training in school can prevent anxiety and depression in children aged 6-16. About 1,750 pupils will take part, with some classes doing the training for 10 weeks and others not. Researchers will track menta…
Sponsor: Lund University • Aim: Prevention
Last updated Sep 05, 2026 00:00 UTC
-
500,000-person study aims to close diabetes screening gaps with tailored outreach
Prevention By invitation onlyThis study tests whether sending personalized screening invitations based on a person's race, ethnicity, and diabetes risk, plus offering phone navigation for those who don't respond, leads to more people getting tested for diabetes compared to generic invitations or usual care. …
Sponsor: University of Texas Southwestern Medical Center • Aim: Prevention
Last updated Sep 04, 2026 00:00 UTC
-
Brain and body boost: Dual-Task training may ease Parkinson's symptoms
Symptom relief By invitation onlyThis study tests whether adding cognitive training to balance and gait exercises helps people with Parkinson's disease improve their balance, walking, and thinking. Fourteen participants will undergo 12 sessions of combined training. The goal is to see if this approach eases move…
Sponsor: Gazi University • Aim: Symptom relief
Last updated Sep 21, 2026 20:00 UTC
-
Can an arthritis drug help cystic fibrosis lungs?
Symptom relief OngoingResearchers are testing whether anakinra, a drug that blocks inflammation, can improve lung function in people with cystic fibrosis. The trial enrolls about 52 participants aged 12 and older who receive daily injections of anakinra or a placebo for 28 days, then switch to the oth…
Phase 2 • Sponsor: Heidelberg University • Aim: Symptom relief
Last updated Sep 21, 2026 20:00 UTC
-
Spinal cord stimulation put to the test for Parkinson's freezing of gait
Symptom relief OngoingFreezing of gait is a disabling symptom of Parkinson's disease that often does not respond well to current treatments. Researchers are testing whether spinal cord stimulation, a device-based therapy already used for chronic pain, can reduce these freezing episodes. In this trial,…
Phase 2 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Symptom relief
Last updated Sep 21, 2026 20:00 UTC
-
Can a vibrating platform steady the wobbly joints of hypermobility?
Symptom relief OngoingResearchers are testing whether adding whole-body vibration to a standard exercise program improves balance and reduces pain in women with hypermobility spectrum disorder. Thirty women aged 18 to 45 who have had musculoskeletal pain for at least three months join either a supervi…
Sponsor: Gökalp Arif Utkugün • Aim: Symptom relief
Last updated Sep 21, 2026 20:00 UTC
-
Hands-On therapy put to the test for spine and jaw pain
Symptom relief By invitation onlyResearchers at Poznan University of Physical Education are studying whether physiotherapy and osteopathic techniques ease pain in the neck, lower back, and jaw. The trial enrolls 300 adults aged 20 to 40 who have a recent episode of neck or lower back pain lasting no more than si…
Sponsor: Poznan University of Physical Education • Aim: Symptom relief
Last updated Sep 21, 2026 20:00 UTC
-
Suture device may get heart patients walking sooner after leg vein procedures
Symptom relief By invitation onlyResearchers are testing whether a suture-based closure device helps patients recover faster after heart procedures that use a large tube placed in the femoral vein. The trial enrolls adults undergoing procedures such as atrial fibrillation ablation, leadless pacemaker insertion, …
Sponsor: Ewha Womans University Mokdong Hospital • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a video-based therapy tame tough behaviors in kids with rare genetic disorders?
Symptom relief OngoingThis study tests a virtual behavioral therapy (Functional Behavioral Training) for children aged 2-12 with genetic syndromes like Fragile X, Angelman, or Rett syndrome who have challenging behaviors. The therapy teaches parents how to identify what triggers problem behaviors and …
Sponsor: Rush University Medical Center • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Hidden braces aim to straighten tilted back molars
Symptom relief CancelledResearchers at Hanoi Medical University are studying whether small lingual appliances can correct an excessive Curve of Wilson at the lower second molars in people already wearing labial fixed braces. The trial uses a split-mouth design: one side of the mouth receives the auxilia…
Sponsor: Hanoi Medical University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Giving Parkinson's patients a say may boost their Brain's ability to learn movement
Symptom relief OngoingPeople with Parkinson's disease often struggle with motivation and motor learning, which can limit rehabilitation. This trial compares two ways of practicing a joystick task: one group chooses the stories and exercises they practice, while the other follows the same routine witho…
Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Dental implant showdown: titanium vs nano-carbon frames
Symptom relief OngoingResearchers compare two materials for the framework that supports a full set of replacement teeth on four dental implants in the lower jaw. Ten completely edentulous patients receive either a titanium or a nano-carbon fiber-reinforced CAD/CAM framework. The study tracks gum healt…
Sponsor: Mansoura University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can red light therapy boost your hormones?
Symptom relief CancelledResearchers are testing whether an 8-week course of Joovv infrared light therapy can change hormone levels in healthy adults. The study measures testosterone in men and estrogen, progesterone, and thyroid-stimulating hormone in women, along with general wellness. Participants use…
Sponsor: ProofPilot • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a personalized mix of nerve stimulation and therapy rewire the brain for better mental health?
Symptom relief OngoingResearchers are testing a personalized, non-drug treatment for adults with ongoing depression, anxiety, trauma-related symptoms, sleep problems, attention difficulties, or substance-use concerns. Instead of assigning treatment by diagnosis alone, the study selects approaches base…
Sponsor: Tactical Mind Research Coalition, Inc. • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Custom-Shaped nose splint may ease recovery for kids after cleft lip surgery
Symptom relief By invitation onlyChildren who have cleft lip repair or nasal scar release often wear a nasal splint while healing. This trial compares the standard hollow, cone-shaped conformer with a new one shaped to match the inside of the nose. Each child tries both types, switching halfway through, and pare…
Phase 2 • Sponsor: East Tennessee Children's Hospital • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Splint showdown: which brace best beats trigger finger?
Symptom relief By invitation onlyResearchers compare two splint designs to see which better eases trigger finger, a condition where a finger catches or locks when bent. Thirty people with trigger finger wear either a metacarpophalangeal joint blocking splint or a relative motion extension splint. The study measu…
Sponsor: Waikato Hospital • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Could a new cycling style help MS patients walk better and feel less tired?
Symptom relief OngoingThis study tests a new type of cycling called eccentric cycling for people with multiple sclerosis. Researchers want to see if it improves muscle strength, walking ability, fatigue, and quality of life better than standard cycling. Sixty adults with MS who can walk independently …
Sponsor: University of Liege • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Vibrating wristband put to the test for Parkinson's relief
Symptom relief OngoingResearchers are exploring whether a wrist-worn device called the Beechband, which delivers intermittent vibrations, can change movement symptoms and everyday experiences for people with Parkinson's disease. About 60 participants will be randomly assigned to wear the device for ei…
Sponsor: University of Exeter • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Eye workouts may steady Parkinson's patients
Symptom relief By invitation onlyThis study tests whether a program of supervised eye exercises can improve physical function, balance, and reduce fear of falling in people with Parkinson's disease. 34 participants will do progressive eye movements and gaze stabilization exercises in a clinic setting. The goal i…
Sponsor: Pardis Specialized Wellness Institute • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
New VR device aims to make exercise fun for kids with muscle weakness
Symptom relief OngoingThis early study tests a virtual reality rehabilitation device for children with spinal muscular atrophy (SMA), a genetic condition that causes progressive muscle weakness. The device uses games, muscle sensors, and a grip-strength ball to make home exercises more engaging. Resea…
Sponsor: University of Oxford • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Can yoga calm anxious minds and sharpen focus?
Symptom relief By invitation onlyResearchers at the University of Illinois at Chicago are studying which parts of a yoga practice affect anxiety, mood, and thinking in highly anxious college women. About 60 participants complete four sessions that include yoga postures, breathwork, meditation, or watching a yoga…
Sponsor: University of Illinois at Chicago • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
New hope for Parkinson's pain: drug trial targets tough-to-treat discomfort
Symptom relief OngoingThis study tests whether a drug called crisugabalin can safely reduce pain in people with Parkinson's disease who have a type of pain called nociplastic pain. About 166 adults will take either the drug or a placebo twice a day for 12 weeks. Researchers will measure pain levels an…
Phase 4 • Sponsor: Guangdong Provincial People's Hospital • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Could a liver drug help people see color? tiny trial launched
Symptom relief PausedThis early-phase trial tests whether an FDA-approved drug called glycerol phenylbutyrate (PBA) can improve vision in people with a rare form of color blindness caused by mutations in the ATF6 gene. Only 2 participants are enrolled, and they will take PBA three times daily while t…
Early phase 1 • Sponsor: Columbia University • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Can better sleep ease Crohn's symptoms? new study investigates
Symptom relief OngoingThis study looks at whether treating insomnia can help people with Crohn's disease feel better, including reducing pain and inflammation. About 83 adults with mild to moderate Crohn's and insomnia will receive a remote sleep treatment. The main goal is to see if the approach is p…
Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Tailored therapy for kids with OCD: a new hope?
Symptom relief OngoingThis study at Johns Hopkins tests whether using personalized mobile health assessments can improve cognitive-behavioral therapy (CBT) for children aged 8-17 with obsessive-compulsive disorder (OCD). 30 participants will receive either standard CBT or CBT guided by their own sympt…
Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
App plus therapist sessions may help WTC responders with PTSD
Symptom relief By invitation onlyThis study tests whether a mobile app called PTSD Coach, with or without brief clinician support, can reduce PTSD, anxiety, depression, and sleep problems in World Trade Center responders living in Florida. About 120 English- or Spanish-speaking responders will be randomly assign…
Sponsor: Florida International University • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Can a Nine-Week group program help blood cancer patients grow through trauma?
Symptom relief OngoingResearchers in Greece are testing a nine-session group program called TRANSFORM for people who have finished treatment for blood cancers such as leukemia, lymphoma, and myeloma. The program combines teaching, reflection, coping exercises, and mindfulness to see whether it can spa…
Sponsor: University of West Attica • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Could a simple drink help clear confusion in hospitalized seniors?
Symptom relief OngoingThis study tests a proprietary amino acid drink given twice daily for up to 4 days to older adults (60+) hospitalized with infections who have delirium. 20 participants get the drink, 20 get standard care, and 20 non-delirious controls are observed. The goal is to see if the drin…
Sponsor: University of Arkansas • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Can a phone app and a health worker ease depression in rural HIV care?
Symptom relief OngoingResearchers are adapting a mobile health program that pairs the PositiveLinks app with video counseling from a community health worker. The study enrolls 60 people in Florida who have HIV and mild to moderate anxiety or depression. Participants receive either the enhanced counsel…
Sponsor: University of Florida • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Can learning positive emotions stop burnout for violence prevention staff?
Symptom relief OngoingThis study tests a program called FOREST that teaches positive emotion skills to staff working in gun violence prevention. The goal is to reduce burnout, anxiety, and depression, and improve well-being and job retention. One hundred employees from UCAN in Chicago will take part o…
Sponsor: Northwestern University • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Can VR and a tiny ear ZAP ease shoulder pain and anxiety?
Symptom relief CancelledThis study combines virtual reality with a gentle electrical pulse on the ear (called taVNS) to help people with chronic shoulder pain who are waiting for surgery. The goal is to see if this drug-free approach can reduce pain, anxiety, and depression. Only 10 people will take par…
Sponsor: East Kent Hospitals University NHS Foundation Trust • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Can a home Brain-Training program ease Parkinson's memory woes?
Symptom relief OngoingThis pilot study tests whether a home-based program called HOBSCOTCH, originally designed for epilepsy, can be adapted for people with Parkinson's disease. Ten participants will work one-on-one with a coach in nine virtual sessions to learn problem-solving strategies and memory a…
Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Can hula dancing ease Parkinson's symptoms?
Symptom relief By invitation onlyResearchers at the University of Hawaii are studying whether a weekly hula class can improve quality of life, well-being, balance, and motor symptoms in people with Parkinson's disease. The trial enrolls 40 adults with idiopathic Parkinson's disease who can attend in-person sessi…
Sponsor: University of Hawaii • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Can a daily pill quiet the spinning of vertigo?
Symptom relief CancelledResearchers are testing an experimental oral tablet called APSLXR in people with Meniere's disease or vertigo of vestibular origin. The main goal is to check whether the drug is safe when taken once a day for 60 days. A small group will also have blood tests to see how the body p…
Phase 1 • Sponsor: Apsen Farmaceutica S.A. • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Can brain stimulation be tuned to improve sleep in Parkinson's?
Symptom relief OngoingThis trial tests whether adjusting deep brain stimulation (DBS) settings specifically for sleep can improve sleep quality in people with Parkinson's disease. Participants already use an adaptive DBS system that responds to brain signals. Researchers will compare three different s…
Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
AI-Powered online therapy aims to ease depression and anxiety
Symptom relief OngoingThis study tests whether an online problem-solving therapy, matched to a person's specific symptoms using machine learning, can reduce depression and anxiety better than usual care. About 380 adults with moderate symptoms will take part. The goal is to create a precise, scalable …
Sponsor: Wuhan Mental Health Centre • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Magic mushroom compound tested for OCD in early trial
Symptom relief OngoingThis early-phase study at Johns Hopkins University is testing whether psilocybin, the active compound in magic mushrooms, can safely help people with obsessive-compulsive disorder (OCD). Thirty-five adults with moderate to severe OCD who have already tried other treatments will r…
Early phase 1 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Exercise may ease IBD symptoms in children, new study hopes to prove
Symptom relief OngoingThis study explores whether physical activity and fitness can reduce inflammation and improve quality of life in children aged 6 to 17 with Crohn's disease or ulcerative colitis. Researchers will track 100 participants over time and test a 12-week supervised exercise program. The…
Sponsor: Universidad Complutense de Madrid • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Can a simple care program boost mood in epilepsy patients?
Symptom relief OngoingThis study tests whether a 24-week collaborative care program can improve quality of life for adults with epilepsy who also have anxiety or depression. The program includes regular check-in calls and expert recommendations from a psychiatrist and neurologist. Researchers will com…
Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Laughing gas takes on the needle: could a simple breath ease one of Medicine's most uncomfortable procedures?
Symptom relief OngoingThis study investigates whether breathing a 50:50 mix of nitrous oxide (laughing gas) and oxygen can reduce pain and anxiety during insertion of a central venous catheter, a common but uncomfortable procedure. Adults aged 18 to 65 who have never used nitrous oxide will be randoml…
Sponsor: Institute for Oncology and Radiology of Serbia • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Can gentle touch therapy calm Parkinson's tremors?
Symptom relief By invitation onlyThis trial tests whether CranioSacral therapy, a gentle manual therapy applied to the feet, diaphragm, neck, and skull, can reduce tremors and improve movement precision in people with Parkinson's disease. Five participants will receive 90-minute sessions twice a month for three …
Sponsor: Zia, Al Raza • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Personalized brain maps could make Parkinson's stimulation more precise
Symptom relief By invitation onlyThis study tests whether using advanced brain imaging to guide deep brain stimulation (DBS) can better control tremor in people with Parkinson's disease while avoiding side effects like involuntary movements. Twenty adults who already have DBS implants will have their stimulation…
Sponsor: Duke University • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Oxygen chamber treatment tested for long COVID fatigue relief
Symptom relief OngoingThis study is testing whether hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) can improve symptoms like fatigue and brain fog in people with post-COVID syndrome. About 40 adults with long COVID will receive the treatment. The main goal is to see if a la…
Sponsor: Sunnybrook Health Sciences Centre • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Can online family therapy ease childhood anxiety and OCD?
Symptom relief OngoingThis study compares two low-intensity family treatments for children aged 7-13 with anxiety or obsessive-compulsive disorder (OCD): internet-delivered cognitive behavioral therapy (CBT) and a parent-led reading program. Both are delivered via telehealth and compared to a relaxati…
Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Spinal zaps and exercise may boost walking after injury
Symptom relief OngoingThis study tests whether combining motor skill training with a non-invasive spinal stimulation can improve walking, balance, and strength while reducing muscle spasticity in people with incomplete spinal cord injury. Twenty-eight participants will do a series of standing exercise…
Sponsor: Shepherd Center, Atlanta GA • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
New coaching program aims to help young cancer survivors connect with friends
Symptom relief OngoingThis study tests a communication coaching program for adolescent and young adult cancer survivors (ages 18-35) who have finished treatment at least a year ago. Participants complete online sessions and AI coaching to improve how they talk with peers. The goal is to see if the pro…
Sponsor: Milton S. Hershey Medical Center • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Promising drug may ease painful genital psoriasis
Symptom relief OngoingThis study tests an injected drug called tildrakizumab for people with moderate to severe genital psoriasis. About 206 adults will receive either the drug or a placebo to see if it clears skin and reduces itching. The goal is to improve comfort and quality of life in this sensiti…
Phase 3 • Sponsor: Sun Pharmaceutical Industries Limited • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Power training shows promise for Parkinson's slowness
Symptom relief OngoingThis study looked at whether a special exercise program focusing on muscle power (moving quickly) could help people with Parkinson's disease who have slow movements (bradykinesia). Twenty-two adults with Parkinson's were split into two groups: one did standard exercises, and the …
Sponsor: Federal University of Health Science of Porto Alegre • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Gut bacteria may hold clues to dozens of diseases
Knowledge-focused PausedResearchers are sequencing the gut microbiomes of people with a wide range of conditions, from autism and Alzheimer's to Crohn's disease and multiple sclerosis, to see whether bacterial patterns differ by disease. The study also enrolls healthy participants for comparison. By mat…
Sponsor: ProgenaBiome • Aim: Knowledge-focused
Last updated Sep 21, 2026 20:00 UTC
-
Sickle cell clues to diabetes risk hidden in DNA
Knowledge-focused OngoingResearchers at the University of Illinois at Chicago are studying how the bodies of adults with sickle cell disease handle glucose, cholesterol, and triglycerides, and why some of them develop diabetes. The study enrolls 75 adults over 35 with major sickle cell genotypes. Partici…
Sponsor: University of Illinois at Chicago • Aim: Knowledge-focused
Last updated Sep 21, 2026 20:00 UTC
-
Massive study digs into why some kids outgrow food allergies
Knowledge-focused By invitation onlyThis research study aims to understand why some people develop food allergies and others outgrow them. Researchers at Children's Hospital of Philadelphia will collect blood samples from 5,300 people (ages 1 month to 65 years) with and without food allergies to study immune cells …
Sponsor: Children's Hospital of Philadelphia • Aim: Knowledge-focused
Last updated Sep 21, 2026 20:00 UTC
-
Why do some people with severe obesity develop kidney disease?
Knowledge-focused OngoingResearchers are following 480 adults with severe obesity in Guadeloupe and French Polynesia for five years. The study checks whether having metabolic syndrome, a cluster of conditions like high blood pressure and high blood sugar, raises the risk of chronic kidney disease, heart …
Sponsor: Clinique • Aim: Knowledge-focused
Last updated Sep 21, 2026 20:00 UTC
-
Dystonia study seeks to map Disease's Real-World toll
Knowledge-focused OngoingThis study watches 200 people with isolated dystonia (affecting more than one body part) to see how the condition changes over time. Researchers will collect information on symptoms, daily activities, pain, and social life using standard rating scales. No experimental treatment i…
Sponsor: Vima Therapeutics • Aim: Knowledge-focused
Last updated Sep 21, 2026 20:00 UTC
-
Heart drug entresto may double as diabetes treatment, small study hints
Knowledge-focused CancelledThis study tests whether a heart failure medication called Entresto (sacubitril/valsartan) can boost a natural hormone that helps control blood sugar after meals. Researchers will give the drug or a comparison drug (valsartan) to 25 adults with type 2 diabetes or prediabetes and …
Phase 3 • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Sep 21, 2026 20:00 UTC
-
Can a One-Page guide spark better End-of-Life talks for dementia patients?
Knowledge-focused OngoingThis study tests a short guide called the 'Jumpstart Guide' to help doctors have better conversations with dementia patients and their families about healthcare goals. Over 1,800 patients and their caregivers are taking part. Researchers will compare whether those whose doctors u…
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Sep 21, 2026 20:00 UTC
-
Tiny hearts, tiny kidneys: new study monitors oxygen in preterm infants
Knowledge-focused OngoingThis study looks at oxygen levels in the kidneys of premature babies born before 32 weeks who have a heart condition called patent ductus arteriosus (PDA). Researchers want to see how kidney oxygen relates to the severity of the heart condition and whether it can predict kidney i…
Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Sep 21, 2026 20:00 UTC
-
Can brain recordings make DBS safer for thinking and memory?
Knowledge-focused OngoingThis study tracks brain activity in 160 Parkinson's patients who have or will receive deep brain stimulation (DBS). Researchers record signals from the brain during memory tasks, with the stimulator on and off, to find patterns linked to cognitive side effects. The goal is to ide…
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Sep 21, 2026 20:00 UTC
-
Can phone coaching help hispanic seniors beat sedentary habits?
Knowledge-focused OngoingThis study enrolls 130 Hispanic adults aged 55+ without dementia to see if a 12-week phone-based coaching program helps them become more active. Participants are randomly assigned to either the coaching program or a general brain health education group. The goal is to see if the …
Sponsor: Kaiser Permanente • Aim: Knowledge-focused
Last updated Sep 21, 2026 20:00 UTC
-
Scientists track eye disease progression over five years
Knowledge-focused OngoingThis study follows 110 people who previously took part in the AREDS or AREDS2 trials to see how age-related macular degeneration (AMD) and cataracts change over time. Participants get a yearly eye exam, including vision tests and eye photos, and may give a blood sample. The goal …
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Heart hole or stroke trigger? global registry tracks who gets closure and what happens next
Knowledge-focused OngoingResearchers are running an international registry to follow adults who had an ischemic stroke or transient ischemic attack and also have a patent foramen ovale, a small opening between the upper chambers of the heart. The registry collects real-world information on how these pati…
Sponsor: Luciano A. Sposato • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
10-Year NF1 study aims to unlock secrets of rare genetic disorder
Knowledge-focused OngoingThis natural history study follows 259 children, adolescents, and adults with Neurofibromatosis Type 1 (NF1) for up to 10 years. Researchers will track tumor growth, monitor quality of life, and perform genetic testing to better understand how the disease changes over time. The g…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Pompe disease study aims to clear path for gene therapy
Knowledge-focused OngoingThis study looks at people with late-onset Pompe disease to measure antibodies against a virus used in gene therapy and against the standard enzyme replacement therapy. It also checks for biomarkers in blood and urine. About 119 teenagers and adults will give samples over 2 years…
Sponsor: Astellas Gene Therapies • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New tools aim to speed up FSHD drug trials
Knowledge-focused OngoingThis study involves 324 adults with facioscapulohumeral muscular dystrophy (FSHD) across 14 international sites. Researchers are testing two new measurement tools—a functional test called FSHD-COM and a muscle-impedance device—to better track disease progression. The goal is to i…
Sponsor: University of Kansas Medical Center • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Blood samples sought to unlock secrets of sickle cell disease
Knowledge-focused By invitation onlyThis study collects blood and other samples from people with sickle cell disease and healthy volunteers to help researchers understand how inflammation affects blood vessels. Up to 2,000 adults aged 18 and older will take part. The samples will be used in lab tests to support fut…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Austrian study maps how lung, heart, and metabolic health interact
Knowledge-focused OngoingThe Austrian LEAD study follows a large group of people to understand how lung, heart, and metabolic health change over time. Researchers measure lung function with spirometry and track body composition and metabolic markers. By observing this group, they aim to learn how these c…
Sponsor: Ludwig Boltzmann Institute for Lung Health • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can a new questionnaire capture life with hereditary amyloidosis?
Knowledge-focused CancelledResearchers in Argentina are developing and testing a self-administered questionnaire to measure how hereditary transthyretin amyloidosis affects patients' physical, emotional, and social quality of life. The study includes input from neurologists, a cardiologist, a psychologist,…
Sponsor: Hospital General de Niños Pedro de Elizalde • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Scientists dig into tissue samples to unravel lung scarring mystery
Knowledge-focused OngoingThis study collects and analyzes blood, DNA, and tissue samples from 315 adults with pulmonary fibrosis, their relatives, and healthy volunteers. The goal is to learn more about the disease's causes, not to test a new treatment. Researchers hope the findings will guide future the…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Could an algorithm replace the eye chart? a trial puts software-guided refraction to the test.
Knowledge-focused OngoingThis study tests whether a software program called the Vision Trainer can guide eyeglass prescriptions as accurately as the traditional manual method performed by trained examiners. Adults with myopia (nearsightedness) will have their prescriptions determined both ways, and the r…
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
NIH launches major study to unravel mysteries of rare genetic diseases
Knowledge-focused By invitation onlyThis study aims to identify genetic, biochemical, and clinical factors linked to disease severity in people with Gaucher disease and other lysosomal storage disorders. Researchers will evaluate up to 1,000 participants, including patients, carriers, and healthy controls, to bette…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Eye disease progression under the microscope: 3-Year study launched
Knowledge-focused OngoingThis study follows 400 people with intermediate age-related macular degeneration (AMD) for about 3 years. Researchers watch how the disease advances to more severe stages and test if measuring the loss of light-sensing cells in the eye can be a useful way to track the disease. No…
Sponsor: Genentech, Inc. • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
New program aims to boost genetic testing in cancer families
Knowledge-focused OngoingThis study looks at whether a website and a genetic family navigator can help more relatives of people with hereditary cancer get genetic testing. About 205 participants will use the online hub and work with a navigator to learn about their cancer risk. The goal is to see if this…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Tiny study probes Mitapivat's inner workings in sickle cell
Knowledge-focused OngoingThis observational study will examine how the drug mitapivat changes red blood cells in 6 people with sickle cell disease. Researchers will measure oxygen binding and cell survival markers from blood samples and muscle oxygen tests. The goal is to understand the drug's effects, n…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists hunt for hidden genes behind family blood cancer clusters
Knowledge-focused OngoingThis long-term study looks at people and families with a higher chance of developing blood or lymph node cancers like leukemia or lymphoma. Researchers collect medical histories, genetic samples, and sometimes perform exams to find inherited genes or environmental triggers. The g…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Which Mini-Implant size works best? new study aims to find out
Knowledge-focused OngoingThis study tests two different diameters (1.6mm and 2mm) of mini-implants placed in the upper jaw to support orthodontic tooth movement. Twenty people receiving braces will get one size on each side of their mouth. Researchers will measure how stable the implants are, how much pa…
Sponsor: University of Baghdad • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Researchers hunt for muscle clues in rare dystrophy
Knowledge-focused OngoingThis pilot study looks at biomarkers in the blood of people with fragile sarcolemmal muscular dystrophy, a condition that makes muscle membranes weak. Researchers will collect blood samples at rest and after exercise during four 5-day hospital stays. The goal is to better underst…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Tongue-Tie surgery in infancy: do feeding, speech, and sleep problems return later?
Knowledge-focused By invitation onlyResearchers at the University of Alberta are following 500 children who had a tongue-tie release as infants to see how often they later develop feeding, speech, dental, or sleep and breathing problems that need further evaluation. Tongue tie is a shortened band under the tongue t…
Sponsor: University of Alberta • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists track families to uncover Cancer's hidden causes
Knowledge-focused OngoingThis study looks at people and families who have a high risk of cancer to learn what genes and environmental factors might increase that risk. Over 5,000 participants are followed over time with questionnaires, medical records, and optional genetic testing. No treatment is given,…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
NIH launches massive sample collection to unlock disease secrets
Knowledge-focused By invitation onlyThis study collects blood, bone marrow, urine, and tissue samples from up to 6,000 people with solid tumors, blood cancers, or non-cancerous blood disorders, as well as from their healthy family members who are stem cell donors. The samples are stored and used in research to bett…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
No-Needle glucose monitor could spot pregnancy risks early
Knowledge-focused CancelledThis pilot study is testing a device called LabClasp that measures blood sugar without needles. Researchers want to see if regular, non-invasive glucose checks can help predict gestational diabetes and preeclampsia in pregnant women. The study plans to enroll 100 women with at le…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
500-Person study aims to crack the code of personalized weight loss
Knowledge-focused By invitation onlyThis study follows 500 obese adults to see how different factors like diet, exercise, stress, and sleep affect weight loss. Researchers collect blood tests, measurements, and questionnaires at the start and during follow-up. The goal is to find patterns that could lead to more pe…
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Can a wearable track your bladder health? new study aims to find out
Knowledge-focused OngoingThis study explores whether wearable bladder devices can help monitor and treat bladder problems in postpartum women and men after prostate surgery. Researchers will test a wearable ultrasound and an intravaginal exerciser to see if they provide useful data for patients and thera…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Spanish databases used to map a rare liver disease
Knowledge-focused OngoingPrimary biliary cholangitis is a rare liver disease that slowly damages the bile ducts and can lead to cirrhosis or a liver transplant. Researchers are studying anonymised health records from about 3,000 adults in four Spanish databases to estimate how many people have the diseas…
Sponsor: Fundacio Privada Mon Clinic Barcelona • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Can wearable sensors and walking tests reliably track nerve damage?
Knowledge-focused OngoingResearchers are checking whether tests of muscle strength, walking, balance, and fine motor skills give consistent results in people with polyneuropathy. About 520 adults with various forms of nerve damage, plus healthy volunteers, take part. Participants complete physical tests,…
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
New study hopes to outsmart pancreatic cancer by gathering clues
Knowledge-focused OngoingThis study collects health information and test results from 317 people at high risk for pancreatic cancer, including those with cysts, genetic syndromes, or other risk factors. Researchers aim to build a database to find better ways to detect the disease early or prevent it. No …
Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
New study tracks rare disease SCA7 to uncover clues for future treatments
Knowledge-focused OngoingThis study follows 25 people with spinocerebellar ataxia type 7 (SCA7) for up to 5 years to learn how the disease changes vision, coordination, and thinking. Participants will have yearly eye exams, brain scans, and neurological tests. No treatment is given; the goal is to gather…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
2000 volunteers needed to test Next-Gen MRI scans
Knowledge-focused OngoingThis study aims to test new MRI sequences in 2000 adults (patients and healthy volunteers) to see if they can produce better images than current methods. Participants will undergo additional scans during their regular MRI. The goal is to improve diagnostic capabilities without di…
Phase 4 • Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Thousands tracked after carpal tunnel surgery: does new device deliver?
Knowledge-focused OngoingThis study is tracking 2000 adults with carpal tunnel syndrome who are having surgery to release the nerve. The surgery uses a special device called UltraGuideCTR, which is guided by ultrasound. Researchers are collecting real-world data on symptoms and hand function for up to 24…
Sponsor: Sonex Health, Inc. • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
New study peers inside lungs to uncover cystic fibrosis damage
Knowledge-focused OngoingThis study aims to understand how small blood vessels in the lungs change as cystic fibrosis (CF) lung disease progresses. Researchers will use imaging to measure blood vessel volume in 86 people with CF aged 5-21. The goal is to learn more about the disease, not to test a new tr…
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Sweetener showdown: erythritol vs. aspartame on blood clot risk
Knowledge-focused OngoingThis study looks at how the common sweetener erythritol affects blood clotting and blood vessel health compared to aspartame. Twenty-four adults with a BMI of 27 or higher will drink beverages sweetened with each sweetener for two weeks. Researchers will measure markers of platel…
Sponsor: University of California, Davis • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Researchers track rare thyroid cancer to uncover its secrets
Knowledge-focused OngoingThis study follows children and adults with medullary thyroid cancer (MTC), often linked to a genetic condition called MEN2. Researchers will track how the cancer grows and affects health over time using regular check-ups, blood tests, and imaging. No treatment is given, but part…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Sound waves may replace X-Rays for dental implant timing
Knowledge-focused OngoingThis study at the University of Michigan is testing whether ultrasound can monitor bone graft healing after tooth extraction, potentially replacing more invasive scans. About 140 adults needing a tooth extraction and bone graft for a future dental implant will have their healing …
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Dialysis showdown: which method protects heart and bones best?
Knowledge-focused OngoingThis study looks at how different types of dialysis affect heart health, bone metabolism, inflammation, and quality of life in people with end-stage kidney disease. Researchers will compare patients on hemodialysis, continuous ambulatory peritoneal dialysis, and automated periton…
Sponsor: Gazi University • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Swedish survey asks: what shapes daily life with chiari malformation?
Knowledge-focused By invitation onlyResearchers at Karolinska Institutet are surveying adults in Sweden who have Chiari malformation type 1, a condition where part of the brain pushes into the spinal canal. The study asks how these patients rate their health-related quality of life compared with the general Swedish…
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
University health survey aims to uncover hidden struggles of students and staff
Knowledge-focused OngoingThis study is a health check for students at Constructor University Bremen and employees at HAW-Hamburg. Researchers will use surveys and interviews to measure loneliness, anxiety, stress, and health habits. The goal is to understand what affects wellbeing and find ways to suppor…
Sponsor: Jacobs University Bremen gGmbH • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
One bite of gluten: scientists track the immune alarm in celiac disease
Knowledge-focused By invitation onlyResearchers at Boston Children's Hospital are studying how the immune system reacts after a single oral dose of gluten powder. The study includes people with celiac disease and healthy controls, all of whom follow a gluten-free diet before the test. By measuring blood levels of i…
Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
New registry tracks SMA in chinese kids to unlock Real-World insights
Knowledge-focused OngoingThis study is a registry that collects information on up to 600 children in China with spinal muscular atrophy (SMA). It aims to describe how the disease progresses and how treatments are used in everyday medical practice. The study does not test a new drug but gathers data to be…
Sponsor: Biogen • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Lupus care under the microscope: new registry tracks Real-World treatment in kazakhstan
Knowledge-focused OngoingThis study is a registry that will follow about 500 adults with lupus (SLE) in Kazakhstan to see how the disease behaves and how doctors treat it in everyday practice. Researchers will look at disease activity, organ damage, and which medications are used. No new treatments are b…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Balloon in the aorta: a new hope for cardiac arrest?
Knowledge-focused OngoingThis study tests whether a balloon device, called REBOA, can be safely used by emergency teams outside a hospital to improve blood flow in people whose heart has stopped (cardiac arrest). The balloon is inserted into the main artery and inflated to redirect blood to the heart and…
Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
100,000 volunteers join digital brain health study to catch dementia early
Knowledge-focused By invitation onlyThis observational study will enroll 100,000 people over age 45 to track early signs of Alzheimer's and Parkinson's using smartphone-based tests, genetic data, and brain scans. Researchers aim to develop better ways to identify who is at risk before symptoms worsen. Participants …
Sponsor: Greece 2021 Committee • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Hidden brain damage in young sickle cell patients: new study aims to find answers
Knowledge-focused OngoingThis study looks at how common strokes and silent brain injuries are in young adults (ages 16-25) with sickle cell anemia, especially in Nigeria where the disease is widespread. Researchers will use brain scans and blood tests to check for damage and identify risk factors like hi…
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Drain or no drain? new study aims to improve Kids' neck surgery recovery
Knowledge-focused By invitation onlyThis study looks at children having surgery to remove a common neck lump called a thyroglossal duct cyst. Some kids will have a small drain placed during surgery, and some will not. The goal is to see if using a drain reduces problems like infection, fluid buildup, or the need fo…
Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
A chest belt that maps the lungs could help breathing machines fit better
Knowledge-focused By invitation onlyResearchers at the Royal Free Hospital are testing whether electrical impedance tomography (EIT), a radiation-free imaging method that uses a chest belt and low-level electrical currents, can help clinicians adjust breathing machines for people with chronic respiratory failure. T…
Sponsor: Royal Free Hospital NHS Foundation Trust • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Braces breakthrough? study tests which wire moves teeth faster
Knowledge-focused By invitation onlyThis study compares stainless steel and titanium-molybdenum alloy wires for moving canine teeth in people with braces. Sixteen participants will have one type of wire on each side of their upper jaw to see which works better. The goal is to find out which wire moves teeth more ef…
Sponsor: Tanzila Rafique • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
New cage for neck surgery under observation – no treatment given
Knowledge-focused OngoingThis study watches 24 adults who are getting standard neck fusion surgery with a special device called the BEE HA cage. The goal is to see how well the cage helps with pain and function over time. No new treatment is tested—just careful tracking of normal surgery results.
Sponsor: Invibio Ltd • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Blood test could spot hidden tumors in NF1 patients
Knowledge-focused By invitation onlyThis study aims to find blood-based biomarkers that signal the presence and size of plexiform neurofibromas in people with Neurofibromatosis type 1 (NF1). Researchers will collect blood samples and use whole-body MRI to compare biomarker levels in 200 participants with different …
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Gene study aims to unlock secrets of kidney disease
Knowledge-focused OngoingThis study looks at 401 people with autosomal dominant polycystic kidney disease (ADPKD) to see how different versions of the PKD1 gene relate to patient traits like age at diagnosis and body size. Researchers are not testing any treatment—they are simply gathering information to…
Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Massive study aims to unlock secrets of childhood nerve and muscle diseases
Knowledge-focused OngoingThis long-term study looks at children and adults with inherited nerve and muscle disorders that start early in life, like muscular dystrophy. Researchers will track symptoms over time and collect genetic samples from affected individuals, their family members, and healthy volunt…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
New study aims to unlock the secrets of a rising lung disease
Knowledge-focused OngoingThis study follows 320 Chinese adults with non-cystic fibrosis bronchiectasis (a chronic lung condition causing cough and infections) and some healthy volunteers for 12 months. Researchers will collect lung function tests, blood samples, and imaging to identify biomarkers and dis…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Researchers watch and learn: PH1 study tracks 207 patients over time
Knowledge-focused OngoingThis study follows 207 people with primary hyperoxaluria type 1 (PH1), a rare kidney disease, to see how the condition progresses over time. Researchers are also checking the long-term safety and real-world effectiveness of the drug lumasiran. Participants are not given any new t…
Sponsor: Alnylam Pharmaceuticals • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
New study aims to uncover hidden heart risks in women
Knowledge-focused OngoingThis pilot study is testing whether it's possible to run a larger study that focuses on heart disease in women. Researchers will gather information from 176 women aged 25-55 in Ontario who have had certain female-specific health issues like pre-eclampsia, gestational diabetes, or…
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Gut fungi linked to lung trouble in HIV patients
Knowledge-focused OngoingThis study looks at whether fungi moving from the gut into the blood can cause inflammation and worsen lung function in people with HIV. Researchers will measure a fungal marker called BDG in blood and urine, and track lung health over three years. The goal is to better understan…
Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Can imaging and monitoring unlock the hidden dangers of mitral valve prolapse?
Knowledge-focused OngoingThis study enrolls adults aged 60 and older who are already participating in a larger trial comparing two ways to repair a leaky mitral valve. Researchers will use heart MRI scans, wearable heart monitors, and tissue samples to look for scarring in the heart muscle and abnormal h…
Sponsor: Annetine Gelijns • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Parkinson's drug may impact gum disease risk
Knowledge-focused OngoingThis study looks at whether the Parkinson's drug Levodopa-Benserazide affects gum health and inflammation. Researchers will measure gum health and saliva markers in 136 people, including Parkinson's patients with and without gum disease, and healthy controls. The goal is to under…
Sponsor: Saglik Bilimleri Universitesi • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
New registry aims to unlock secrets of rare bone disease HPP
Knowledge-focused By invitation onlyThis long-term study follows over 1,500 people of all ages with hypophosphatasia (HPP), a rare bone disease. Researchers will collect information on how the disease progresses, its impact on daily life, and the long-term safety and effectiveness of the treatment asfotase alfa. Th…
Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
New study aims to sharpen tools for tracking becker muscular dystrophy
Knowledge-focused OngoingThis 24-month observational study will follow 80 people with Becker muscular dystrophy (BMD) to better understand how the disease progresses. Researchers will measure muscle strength, walking speed, breathing, and heart function using standard tests. The goal is to identify which…
Sponsor: Virginia Commonwealth University • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Florida launches brain disease biobank to fuel future discoveries
Knowledge-focused OngoingThis study is creating a statewide collection of blood samples and medical information from people with various brain blood vessel diseases, such as stroke and dementia. The goal is to build a resource that scientists can use in future research to better understand and potentiall…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
New study tracks early signs of pompe disease in newborns
Knowledge-focused OngoingThis study follows 20 newborns and children diagnosed with late-onset Pompe disease through newborn screening. Researchers will track their health for up to 4.5 years to document early muscle and joint symptoms, biomarkers, and quality of life. The goal is to learn when to start …
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
A Baby's fidgets may reveal brain health: study tests early warning signs
Knowledge-focused OngoingResearchers are studying the natural fidgety movements of infants to see if these movements can help predict cerebral palsy and other developmental issues. They will follow 350 babies, including healthy full-term infants and those at higher risk due to medical conditions, trackin…
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Can we predict who will have memory issues after brain surgery for Parkinson's?
Knowledge-focused OngoingThis study follows 30 people with Parkinson's disease who are scheduled to receive deep brain stimulation (DBS). Researchers will test whether brain scans, thinking tests, and other measures can predict who might experience cognitive decline after surgery. Participants complete t…
Sponsor: Charite University, Berlin, Germany • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Diet soda showdown: stevia vs. aspartame – which is better for your gut?
Knowledge-focused OngoingThis study looked at 41 healthy adults who regularly drink sugary sodas. Researchers replaced their sugary drinks with either stevia-sweetened or aspartame-sweetened beverages for 10 weeks. The goal was to see how these alternatives affect metabolism and gut bacteria. The results…
Sponsor: Laval University • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Could a spin class recharge the Parkinson's brain?
Knowledge-focused OngoingThis study asks whether exercise can improve how the brain produces and uses energy in people with Parkinson's disease. Researchers will scan participants' brains before and after a six-month program of supervised aerobic cycling, comparing them to a group doing stretching or yog…
Sponsor: Pacific Parkinson's Research Centre • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
New study analyzes Odevixibat's impact on rare liver disease outcomes
Knowledge-focused OngoingThis study looks at a rare liver disease called PFIC, which causes severe itching and liver damage. Researchers compare patients who took the drug odevixibat to those who did not, using data from past studies and a patient registry. The goal is to see if odevixibat helps avoid li…
Sponsor: Ipsen • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
HIV patients over 75: are too many pills harming healthy aging?
Knowledge-focused PausedThis study looks at people with HIV who are 75 or older and take at least five medications regularly. Researchers want to understand how this 'polypharmacy' affects healthy aging and quality of life. They will interview participants and review their medical records to count medic…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Watching the brain and body during OCD triggers: a window into the disorder
Knowledge-focused OngoingResearchers at Baylor College of Medicine are studying how brain activity and visible behaviors, like head movements, facial expressions, and voice tone, change during tasks that trigger OCD symptoms. Adults with OCD and healthy volunteers will complete tasks that provoke distres…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Massive Real-World study tracks roche eye drugs in 6,000 patients
Knowledge-focused OngoingThis study is collecting long-term, real-world data from about 6,000 adults being treated with Roche eye medications (Faricimab or the Port Delivery System with Ranibizumab) for conditions like wet age-related macular degeneration and diabetic macular edema. The goal is to unders…
Sponsor: Hoffmann-La Roche • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
50,000 samples to unlock secrets of hereditary tumors
Knowledge-focused CancelledThis study will collect blood and tumor tissue from up to 50,000 adults with hereditary or genetic-linked cancers. Researchers will use these samples to create lab-grown tumor models, like mini-tumors, to study how these cancers work and test new treatments. The goal is to better…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
New eye imaging could reveal hidden clues to vision loss
Knowledge-focused By invitation onlyThis study explores whether combining three eye-imaging techniques can reveal how structural damage in the retina relates to vision loss in people with geographic atrophy, a form of age-related macular degeneration. Researchers will use OCT scans, ultra-high-resolution AOSLO imag…
Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Scientists track rare eye disease to prepare for future treatments
Knowledge-focused OngoingThis study follows 68 people aged 12 and older who have ABCA4 gene mutations, which can cause vision loss from diseases like Stargardt disease. Over 10 years, researchers will collect blood and skin samples and perform detailed eye exams to understand how the disease progresses. …
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Smart sensors could revolutionize rett syndrome monitoring
Knowledge-focused OngoingThis study tests whether wearable biosensors can accurately track symptoms like heart rate, breathing, sleep, and movement in people with Rett syndrome. Up to 30 participants will use the devices at home for 9 weeks and also undergo one overnight sleep study in the clinic. The go…
Sponsor: Rett Syndrome Research Trust • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Tiny study probes gene link to kidney stones
Knowledge-focused By invitation onlyThis study looks at how a specific gene change (AGXT) affects oxalate production in people who have had calcium oxalate kidney stones. Four participants will eat a low-oxalate diet for five days and then receive an intravenous dose of glycolate. Researchers will measure oxalate l…
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
VHL tumor growth study aims to predict which lesions need surgery
Knowledge-focused OngoingThis 5-year study follows 250 people with von Hippel-Lindau disease who have brain or spinal cord tumors. Researchers use regular MRI scans and blood tests to see how fast tumors grow and what factors like hormones might affect growth. The goal is to better understand which tumor…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Scientists collect skin cells to pave way for future immune disease cures
Knowledge-focused By invitation onlyThis study collects small skin samples from people with primary immunodeficiency or immune regulation disorders, as well as from healthy volunteers. Researchers will use these cells to create cell lines for laboratory research. The goal is to better understand immune diseases and…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC